index	sentence	label
0	@PROTEIN$ enables Ca2+-activated @COMPOUND$-conductance in epithelia.	1
1	Calcium-dependent Cl (-) currents were activated by @COMPOUND$ in HEK293 cells expressing @PROTEIN$.	0
2	Calcium-dependent @COMPOUND$ (-) currents were activated by ATP in HEK293 cells expressing @PROTEIN$.	0
3	The absorption spectrum of the @PROTEIN$ enzyme showed an absorption peak at 425nm indicating that the enzyme had iron-@COMPOUND$ clusters.	1
4	Based on these validities we identified alterations in the @PROTEIN$ gene in the CA1 and amygdala regions, specifically in exposed PTSD-like rats, which were normalized after treatment with @COMPOUND$.	1
5	@COMPOUND$ inhalation induced: (1) a transient bronchial inflammation, dominated by neutrophils; (2) a neutrophilia of the blood that persisted for up to 4 weeks; (3) a transient increased bronchial reactivity, and (4) a significant increase in @PROTEIN$ activity in the BALF.	1
6	Short-term withdrawal of @COMPOUND$ induces endothelial dysfunction in patients with coronary artery disease: a dose-response effect dependent on endothelial @PROTEIN$.	1
7	The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against DMBA-induced changes in levels of some (superoxide dismutase (SOD), catalase (@PROTEIN$), @COMPOUND$ peroxidase (GPx), and glutathione reductase (GR) activities and total glutathione (GSH), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0
8	The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against @COMPOUND$-induced changes in levels of some (superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GPx), and glutathione reductase (GR) activities and total glutathione (GSH), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0
9	The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against DMBA-induced changes in levels of some (superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione peroxidase (GPx), and glutathione reductase (GR) activities and total glutathione (@COMPOUND$), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0
10	The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against DMBA-induced changes in levels of some (superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GPx), and glutathione reductase (GR) activities and total glutathione (@COMPOUND$), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0
11	The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against DMBA-induced changes in levels of some (superoxide dismutase (@PROTEIN$), catalase (CAT), @COMPOUND$ peroxidase (GPx), and glutathione reductase (GR) activities and total glutathione (GSH), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0
12	The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against @COMPOUND$-induced changes in levels of some (superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), and @PROTEIN$ (GR) activities and total glutathione (GSH), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0
13	The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against DMBA-induced changes in levels of some (@PROTEIN$ (SOD), catalase (CAT), glutathione peroxidase (GPx), and glutathione reductase (GR) activities and total glutathione (@COMPOUND$), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0
14	The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against @COMPOUND$-induced changes in levels of some (superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione peroxidase (GPx), and glutathione reductase (GR) activities and total glutathione (GSH), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0
15	The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against @COMPOUND$-induced changes in levels of some (@PROTEIN$ (SOD), catalase (CAT), glutathione peroxidase (GPx), and glutathione reductase (GR) activities and total glutathione (GSH), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0
16	The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against @COMPOUND$-induced changes in levels of some (superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione peroxidase (GPx), and glutathione reductase (GR) activities and total glutathione (GSH), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0
17	The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against DMBA-induced changes in levels of some (superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione peroxidase (GPx), and glutathione reductase (GR) activities and total glutathione (@COMPOUND$), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0
18	The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against DMBA-induced changes in levels of some (@PROTEIN$ (SOD), catalase (CAT), @COMPOUND$ peroxidase (GPx), and glutathione reductase (GR) activities and total glutathione (GSH), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0
19	The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against DMBA-induced changes in levels of some (superoxide dismutase (SOD), catalase (CAT), @COMPOUND$ peroxidase (GPx), and @PROTEIN$ (GR) activities and total glutathione (GSH), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0
20	The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against DMBA-induced changes in levels of some (superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione peroxidase (GPx), and glutathione reductase (GR) activities and total glutathione (@COMPOUND$), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0
21	The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against DMBA-induced changes in levels of some (superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), and @PROTEIN$ (GR) activities and total glutathione (@COMPOUND$), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0
22	The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against @COMPOUND$-induced changes in levels of some (superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione peroxidase (GPx), and glutathione reductase (GR) activities and total glutathione (GSH), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0
23	The protective effects of novel synthetic organoselenium compounds (Se I and Se II) against DMBA-induced changes in levels of some (superoxide dismutase (SOD), @PROTEIN$ (CAT), @COMPOUND$ peroxidase (GPx), and glutathione reductase (GR) activities and total glutathione (GSH), malonedialdehyde (MDA)) parameters in rat lung and kidney were investigated.	0
24	To test this hypothesis, we investigated whether disruption of the oxytocin gene (@PROTEIN$-/-) made mice more susceptible to the psychosis-related effects of amphetamine (Amp), @COMPOUND$ (Apo) and phencyclidine (PCP).	0
25	To test this hypothesis, we investigated whether disruption of the @PROTEIN$ gene (Oxt-/-) made mice more susceptible to the psychosis-related effects of amphetamine (@COMPOUND$), apomorphine (Apo) and phencyclidine (PCP).	0
26	To test this hypothesis, we investigated whether disruption of the @PROTEIN$ gene (Oxt-/-) made mice more susceptible to the psychosis-related effects of amphetamine (Amp), @COMPOUND$ (Apo) and phencyclidine (PCP).	0
27	To test this hypothesis, we investigated whether disruption of the @PROTEIN$ gene (Oxt-/-) made mice more susceptible to the psychosis-related effects of @COMPOUND$ (Amp), apomorphine (Apo) and phencyclidine (PCP).	0
28	To test this hypothesis, we investigated whether disruption of the oxytocin gene (@PROTEIN$-/-) made mice more susceptible to the psychosis-related effects of @COMPOUND$ (Amp), apomorphine (Apo) and phencyclidine (PCP).	0
29	To test this hypothesis, we investigated whether disruption of the oxytocin gene (@PROTEIN$-/-) made mice more susceptible to the psychosis-related effects of amphetamine (Amp), apomorphine (Apo) and @COMPOUND$ (PCP).	0
30	To test this hypothesis, we investigated whether disruption of the @PROTEIN$ gene (Oxt-/-) made mice more susceptible to the psychosis-related effects of amphetamine (Amp), apomorphine (Apo) and @COMPOUND$ (PCP).	0
31	To test this hypothesis, we investigated whether disruption of the oxytocin gene (@PROTEIN$-/-) made mice more susceptible to the psychosis-related effects of amphetamine (@COMPOUND$), apomorphine (Apo) and phencyclidine (PCP).	0
32	RT(2) Profiler PCR Array was used to identify differentially expressed genes in Dox and/or @COMPOUND$ treatment groups, based on significance of results 4 genes were selected: MDR1, Bcl2, P53 and @PROTEIN$ D1.	1
33	RT(2) Profiler PCR Array was used to identify differentially expressed genes in Dox and/or @COMPOUND$ treatment groups, based on significance of results 4 genes were selected: MDR1, Bcl2, @PROTEIN$ and Cyclin D1.	1
34	RT(2) Profiler PCR Array was used to identify differentially expressed genes in Dox and/or @COMPOUND$ treatment groups, based on significance of results 4 genes were selected: @PROTEIN$, Bcl2, P53 and Cyclin D1.	1
35	RT(2) Profiler PCR Array was used to identify differentially expressed genes in Dox and/or @COMPOUND$ treatment groups, based on significance of results 4 genes were selected: MDR1, @PROTEIN$, P53 and Cyclin D1.	1
36	The array and western blotting showed that Bcl2 and @PROTEIN$ D1 expression were down regulated; P53 expression was not affected while MDR1 was over expressed by combination of @COMPOUND$ with Dox.	1
37	The array and western blotting showed that Bcl2 and Cyclin D1 expression were down regulated; P53 expression was not affected while @PROTEIN$ was over expressed by combination of @COMPOUND$ with Dox.	1
38	The array and western blotting showed that Bcl2 and Cyclin D1 expression were down regulated; @PROTEIN$ expression was not affected while MDR1 was over expressed by combination of @COMPOUND$ with Dox.	0
39	The array and western blotting showed that @PROTEIN$ and Cyclin D1 expression were down regulated; P53 expression was not affected while MDR1 was over expressed by combination of @COMPOUND$ with Dox.	1
40	In conclusion, @COMPOUND$ chemosensitizes resistant breast cancer cells to Dox cytotoxicity by down regulating expression of Bcl2 and @PROTEIN$ D1, augmenting caspase 3 activity as well as inducing cell cycle block in G(1) and S phases.	1
41	In conclusion, @COMPOUND$ chemosensitizes resistant breast cancer cells to Dox cytotoxicity by down regulating expression of @PROTEIN$ and Cyclin D1, augmenting caspase 3 activity as well as inducing cell cycle block in G(1) and S phases.	1
42	Neither @PROTEIN$ nor ATP altered production of reactive oxygen intermediates (ROI) or reactive @COMPOUND$ intermediates (RNI) by bovine monocytes.	0
43	Neither @PROTEIN$ nor ATP altered production of reactive @COMPOUND$ intermediates (ROI) or reactive nitrogen intermediates (RNI) by bovine monocytes.	0
44	Neither @PROTEIN$ nor @COMPOUND$ altered production of reactive oxygen intermediates (ROI) or reactive nitrogen intermediates (RNI) by bovine monocytes.	0
45	@PROTEIN$ did not show any effect in long photoperiod but decreased proliferation by stimulating @COMPOUND$ in short photoperiod.	1
46	Surprisingly, a deletion of the @PROTEIN$ gene affected not only insoluble @COMPOUND$) reduction, which requires pili, but also soluble Fe(III) reduction, which, in contrast, does not require pili.	1
47	Systemic administration of @PROTEIN$ vesicle elevates tumor tissue @COMPOUND$ tension and modifies tumor response to irradiation.	1
48	The effect of the polymorphism is non-conservative and results in a glutamine to @COMPOUND$ change (Gln460Arg), which is likely to affect @PROTEIN$ dimerization and protein-protein interactions.	1
49	The effect of the polymorphism is non-conservative and results in a @COMPOUND$ to arginine change (Gln460Arg), which is likely to affect @PROTEIN$ dimerization and protein-protein interactions.	1
50	Increased @COMPOUND$ tone and decreased @PROTEIN$ concentrations may also contribute to reduced GH levels.	0
51	Furthermore, it has also been reported that @COMPOUND$-treated pigs significantly increase mean arterial blood pressure compared with controls and that the decrease in @PROTEIN$ synthesis and release contributes to the elevated blood pressure.	1
52	Since @COMPOUND$ is metabolized through @PROTEIN$, we genotyped six genetic polymorphisms previously described in poor metabolizers but could not confirm these pharmacogenetic bases in this case.	1
53	"To determine if response to endocrine therapy of breast cancer can be predicted by either a metabolic ""flare reaction"" detected by positron emission tomography (PET) with 2-((18)F)-fluoro-@COMPOUND$ (FDG), induced by an estradiol challenge, or by @PROTEIN$ (ER) status, determined by PET with the estrogen analog 16alpha-((18)F)fluoroestradiol-17beta (FES)."	0
54	"To determine if response to endocrine therapy of breast cancer can be predicted by either a metabolic ""flare reaction"" detected by positron emission tomography (PET) with 2-((18)F)-fluoro-2-deoxyglucose (FDG), induced by an @COMPOUND$ challenge, or by @PROTEIN$ (ER) status, determined by PET with the estrogen analog 16alpha-((18)F)fluoroestradiol-17beta (FES)."	0
55	In present study, we investigated the combined effect of @COMPOUND$ and baicalin on pancreatic damage and pancreatitis associated lung injury, as well as tissue @PROTEIN$ expression in the setting of AP.	0
56	In present study, we investigated the combined effect of emodin and @COMPOUND$ on pancreatic damage and pancreatitis associated lung injury, as well as tissue @PROTEIN$ expression in the setting of AP.	0
57	The results showed that combination of emodin and @COMPOUND$ significantly reduced serum amylase, tumor necrosis factor-alpha and interleukin-6, attenuated pancreatic and pulmonary damage, also suppressed @PROTEIN$ expression in pancreas and lung.	1
58	The results showed that combination of @COMPOUND$ and baicalin significantly reduced serum amylase, tumor necrosis factor-alpha and interleukin-6, attenuated pancreatic and pulmonary damage, also suppressed @PROTEIN$ expression in pancreas and lung.	1
59	The results showed that combination of @COMPOUND$ and baicalin significantly reduced serum amylase, @PROTEIN$-alpha and interleukin-6, attenuated pancreatic and pulmonary damage, also suppressed TLR4 expression in pancreas and lung.	1
60	The results showed that combination of emodin and @COMPOUND$ significantly reduced serum amylase, tumor necrosis factor-alpha and @PROTEIN$, attenuated pancreatic and pulmonary damage, also suppressed TLR4 expression in pancreas and lung.	1
61	The results showed that combination of @COMPOUND$ and baicalin significantly reduced serum amylase, tumor necrosis factor-alpha and @PROTEIN$, attenuated pancreatic and pulmonary damage, also suppressed TLR4 expression in pancreas and lung.	1
62	The results showed that combination of emodin and @COMPOUND$ significantly reduced serum amylase, @PROTEIN$-alpha and interleukin-6, attenuated pancreatic and pulmonary damage, also suppressed TLR4 expression in pancreas and lung.	1
63	The anti-neoplastic drug @COMPOUND$ binds to @PROTEIN$ to prevent tumor cell division, promoting cell death.	1
64	In the current study, we knocked down @PROTEIN$ expression using cognate siRNA during low-dose @COMPOUND$ treatment to induce apoptosis in two human glioblastoma U138MG and U251MG cell lines.	1
65	The cells were treated with either 100 nM @COMPOUND$ or 100 nM Bcl-2 siRNA or both for 72 h. Immunofluorescent stainings for calpain and active caspase-3 showed increases in expression and co-localization of these @PROTEIN$ in apoptotic cells.	1
66	Our current study demonstrated that Bcl-2 siRNA significantly augmented @COMPOUND$ mediated apoptosis in different human glioblastoma cells through induction of @PROTEIN$ and caspase proteolytic activities.	1
67	Based on these findings, altered expression of @PROTEIN$ in most areas of the striatum suggests that widespread changes to the myelin structure could be associated with the adaptive changes following chronic @COMPOUND$ abuse.	1
68	No correlation was detected between serum @PROTEIN$ level and @COMPOUND$-25(OH)D3, which was under normal range in 60% of the patients.	0
69	The higher @PROTEIN$ levels in women was accompanied by higher serum levels of glucose, albumin, Ca, @COMPOUND$, Na and FT4.	1
70	The higher @PROTEIN$ levels in women was accompanied by higher serum levels of glucose, albumin, Ca, cholesterol, @COMPOUND$ and FT4.	1
71	The higher @PROTEIN$ levels in women was accompanied by higher serum levels of @COMPOUND$, albumin, Ca, cholesterol, Na and FT4.	1
72	Comparison of 50 patients with the lowest @PROTEIN$ levels (mean of 3.4ng/ml) to 50 patients with highest leptin levels (mean of 34ng/ml), did not indicate differences in both @COMPOUND$ and ICTP between these two populations in spite of the highly significant difference in leptin levels.	0
73	Indeed, treatment of cells with 1 muM @COMPOUND$ (ATRA) or 1 muM 13-cis retinoic acid (13-CRA) for 7 days induced astrocytic differentiation with upregulation of glial fibrillary @PROTEIN$ (GFAP) and down regulation of telomerase activity.	1
74	Indeed, treatment of cells with 1 muM all-trans @COMPOUND$ (ATRA) or 1 muM 13-cis retinoic acid (13-CRA) for 7 days induced astrocytic differentiation with upregulation of glial fibrillary acidic protein (@PROTEIN$) and down regulation of telomerase activity.	1
75	Indeed, treatment of cells with 1 muM @COMPOUND$ (ATRA) or 1 muM 13-cis retinoic acid (13-CRA) for 7 days induced astrocytic differentiation with upregulation of glial fibrillary acidic protein (@PROTEIN$) and down regulation of telomerase activity.	1
76	Indeed, treatment of cells with 1 muM all-trans retinoic acid (@COMPOUND$) or 1 muM 13-cis retinoic acid (13-CRA) for 7 days induced astrocytic differentiation with upregulation of glial fibrillary @PROTEIN$ (GFAP) and down regulation of telomerase activity.	1
77	Indeed, treatment of cells with 1 muM all-trans @COMPOUND$ (ATRA) or 1 muM 13-cis retinoic acid (13-CRA) for 7 days induced astrocytic differentiation with upregulation of glial fibrillary @PROTEIN$ (GFAP) and down regulation of telomerase activity.	1
78	Indeed, treatment of cells with 1 muM all-trans retinoic acid (@COMPOUND$) or 1 muM 13-cis retinoic acid (13-CRA) for 7 days induced astrocytic differentiation with upregulation of glial fibrillary acidic protein (@PROTEIN$) and down regulation of telomerase activity.	1
79	Wright staining and ApopTag assay showed, respectively, morphological and biochemical features of apoptosis in glioblastoma cells following exposure to 200 units/ml @PROTEIN$ for 48 h. Induction of differentiation was associated with decreases in levels of nuclear factor kappa B (NFkappaB), inducible @COMPOUND$ synthase (iNOS), and production of nitric oxide (NO) so as to increase sensitivity to IFN-gamma for apoptosis.	0
80	Wright staining and ApopTag assay showed, respectively, morphological and biochemical features of apoptosis in glioblastoma cells following exposure to 200 units/ml IFN-gamma for 48 h. Induction of differentiation was associated with decreases in levels of nuclear factor kappa B (NFkappaB), inducible @COMPOUND$ synthase (@PROTEIN$), and production of nitric oxide (NO) so as to increase sensitivity to IFN-gamma for apoptosis.	0
81	To investigate overnight variations in absolute values and patterns of cytokines including interleukin 6 (@PROTEIN$) and tumour necrosis factor alpha (TNFalpha) in rheumatoid arthritis (RA), and to relate any changes to those occurring in blood @COMPOUND$.	0
82	To investigate overnight variations in absolute values and patterns of cytokines including interleukin 6 (IL6) and tumour necrosis factor alpha (@PROTEIN$) in rheumatoid arthritis (RA), and to relate any changes to those occurring in blood @COMPOUND$.	0
83	To investigate overnight variations in absolute values and patterns of cytokines including @PROTEIN$ (IL6) and tumour necrosis factor alpha (TNFalpha) in rheumatoid arthritis (RA), and to relate any changes to those occurring in blood @COMPOUND$.	0
84	The net exercise-induced increase in 6-keto-PGF (1alpha) concentration, expressed as the difference between the end-exercise minus pre-exercise concentration positively correlated with VO(2max) (r=0.78, p=0.004) as well as with the net VO(2) increase at exhaustion (r=0.81, p=0.003), but not with other respiratory, cardiac, metabolic or inflammatory parameters of the exercise (minute ventilation, heart rate, plasma @COMPOUND$, IL-6 or @PROTEIN$ concentrations).	0
85	The net exercise-induced increase in 6-keto-PGF (1alpha) concentration, expressed as the difference between the end-exercise minus pre-exercise concentration positively correlated with VO(2max) (r=0.78, p=0.004) as well as with the net VO(2) increase at exhaustion (r=0.81, p=0.003), but not with other respiratory, cardiac, metabolic or inflammatory parameters of the exercise (minute ventilation, heart rate, plasma @COMPOUND$, @PROTEIN$ or TNF-alpha concentrations).	0
86	The net exercise-induced increase in 6-keto-@PROTEIN$ (1alpha) concentration, expressed as the difference between the end-exercise minus pre-exercise concentration positively correlated with VO(2max) (r=0.78, p=0.004) as well as with the net VO(2) increase at exhaustion (r=0.81, p=0.003), but not with other respiratory, cardiac, metabolic or inflammatory parameters of the exercise (minute ventilation, heart rate, plasma @COMPOUND$, IL-6 or TNF-alpha concentrations).	0
87	Of the compounds synthesized, @COMPOUND$, which has a primary amide at warhead region of the inhibitor most potently inhibited mu-@PROTEIN$ with an IC(50) value of 2.81+/-1.26 microM, which is ca.	1
88	Serine and cysteine @PROTEIN$ proved to be suitable tools for the production of amino acids and peptides conjugated to @COMPOUND$, whereas metalloproteases do not seem to be very qualified for accepting this nucleophile.	0
89	Activation of ErbB3, @PROTEIN$ and Erk is essential for growth of human breast cancer cell lines with acquired resistance to @COMPOUND$.	0
90	Treatment with the EGFR inhibitor @COMPOUND$ preferentially inhibited growth and reduced the S phase fraction in the resistant cell lines concomitant with inhibition of Erk and unaltered @PROTEIN$ activation.	0
91	@COMPOUND$ protects from hepatic reperfusion injury through inhibition of IKK and @PROTEIN$ pathways and modification of cell proliferation.	1
92	@COMPOUND$ significantly improved animal survival and decreased transaminase levels, the indices for necrosis, liver damage, leukocyte infiltration, and @PROTEIN$ expression.	1
93	At the same time, @COMPOUND$ reduced the expression of both @PROTEIN$ 0.05).	1
94	@COMPOUND$ is hepatoprotective most likely via mechanisms including inhibition of IKK and @PROTEIN$ pathways and regulation of cell proliferation.	1
95	Here, we examine the effect of resistin on @COMPOUND$ uptake in human trophoblast cells and we demonstrate that transplacental glucose transport is mediated by @PROTEIN$ (GLUT)-1.	1
96	ERK1 and 2 activation stimulated @PROTEIN$ synthesis and resulted in increase of placental @COMPOUND$ uptake.	1
97	@PROTEIN$ and 2 activation stimulated GLUT-1 synthesis and resulted in increase of placental @COMPOUND$ uptake.	1
98	High resistin levels (50-100 ng/ml) seem able to affect @COMPOUND$-uptake, presumably by decreasing the cell surface @PROTEIN$.	1
99	Replacement doses of hydrocortisone (HC) (10 mg/m2/day) failed to produce a feedback inhibition of @PROTEIN$ (ACTH), and @COMPOUND$ levels remained high.	0
100	Replacement doses of @COMPOUND$ (HC) (10 mg/m2/day) failed to produce a feedback inhibition of adrenocorticotropic hormone (@PROTEIN$), and testosterone levels remained high.	0
101	Replacement doses of hydrocortisone (HC) (10 mg/m2/day) failed to produce a feedback inhibition of adrenocorticotropic hormone (@PROTEIN$), and @COMPOUND$ levels remained high.	0
102	Replacement doses of @COMPOUND$ (HC) (10 mg/m2/day) failed to produce a feedback inhibition of @PROTEIN$ (ACTH), and testosterone levels remained high.	0
103	Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), glutathione-S-transferase (@PROTEIN$), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (@COMPOUND$) and total thiols.	0
104	Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), glutathione-S-transferase (@PROTEIN$), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, @COMPOUND$ (GSH) and total thiols.	0
105	@COMPOUND$ exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (GSH) and total thiols.	1
106	Cadmium exposure diminished the activities of enzymatic antioxidants, @PROTEIN$ (SOD), catalase (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (@COMPOUND$) and total thiols.	0
107	Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, @COMPOUND$ (GSH) and total thiols.	0
108	Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, @COMPOUND$ (GSH) and total thiols.	0
109	Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, @COMPOUND$ (GSH) and total thiols.	0
110	Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, @COMPOUND$ (GSH) and total thiols.	0
111	Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (@COMPOUND$) and total thiols.	0
112	@COMPOUND$ exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), glutathione-S-transferase (@PROTEIN$), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (GSH) and total thiols.	1
113	Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), glutathione-S-transferase (GST), @PROTEIN$ (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (@COMPOUND$) and total thiols.	0
114	@COMPOUND$ exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (@PROTEIN$) as well as non-enzymatic antioxidant, reduced glutathione (GSH) and total thiols.	1
115	Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (@COMPOUND$) and total thiols.	0
116	@COMPOUND$ exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (GSH) and total thiols.	1
117	Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), @PROTEIN$ (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (@COMPOUND$) and total thiols.	0
118	Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (@PROTEIN$) as well as non-enzymatic antioxidant, @COMPOUND$ (GSH) and total thiols.	0
119	Cadmium exposure diminished the activities of enzymatic antioxidants, @PROTEIN$ (SOD), catalase (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, @COMPOUND$ (GSH) and total thiols.	0
120	@COMPOUND$ exposure diminished the activities of enzymatic antioxidants, @PROTEIN$ (SOD), catalase (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (GSH) and total thiols.	1
121	Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), @PROTEIN$ (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, @COMPOUND$ (GSH) and total thiols.	0
122	@COMPOUND$ exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), glutathione-S-transferase (GST), @PROTEIN$ (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (GSH) and total thiols.	1
123	@COMPOUND$ exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), @PROTEIN$ (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (GSH) and total thiols.	1
124	Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (@COMPOUND$) and total thiols.	0
125	@COMPOUND$ exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (GSH) and total thiols.	1
126	Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), glutathione-S-transferase (GST), @PROTEIN$ (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, @COMPOUND$ (GSH) and total thiols.	0
127	@COMPOUND$ exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (GSH) and total thiols.	1
128	Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (G6PD) as well as non-enzymatic antioxidant, reduced glutathione (@COMPOUND$) and total thiols.	0
129	Cadmium exposure diminished the activities of enzymatic antioxidants, superoxide dismutase (SOD), catalase (CAT), glutathione-S-transferase (GST), glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate dehydrogenase (@PROTEIN$) as well as non-enzymatic antioxidant, reduced glutathione (@COMPOUND$) and total thiols.	0
130	On the other hand, the levels of oxidized glutathione (@COMPOUND$), lipid peroxidation, protein carbonylation, DNA fragmentation, concentration of superoxide radicals and activities of cytochrome P450 enzymes (@PROTEIN$ P450s) have been found to increase due to cadmium intoxication.	0
131	On the other hand, the levels of oxidized glutathione (GSSG), lipid peroxidation, protein carbonylation, DNA fragmentation, concentration of superoxide radicals and activities of cytochrome P450 enzymes (@PROTEIN$ P450s) have been found to increase due to @COMPOUND$ intoxication.	1
132	On the other hand, the levels of oxidized glutathione (@COMPOUND$), lipid peroxidation, protein carbonylation, DNA fragmentation, concentration of superoxide radicals and activities of @PROTEIN$ enzymes (CYP P450s) have been found to increase due to cadmium intoxication.	0
133	On the other hand, the levels of @COMPOUND$ (GSSG), lipid peroxidation, protein carbonylation, DNA fragmentation, concentration of superoxide radicals and activities of @PROTEIN$ enzymes (CYP P450s) have been found to increase due to cadmium intoxication.	0
134	On the other hand, the levels of oxidized glutathione (GSSG), lipid peroxidation, protein carbonylation, DNA fragmentation, concentration of superoxide radicals and activities of @PROTEIN$ enzymes (CYP P450s) have been found to increase due to @COMPOUND$ intoxication.	1
135	On the other hand, the levels of oxidized glutathione (GSSG), lipid peroxidation, protein carbonylation, DNA fragmentation, concentration of @COMPOUND$ radicals and activities of cytochrome P450 enzymes (@PROTEIN$ P450s) have been found to increase due to cadmium intoxication.	0
136	On the other hand, the levels of @COMPOUND$ (GSSG), lipid peroxidation, protein carbonylation, DNA fragmentation, concentration of superoxide radicals and activities of cytochrome P450 enzymes (@PROTEIN$ P450s) have been found to increase due to cadmium intoxication.	0
137	On the other hand, the levels of oxidized glutathione (GSSG), lipid peroxidation, protein carbonylation, DNA fragmentation, concentration of @COMPOUND$ radicals and activities of @PROTEIN$ enzymes (CYP P450s) have been found to increase due to cadmium intoxication.	0
138	The discovery of the PLN/@PROTEIN$ interaction therefore unveils an important new link between @COMPOUND$+) homeostasis and cell survival, with significant therapeutic potential.	0
139	The discovery of the @PROTEIN$/HAX-1 interaction therefore unveils an important new link between @COMPOUND$+) homeostasis and cell survival, with significant therapeutic potential.	0
140	Analysis of the protein domain features indicated typical conserved @COMPOUND$ residues containing a single whey acidic protein (@PROTEIN$) domain at the C-terminus.	0
141	Analysis of the protein domain features indicated typical conserved @COMPOUND$ residues containing a single @PROTEIN$ (WAP) domain at the C-terminus.	0
142	To get insight into the underlying mechanisms, we compared the ability of recombinant wild type and variant (D327N) @PROTEIN$ to influence @COMPOUND$ effects in MCF-7 breast cancer cells.	1
143	D327N @PROTEIN$ was more effective than wild type protein in inhibiting @COMPOUND$-induced cell proliferation and anti-apoptosis.	1
144	Our results suggest that @COMPOUND$)-induced changes in cytokine secretion by monocytes are diverse and may be influenced by Nrf2 but are not likely influenced by changes in whole-cell @PROTEIN$ levels.	1
145	Our results suggest that @COMPOUND$)-induced changes in cytokine secretion by monocytes are diverse and may be influenced by @PROTEIN$ but are not likely influenced by changes in whole-cell Trx1 levels.	1
146	The gene expressions of CYP1A1 and @PROTEIN$ in the placenta increased significantly in @COMPOUND$-treated groups on GD 15 and GD 18, but returned to the level similar to the corresponding control on GD 21.	1
147	The gene expressions of @PROTEIN$ and CYP2E1 in the placenta increased significantly in @COMPOUND$-treated groups on GD 15 and GD 18, but returned to the level similar to the corresponding control on GD 21.	1
148	In @COMPOUND$ group, there was a decrease of @PROTEIN$ expression on GD 15, GD 18, and GD 21, with the most significant decrease on GD 15.	1
149	The present study was designed to understand the effects of sublethal concentrations of @COMPOUND$ (DIC) on hematological constituent (red blood corpuscles, white blood corpuscles (WBC), mean cell volume, mean corpuscular hemoglobin, mean corpuscular hemoglobin concentration, platelet counts, hemoglobin and hematocrite levels) and serum damage marker enzymes (@PROTEIN$, alanin aminotransferase, alkaline phosphatase, and lactate dehydrogenase) in rats at subacute period under laboratory conditions.	0
150	The present study was designed to understand the effects of sublethal concentrations of @COMPOUND$ (DIC) on hematological constituent (red blood corpuscles, white blood corpuscles (WBC), mean cell volume, mean corpuscular hemoglobin, mean corpuscular hemoglobin concentration, platelet counts, hemoglobin and hematocrite levels) and serum damage marker enzymes (aspartate aminotransferase, alanin aminotransferase, @PROTEIN$, and lactate dehydrogenase) in rats at subacute period under laboratory conditions.	0
151	The present study was designed to understand the effects of sublethal concentrations of @COMPOUND$ (DIC) on hematological constituent (red blood corpuscles, white blood corpuscles (WBC), mean cell volume, mean corpuscular @PROTEIN$, mean corpuscular hemoglobin concentration, platelet counts, hemoglobin and hematocrite levels) and serum damage marker enzymes (aspartate aminotransferase, alanin aminotransferase, alkaline phosphatase, and lactate dehydrogenase) in rats at subacute period under laboratory conditions.	0
152	@COMPOUND$ is known to bind @PROTEIN$, beta1 integrin and focal adhesion kinase, members of focal contacts, multi-protein complexes that mediate cell adhesion to the extracellular matrix.	1
153	The recombinant protein exhibited high @PROTEIN$ activity and could catalyze the conversion of L:-Phe to @COMPOUND$.	0
154	Functional polymorphisms in the @PROTEIN$ and serotonin transporter genes, and depression and fatigue induced by interferon-alpha and @COMPOUND$ treatment.	1
155	She had a mutation in @PROTEIN$ gene consisting of an aminoacid change of Alanine to @COMPOUND$ in exon 5 (A382V).	1
156	She had a mutation in @PROTEIN$ gene consisting of an aminoacid change of @COMPOUND$ to Valine in exon 5 (A382V).	1
157	Decreased hepatic @PROTEIN$ secretion is correlated with reduced hepatic @COMPOUND$ production but is not associated with insulin resistance in patients with liver cirrhosis.	1
158	Decreased hepatic RBP4 secretion is correlated with reduced hepatic @COMPOUND$ production but is not associated with @PROTEIN$ resistance in patients with liver cirrhosis.	0
159	@COMPOUND$-induced growth suppression was associated with inactivation of downstream targets of mTOR, reduction in VEGF expression and microvessel density, inhibition of cell proliferation, up-regulation of p27 (Kip1) and down-regulation of p21 (@PROTEIN$/Waf1), Cdk-6, Cdk-2, Cdk-4, cdc-25C, cyclin B1 and c-Myc.	1
160	@COMPOUND$-induced growth suppression was associated with inactivation of downstream targets of mTOR, reduction in VEGF expression and microvessel density, inhibition of cell proliferation, up-regulation of @PROTEIN$ (Kip1) and down-regulation of p21 (Cip1/Waf1), Cdk-6, Cdk-2, Cdk-4, cdc-25C, cyclin B1 and c-Myc.	1
161	@COMPOUND$-induced growth suppression was associated with inactivation of downstream targets of mTOR, reduction in @PROTEIN$ expression and microvessel density, inhibition of cell proliferation, up-regulation of p27 (Kip1) and down-regulation of p21 (Cip1/Waf1), Cdk-6, Cdk-2, Cdk-4, cdc-25C, cyclin B1 and c-Myc.	1
162	@COMPOUND$-induced growth suppression was associated with inactivation of downstream targets of mTOR, reduction in VEGF expression and microvessel density, inhibition of cell proliferation, up-regulation of p27 (Kip1) and down-regulation of p21 (Cip1/Waf1), @PROTEIN$-6, Cdk-2, Cdk-4, cdc-25C, cyclin B1 and c-Myc.	1
163	@COMPOUND$-induced growth suppression was associated with inactivation of downstream targets of mTOR, reduction in VEGF expression and microvessel density, inhibition of cell proliferation, up-regulation of p27 (Kip1) and down-regulation of p21 (Cip1/Waf1), Cdk-6, Cdk-2, Cdk-4, cdc-25C, cyclin B1 and @PROTEIN$.	1
164	@COMPOUND$-induced growth suppression was associated with inactivation of downstream targets of mTOR, reduction in VEGF expression and microvessel density, inhibition of cell proliferation, up-regulation of p27 (Kip1) and down-regulation of p21 (Cip1/@PROTEIN$), Cdk-6, Cdk-2, Cdk-4, cdc-25C, cyclin B1 and c-Myc.	1
165	@COMPOUND$-induced growth suppression was associated with inactivation of downstream targets of mTOR, reduction in VEGF expression and microvessel density, inhibition of cell proliferation, up-regulation of p27 (Kip1) and down-regulation of @PROTEIN$ (Cip1/Waf1), Cdk-6, Cdk-2, Cdk-4, cdc-25C, cyclin B1 and c-Myc.	1
166	@COMPOUND$-induced growth suppression was associated with inactivation of downstream targets of mTOR, reduction in VEGF expression and microvessel density, inhibition of cell proliferation, up-regulation of p27 (Kip1) and down-regulation of p21 (Cip1/Waf1), Cdk-6, Cdk-2, Cdk-4, cdc-25C, @PROTEIN$ B1 and c-Myc.	1
167	@COMPOUND$-induced growth suppression was associated with inactivation of downstream targets of @PROTEIN$, reduction in VEGF expression and microvessel density, inhibition of cell proliferation, up-regulation of p27 (Kip1) and down-regulation of p21 (Cip1/Waf1), Cdk-6, Cdk-2, Cdk-4, cdc-25C, cyclin B1 and c-Myc.	1
168	However, @COMPOUND$ exhibited more potency in reducing @PROTEIN$ activity than methiocarb.	1
169	However, methomyl exhibited more potency in reducing @PROTEIN$ activity than @COMPOUND$.	1
170	Early and late 2-cell and late 4-cell stage embryos, prepared by in vitro fertilization (IVF), parthenogenetic activation (PG), and nuclear transfer of mouse embryonic fibroblast (MEF) and mouse HM1 embryonic stem cells (HM1), were processed for autoradiography following (3)H-@COMPOUND$ incubation (transcriptional activity), transmission electron microscopy (ultrastructure) and immunofluorescence (nucleolar proteins; upstream binding factor, UBF and @PROTEIN$, B23).	0
171	Early and late 2-cell and late 4-cell stage embryos, prepared by in vitro fertilization (IVF), parthenogenetic activation (PG), and nuclear transfer of mouse embryonic fibroblast (MEF) and mouse HM1 embryonic stem cells (HM1), were processed for autoradiography following (3)H-@COMPOUND$ incubation (transcriptional activity), transmission electron microscopy (ultrastructure) and immunofluorescence (nucleolar proteins; upstream binding factor, @PROTEIN$ and nucleophosmin, B23).	0
172	Early and late 2-cell and late 4-cell stage embryos, prepared by in vitro fertilization (IVF), parthenogenetic activation (PG), and nuclear transfer of mouse embryonic fibroblast (MEF) and mouse HM1 embryonic stem cells (HM1), were processed for autoradiography following (3)H-@COMPOUND$ incubation (transcriptional activity), transmission electron microscopy (ultrastructure) and immunofluorescence (nucleolar proteins; upstream binding factor, UBF and nucleophosmin, @PROTEIN$).	0
173	The results showed that portal pressure and IHR, hepatic levels of PIIINP, hepatic collagen deposition, mRNA expression of PIIIP-alpha1 and TGF-beta1, protein expression of @PROTEIN$ and TXS, and production of @COMPOUND$ in liver perfusates were significantly decreased in UDCA-treated BDL rats.	0
174	The results showed that portal pressure and IHR, hepatic levels of PIIINP, hepatic collagen deposition, mRNA expression of PIIIP-@PROTEIN$ and TGF-beta1, protein expression of iNOS and TXS, and production of @COMPOUND$ in liver perfusates were significantly decreased in UDCA-treated BDL rats.	0
175	The results showed that portal pressure and IHR, hepatic levels of PIIINP, hepatic collagen deposition, mRNA expression of PIIIP-alpha1 and @PROTEIN$, protein expression of iNOS and TXS, and production of @COMPOUND$ in liver perfusates were significantly decreased in UDCA-treated BDL rats.	0
176	The results showed that portal pressure and IHR, hepatic levels of PIIINP, hepatic collagen deposition, mRNA expression of PIIIP-alpha1 and TGF-beta1, protein expression of iNOS and @PROTEIN$, and production of @COMPOUND$ in liver perfusates were significantly decreased in UDCA-treated BDL rats.	0
177	The increased levels of hepatic @COMPOUND$ and @PROTEIN$ activity and decreased levels of TBARS and nitrite were also observed in UDCA-treated BDL rats.	0
178	Prior to @COMPOUND$ supplementation, exercise induced a significant decrease in @PROTEIN$ activity, EMF, vitamin E concentration and a significant increase in MDA concentration at t+1d.	0
179	Prior to vitamin E supplementation, exercise induced a significant decrease in @PROTEIN$ activity, @COMPOUND$, vitamin E concentration and a significant increase in MDA concentration at t+1d.	0
180	After a 10 week vitamin E supplementation period, these exercise-induced changes in @PROTEIN$ activity, @COMPOUND$ and MDA concentration were still significant in the control group, but not in the supplemented group.	0
181	After a 10 week @COMPOUND$ supplementation period, these exercise-induced changes in @PROTEIN$ activity, EMF and MDA concentration were still significant in the control group, but not in the supplemented group.	1
182	Using both physiologically achievable (2 microM) and supraphysiological (10 microM) concentrations, we investigated the ability of @COMPOUND$ and its predominant human metabolites to attenuate the expression of vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1) and monocyte chemoattractant protein-1 (MCP-1) in human umbilical artery smooth muscle cells (HUASMC) activated by tumor necrosis factor-alpha (@PROTEIN$).	0
183	Using both physiologically achievable (2 microM) and supraphysiological (10 microM) concentrations, we investigated the ability of @COMPOUND$ and its predominant human metabolites to attenuate the expression of vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1) and @PROTEIN$ (MCP-1) in human umbilical artery smooth muscle cells (HUASMC) activated by tumor necrosis factor-alpha (TNFalpha).	0
184	Using both physiologically achievable (2 microM) and supraphysiological (10 microM) concentrations, we investigated the ability of @COMPOUND$ and its predominant human metabolites to attenuate the expression of vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1) and monocyte chemoattractant protein-1 (MCP-1) in human umbilical artery smooth muscle cells (HUASMC) activated by @PROTEIN$-alpha (TNFalpha).	0
185	Using both physiologically achievable (2 microM) and supraphysiological (10 microM) concentrations, we investigated the ability of @COMPOUND$ and its predominant human metabolites to attenuate the expression of vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (@PROTEIN$) and monocyte chemoattractant protein-1 (MCP-1) in human umbilical artery smooth muscle cells (HUASMC) activated by tumor necrosis factor-alpha (TNFalpha).	0
186	Using both physiologically achievable (2 microM) and supraphysiological (10 microM) concentrations, we investigated the ability of @COMPOUND$ and its predominant human metabolites to attenuate the expression of vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1) and monocyte chemoattractant protein-1 (@PROTEIN$) in human umbilical artery smooth muscle cells (HUASMC) activated by tumor necrosis factor-alpha (TNFalpha).	0
187	Using both physiologically achievable (2 microM) and supraphysiological (10 microM) concentrations, we investigated the ability of @COMPOUND$ and its predominant human metabolites to attenuate the expression of vascular cell adhesion molecule-1 (@PROTEIN$), intercellular adhesion molecule-1 (ICAM-1) and monocyte chemoattractant protein-1 (MCP-1) in human umbilical artery smooth muscle cells (HUASMC) activated by tumor necrosis factor-alpha (TNFalpha).	0
188	@COMPOUND$ was able to reduce @PROTEIN$-induced upregulation of VCAM-1, ICAM-1 and MCP-1 at both the protein and transcript (mRNA) level in HUASMC.	1
189	@COMPOUND$ was able to reduce TNFalpha-induced upregulation of VCAM-1, @PROTEIN$ and MCP-1 at both the protein and transcript (mRNA) level in HUASMC.	1
190	@COMPOUND$ was able to reduce TNFalpha-induced upregulation of VCAM-1, ICAM-1 and @PROTEIN$ at both the protein and transcript (mRNA) level in HUASMC.	1
191	@COMPOUND$ was able to reduce TNFalpha-induced upregulation of @PROTEIN$, ICAM-1 and MCP-1 at both the protein and transcript (mRNA) level in HUASMC.	1
192	However the quercetin metabolites, @COMPOUND$, quercetin 3-glucuronide and 3'-methylquercetin 3-glucuronide, had no effect on @PROTEIN$-induced up regulation of adhesion molecule or chemokine expression, at either concentration tested.	0
193	Postsynaptic action of @COMPOUND$ is mediated through metabotropic P2Y and ionotropic @PROTEIN$ receptors abundantly expressed in neural cells.	1
194	"Lack of @COMPOUND$ significantly changed mucin (MUC) dynamics, as reflected by the enlarged goblet-cell ""cup"" area relative to controls; decreased @PROTEIN$ mRNA expression in the jejunum, ileum and colon of VAD rats and increased MUC3 mRNA expression in the ileum and colon of these rats."	1
195	"Lack of @COMPOUND$ significantly changed mucin (MUC) dynamics, as reflected by the enlarged goblet-cell ""cup"" area relative to controls; decreased MUC2 mRNA expression in the jejunum, ileum and colon of VAD rats and increased @PROTEIN$ mRNA expression in the ileum and colon of these rats."	1
196	In addition, @COMPOUND$ deficiency down-regulated @PROTEIN$ 6 mRNA expression while up-regulating toll-like receptors 2 and 5 mRNA expressions.	1
197	Using in vitro binding assays we have demonstrated that transcription factors Sp3, ZBP-89 and NF-Y are capable of binding to the @PROTEIN$ promoter region spanning the sequence-200 to-162 relative to ATG and that formation of complexes could be efficiently reduced by @COMPOUND$.	1
198	Using in vitro binding assays we have demonstrated that @PROTEIN$, ZBP-89 and NF-Y are capable of binding to the SOX18 promoter region spanning the sequence-200 to-162 relative to ATG and that formation of complexes could be efficiently reduced by @COMPOUND$.	1
199	Treatment with @PROTEIN$ indicates that the dimensions of the small fibrils may be dependent upon the presence of @COMPOUND$ within the matrix.	1
200	Screening of risk factors for thromboembolism revealed that all patients carried a @PROTEIN$ 677C--&gt;T (MTHFR) mutation in a gene involved in folate metabolism, and either borderline or elevated @COMPOUND$ levels.	0
201	Screening of risk factors for thromboembolism revealed that all patients carried a methylenetetrahydrofolate reductase 677C--&gt;T (@PROTEIN$) mutation in a gene involved in folate metabolism, and either borderline or elevated @COMPOUND$ levels.	0
202	Multiple metabolic and neuroendocrine mechanisms are responsible for the CR-mediated anti-inflammatory effects, including reduced adiposity and secretion of pro-inflammatory adipokines, enhanced glucocorticoid production, reduced plasma @COMPOUND$ and advanced glycation end-product concentrations, increased parasympathetic tone, and increased @PROTEIN$ production.	0
203	To achieve enzymatic production of calcium-stearate at unfavorable conditions, i.e., pH 10 and 60 degrees C, suitable @PROTEIN$ was selected and reaction conditions were optimized using calcium @COMPOUND$ and hydrogenated beef tallow as substrates.	1
204	To achieve enzymatic production of @COMPOUND$ at unfavorable conditions, i.e., pH 10 and 60 degrees C, suitable @PROTEIN$ was selected and reaction conditions were optimized using calcium hydroxide and hydrogenated beef tallow as substrates.	1
205	Under optimum conditions, 95% of beef tallow, in 2.5 h, was converted into @COMPOUND$ by using commercial @PROTEIN$ SDL 451.	1
206	Pharmacological (@COMPOUND$) and molecular (shRNA) transcription inhibitor were used to impede formation of @PROTEIN$ transcripts.	1
207	The results showed that @COMPOUND$ augmented splenic-specific IgG1 and IL-4 as well as cell proliferation but suppressed specific IgG2a and @PROTEIN$ levels.	1
208	The results showed that @COMPOUND$ augmented splenic-specific IgG1 and @PROTEIN$ as well as cell proliferation but suppressed specific IgG2a and IFN-gamma levels.	1
209	@PROTEIN$ deletion blocks extinction of @COMPOUND$ place preference conditioning.	1
210	Accordingly, to assess its potential role in the long-lasting behavioral effects of drugs of abuse, we have investigated the impact of @PROTEIN$ deletion on sustained behavioral responses elicited by repeated @COMPOUND$ administration.	0
211	In 17 adults on a fixed metabolic diet, an 11-day course of @COMPOUND$ increased serum @PROTEIN$ and basal gastric acid output, but not maximal gastric acid output, compared with a placebo.	1
212	In this study, we tested the hypothesis that the Angiopoietin 1 (Ang1)/@PROTEIN$ pathway mediates @COMPOUND$-induced vascular integrity and migration of neuroblasts after stroke.	0
213	In this study, we tested the hypothesis that the Angiopoietin 1 (@PROTEIN$)/Tie2 pathway mediates @COMPOUND$-induced vascular integrity and migration of neuroblasts after stroke.	0
214	@COMPOUND$ treatment significantly decreased blood-brain barrier (BBB) leakage and concomitantly, increased Ang1, @PROTEIN$ and Occludin expression in the ischaemic border (IBZ) compared to the MCAo control group.	1
215	@COMPOUND$ treatment significantly decreased blood-brain barrier (BBB) leakage and concomitantly, increased Ang1, Tie2 and @PROTEIN$ expression in the ischaemic border (IBZ) compared to the MCAo control group.	1
216	@COMPOUND$ treatment significantly decreased blood-brain barrier (BBB) leakage and concomitantly, increased @PROTEIN$, Tie2 and Occludin expression in the ischaemic border (IBZ) compared to the MCAo control group.	1
217	@COMPOUND$ also significantly increased doublecortin (@PROTEIN$, a marker of migrating neuroblasts) expression in the IBZ compared to control MCAo rats.	1
218	The data show that @COMPOUND$ treatment of RBMEC increased Ang1 and @PROTEIN$ gene and protein expression and promoted phosphorylated-Tie2 activity.	1
219	The data show that @COMPOUND$ treatment of RBMEC increased @PROTEIN$ and Tie2 gene and protein expression and promoted phosphorylated-Tie2 activity.	1
220	@COMPOUND$ treatment of stroke increases Ang1/@PROTEIN$ expression and thereby reduces BBB leakage and promotes vascular stabilization.	1
221	@COMPOUND$ treatment of stroke increases @PROTEIN$/Tie2 expression and thereby reduces BBB leakage and promotes vascular stabilization.	1
222	Ang1/@PROTEIN$ expression induced by @COMPOUND$ treatment promotes neuroblast micro-vascular coupling after stroke.	1
223	@PROTEIN$/Tie2 expression induced by @COMPOUND$ treatment promotes neuroblast micro-vascular coupling after stroke.	1
224	The amino acid sequence deduced from the coding sequence encodes for @PROTEIN$ of 73 amino acids containing 21 @COMPOUND$ residues.	1
225	Transformation was achieved using a vector that targets genes to the rrn16/rps12 intergenic region of the sugar beet plastome, employing the @PROTEIN$ gene as a selectable marker against @COMPOUND$ and the gfp gene for visual screening of plastid transformants.	1
226	Transformation was achieved using a vector that targets genes to the rrn16/@PROTEIN$ intergenic region of the sugar beet plastome, employing the aadA gene as a selectable marker against @COMPOUND$ and the gfp gene for visual screening of plastid transformants.	0
227	@COMPOUND$ inhibits serum amyloid a-induced @PROTEIN$ expression in human endothelial cells.	1
228	Patients under clozapine-@COMPOUND$ therapy developed a rise of serum @PROTEIN$ levels.	1
229	Patients under @COMPOUND$-risperidone therapy developed a rise of serum @PROTEIN$ levels.	1
230	Only the intracellular @PROTEIN$ response in the lower tertile of IL-2 production was improved with @COMPOUND$ indicating a small influence.	1
231	The elevation of @COMPOUND$ plasma levels by a perioperative intravenous infusion of L-alanyl-L-glutamine influenced the intracellular expression of @PROTEIN$ in the lower tertile only slightly.	1
232	Determination of bioactive matter by affinity adsorption solid substrate-room temperature phosphorimetry based on @PROTEIN$ labeled with self-ordered ring of @COMPOUND$.	0
233	Specific affinity adsorption (AA) reactions could be carried out between the products of concanavalin @PROTEIN$ (Con A), triticum vulgaris lectin (WGA) labeled with ESOR and alpha-fetoprotein variant (AFP-V), alkaline phosphatase (ALP), @COMPOUND$ (G), respectively.	0
234	Specific affinity adsorption (AA) reactions could be carried out between the products of concanavalin agglutinin (Con A), triticum vulgaris lectin (WGA) labeled with ESOR and alpha-fetoprotein variant (AFP-V), alkaline phosphatase (@PROTEIN$), @COMPOUND$ (G), respectively.	0
235	Specific affinity adsorption (AA) reactions could be carried out between the products of concanavalin agglutinin (Con A), triticum vulgaris @PROTEIN$ (WGA) labeled with ESOR and alpha-fetoprotein variant (AFP-V), alkaline phosphatase (ALP), @COMPOUND$ (G), respectively.	0
236	Specific affinity adsorption (AA) reactions could be carried out between the products of concanavalin agglutinin (Con A), triticum vulgaris lectin (WGA) labeled with ESOR and alpha-fetoprotein variant (@PROTEIN$-V), alkaline phosphatase (ALP), @COMPOUND$ (G), respectively.	0
237	Specific affinity adsorption (AA) reactions could be carried out between the products of concanavalin agglutinin (Con A), triticum vulgaris lectin (WGA) labeled with ESOR and alpha-fetoprotein variant (AFP-V), @PROTEIN$ (ALP), @COMPOUND$ (G), respectively.	0
238	Specific affinity adsorption (AA) reactions could be carried out between the products of concanavalin agglutinin (@PROTEIN$), triticum vulgaris lectin (WGA) labeled with ESOR and alpha-fetoprotein variant (AFP-V), alkaline phosphatase (ALP), @COMPOUND$ (G), respectively.	0
239	With supplementation of @COMPOUND$ in diet, lower expression of GFAP and @PROTEIN$ while higher expression of GLAST, GS and GAD in retina of diabetic rats were determinated by RT-PCR 0.05).	1
240	With supplementation of @COMPOUND$ in diet, lower expression of @PROTEIN$ and VEGF while higher expression of GLAST, GS and GAD in retina of diabetic rats were determinated by RT-PCR 0.05).	1
241	With supplementation of @COMPOUND$ in diet, lower expression of GFAP and VEGF while higher expression of GLAST, GS and @PROTEIN$ in retina of diabetic rats were determinated by RT-PCR 0.05).	1
242	With supplementation of @COMPOUND$ in diet, lower expression of GFAP and VEGF while higher expression of @PROTEIN$, GS and GAD in retina of diabetic rats were determinated by RT-PCR 0.05).	1
243	@PROTEIN$, VEGF, GLAST, GS and GAD expressions in normal controls were not altered by @COMPOUND$ treatment.	0
244	GFAP, VEGF, @PROTEIN$, GS and GAD expressions in normal controls were not altered by @COMPOUND$ treatment.	0
245	GFAP, VEGF, GLAST, GS and @PROTEIN$ expressions in normal controls were not altered by @COMPOUND$ treatment.	0
246	GFAP, @PROTEIN$, GLAST, GS and GAD expressions in normal controls were not altered by @COMPOUND$ treatment.	0
247	It has been reported that @COMPOUND$ may affect hepatoma cell growth in vitro by suppressing transforming growth factor beta-1 (@PROTEIN$) expression, suggesting that tamoxifen might also retard fibrogenesis.	1
248	Thus, we examined whether @COMPOUND$ might suppress @PROTEIN$ expression and consequently inhibit the process of hepatic fibrosis in vivo.	0
249	7,12-Dimethyl-benz(a) anthracene (@COMPOUND$) can induce expressions of CYP1A1 and @PROTEIN$ which are known to be responsive to PAH.	1
250	7,12-Dimethyl-benz(a) anthracene (@COMPOUND$) can induce expressions of @PROTEIN$ and CYP1B1 which are known to be responsive to PAH.	1
251	Genetic variants of @PROTEIN$ (CYP2C9) and vitamin K epoxide reductase (VKORC1) are known to influence @COMPOUND$ dose, but the effect of other genes has not been fully elucidated.	1
252	Genetic variants of cytochrome P450 2C9 (CYP2C9) and vitamin K epoxide reductase (@PROTEIN$) are known to influence @COMPOUND$ dose, but the effect of other genes has not been fully elucidated.	1
253	Genetic variants of cytochrome P450 2C9 (@PROTEIN$) and vitamin K epoxide reductase (VKORC1) are known to influence @COMPOUND$ dose, but the effect of other genes has not been fully elucidated.	1
254	In conclusion, CYP2C9 and @PROTEIN$ significantly influenced @COMPOUND$ dose and predicted individuals predisposed to unstable anticoagulation.	1
255	In conclusion, @PROTEIN$ and VKORC1 significantly influenced @COMPOUND$ dose and predicted individuals predisposed to unstable anticoagulation.	1
256	Acute @COMPOUND$, through D(2) dopamine receptors, induced a dose-response increase in @PROTEIN$ in the cortex, with opposite effects over pFADD (Ser191/194), and no induction of apoptotic cell death (poly-(ADP-ribose) polymerase cleavage).	1
257	Acute @COMPOUND$, through @PROTEIN$, induced a dose-response increase in FADD protein in the cortex, with opposite effects over pFADD (Ser191/194), and no induction of apoptotic cell death (poly-(ADP-ribose) polymerase cleavage).	1
258	@PROTEIN$ was increased by @COMPOUND$ in cytosol (approximately 142%), membranes (approximately 23%) and nucleus (approximately 54%).	1
259	In a second experiment, possible @PROTEIN$ differences were investigated in rats selectively bred for differential responsiveness to novelty, propensity for drug-seeking and @COMPOUND$ sensitization.	0
260	@PROTEIN$ have the unique ability to catalyze oxidative cleavage of C-C bonds and @COMPOUND$ (C-O-C) bonds in non-phenolic aromatic substrates of high redox potential.	1
261	Manganese @PROTEIN$ oxidize Mn(II) to @COMPOUND$), which facilitates the degradation of phenolic compounds or, in turn, oxidizes a second mediator for the breakdown of non-phenolic compounds.	1
262	Manganese @PROTEIN$ oxidize @COMPOUND$) to Mn(III), which facilitates the degradation of phenolic compounds or, in turn, oxidizes a second mediator for the breakdown of non-phenolic compounds.	1
263	@PROTEIN$ are multi-@COMPOUND$-containing proteins that catalyze the oxidation of phenolic substrates with concomitant reduction of molecular oxygen to water.	1
264	@PROTEIN$ are multi-copper-containing proteins that catalyze the oxidation of phenolic substrates with concomitant reduction of molecular @COMPOUND$ to water.	1
265	The co-expression of @PROTEIN$ with M6B results in a significant decrease in SERT-mediated @COMPOUND$ uptake caused by a down-regulation of SERT surface expression.	1
266	The co-expression of SERT with @PROTEIN$ results in a significant decrease in SERT-mediated @COMPOUND$ uptake caused by a down-regulation of SERT surface expression.	1
267	@COMPOUND$ effects on neuronal ultrastructure and expression of @PROTEIN$ (MAP2) in rats with acute spinal cord injury.	1
268	@COMPOUND$ effects on neuronal ultrastructure and expression of microtubule-associated protein 2 (@PROTEIN$) in rats with acute spinal cord injury.	1
269	(4) Our data indicated that @COMPOUND$ maintained in part neuronal ultrastructure, attenuated chromatolysis, and preclude the loss of @PROTEIN$, suggesting a protective effect during the early phases of spinal cord injury.	1
270	In conclusion, our results indicate that chronic @COMPOUND$ modulates the expression and subcellular localization of proteins implicated in @PROTEIN$ signaling, calcium-buffering potential, and trafficking.	1
271	With the exception of specific genetic defects in purine metabolism, increased @COMPOUND$ is generally associated with important risk factors for atherosclerosis like hypertension, abdominal obesity, @PROTEIN$ resistance, the metabolic syndrome and renal failure.	1
272	With the exception of specific genetic defects in @COMPOUND$ metabolism, increased uric acid is generally associated with important risk factors for atherosclerosis like hypertension, abdominal obesity, @PROTEIN$ resistance, the metabolic syndrome and renal failure.	0
273	The distribution of sugar moieties within the epididymal region of the Sudani duck was investigated using ten different @COMPOUND$ (FITC) conjugated @PROTEIN$.	0
274	The distribution of sugar moieties within the epididymal region of the Sudani duck was investigated using ten different fluorescein isothiocyanate (@COMPOUND$) conjugated @PROTEIN$.	0
275	We systematically investigated whether PD-related stresses including MG132 and epoxomicin (proteasomal impairment), tunicamycin (unfolded protein stress), and @COMPOUND$ (mitochondrial dysfunction) resulted in expressional changes of parkin and other E3 @PROTEIN$ ligases (dorfin, SIAH-1).	0
276	We systematically investigated whether PD-related stresses including MG132 and epoxomicin (proteasomal impairment), tunicamycin (unfolded protein stress), and @COMPOUND$ (mitochondrial dysfunction) resulted in expressional changes of parkin and other E3 ubiquitin ligases (@PROTEIN$, SIAH-1).	0
277	We systematically investigated whether PD-related stresses including @COMPOUND$ and epoxomicin (proteasomal impairment), tunicamycin (unfolded protein stress), and rotenone (mitochondrial dysfunction) resulted in expressional changes of parkin and other E3 ubiquitin ligases (@PROTEIN$, SIAH-1).	0
278	We systematically investigated whether PD-related stresses including @COMPOUND$ and epoxomicin (proteasomal impairment), tunicamycin (unfolded protein stress), and rotenone (mitochondrial dysfunction) resulted in expressional changes of parkin and other E3 @PROTEIN$ ligases (dorfin, SIAH-1).	0
279	Although the co-expression of @PROTEIN$ and CMP-SAS did not further increase sialylation, an increase in the intracellular pool of CMP-@COMPOUND$ was noted.	1
280	NOPE-@COMPOUND$ treatment improved @PROTEIN$ 0.0001).	1
281	Expression of @PROTEIN$ reduced the intracellular @COMPOUND$ concentration from 140 to 11 mM and resulted in maximal excretion rates of 11.2 nmol min(-1) mg(-1) as compared to 2.3 nmol min(-1) mg(-1) obtained without rhtC expression.	1
282	In combination with an @PROTEIN$ mutation generated and introduced into the chromosome, an accumulation of up to 54 mM @COMPOUND$ was achieved as compared to 21 mM obtained with the ancestor strain.	1
283	Cell exposure to 250 microM @COMPOUND$ was able to induce @PROTEIN$ 2 up-regulation and increased in situ transglutaminase activity.	1
284	Cell exposure to 250 microM @COMPOUND$ was able to induce @PROTEIN$ up-regulation and increased in situ transglutaminase activity.	1
285	@COMPOUND$ also induced NF-kappaB activation that seemed associated with @PROTEIN$ 2 up-regulation since the specific NF-kappaB inhibition by SN50 was able to reduce transglutaminase expression and activity levels.	1
286	@COMPOUND$ also induced NF-kappaB activation that seemed associated with @PROTEIN$ up-regulation since the specific NF-kappaB inhibition by SN50 was able to reduce transglutaminase expression and activity levels.	1
287	@PROTEIN$-antagonistic effects of hormones, cytokines and excess metabolic substrates such as @COMPOUND$ and fatty acids may be exerted via common mechanisms involving for example reactive oxygen species (ROS) accumulation and associated inflammatory responses.	1
288	The rise in (@COMPOUND$+))(i) elicited by hGH is associated with an enhanced insulin secretion, effects that are mediated mainly through the @PROTEIN$ receptor.	1
289	The rise in (@COMPOUND$+))(i) elicited by hGH is associated with an enhanced @PROTEIN$ secretion, effects that are mediated mainly through the prolactin receptor.	1
290	These mechanisms indicate that a rise in (@COMPOUND$+))(i) elicited by activation of PRLR is @PROTEIN$-dependent and is associated with enhanced insulin secretion.	1
291	These mechanisms indicate that a rise in (@COMPOUND$+))(i) elicited by activation of PRLR is JAK2-dependent and is associated with enhanced @PROTEIN$ secretion.	1
292	These mechanisms indicate that a rise in (@COMPOUND$+))(i) elicited by activation of @PROTEIN$ is JAK2-dependent and is associated with enhanced insulin secretion.	1
293	In contrast, GH receptor-mediated increase in (@COMPOUND$+))(i) is @PROTEIN$-independent and is dissociated from insulin secretion.	1
294	In contrast, GH receptor-mediated increase in (@COMPOUND$+))(i) is JAK2-independent and is dissociated from @PROTEIN$ secretion.	0
295	In contrast, @PROTEIN$-mediated increase in (@COMPOUND$+))(i) is JAK2-independent and is dissociated from insulin secretion.	1
296	SEMG I expression is upregulated by @PROTEIN$, IL-6 and @COMPOUND$.	0
297	@PROTEIN$ I expression is upregulated by IL-4, IL-6 and @COMPOUND$.	1
298	SEMG I expression is upregulated by IL-4, @PROTEIN$ and @COMPOUND$.	0
299	Consumption of the trichothecene mycotoxin @COMPOUND$ (DON) induces @PROTEIN$ (IL-6)-dependent IgA nephropathy (IgAN) in mice.	1
300	Consumption of the trichothecene mycotoxin @COMPOUND$ (DON) induces interleukin-6 (@PROTEIN$)-dependent IgA nephropathy (IgAN) in mice.	1
301	The purpose of this study was to identify the signal transduction pathways by which DON up-regulates @PROTEIN$ in the peritoneal macrophage and how consumption of fish oil enriched with the n-3 PUFA @COMPOUND$ (DHA) suppresses these processes.	1
302	Under the condition of delayed intervention (30 days after deafening) following @COMPOUND$+ furosemide deafening in rats, we conclude that chronic intracochlear electrical stimulation (ES) and continuous intracochlear administration of @PROTEIN$ (BDNF) enhance spiral ganglion cell (SGC) body and peripheral process survival and improve auditory sensitivity.	0
303	Under the condition of delayed intervention (30 days after deafening) following @COMPOUND$+ furosemide deafening in rats, we conclude that chronic intracochlear electrical stimulation (ES) and continuous intracochlear administration of brain-derived neurotrophic factor (@PROTEIN$) enhance spiral ganglion cell (SGC) body and peripheral process survival and improve auditory sensitivity.	0
304	Under the condition of delayed intervention (30 days after deafening) following gentamicin+ @COMPOUND$ deafening in rats, we conclude that chronic intracochlear electrical stimulation (ES) and continuous intracochlear administration of @PROTEIN$ (BDNF) enhance spiral ganglion cell (SGC) body and peripheral process survival and improve auditory sensitivity.	0
305	Under the condition of delayed intervention (30 days after deafening) following gentamicin+ @COMPOUND$ deafening in rats, we conclude that chronic intracochlear electrical stimulation (ES) and continuous intracochlear administration of brain-derived neurotrophic factor (@PROTEIN$) enhance spiral ganglion cell (SGC) body and peripheral process survival and improve auditory sensitivity.	0
306	Purinergic receptor agonists @COMPOUND$ and UTP selectively activate certain @PROTEIN$ family tyrosine kinases and stimulate Na,K-ATPase activity.	1
307	Purinergic receptor agonists ATP and @COMPOUND$ selectively activate certain @PROTEIN$ family tyrosine kinases and stimulate Na,K-ATPase activity.	1
308	The proportion of @PROTEIN$ molecules that are directed to the novel cleavage pathway is regulated by the ratio of free @COMPOUND$ and cholesteryl esters in cells.	1
309	Comparison of the PTM's of @PROTEIN$'s isolated from several vertebrate species reveals marked differences in their @COMPOUND$ content.	1
310	Chicken @PROTEIN$ does not share any phosphorylated sites with dogfish MBP ; However, it does contain phosphorylated serine and @COMPOUND$ residues in common with mammalian MBP.	1
311	Chicken @PROTEIN$ does not share any phosphorylated sites with dogfish MBP ; However, it does contain phosphorylated @COMPOUND$ and threonine residues in common with mammalian MBP.	1
312	@COMPOUND$/NaPB administration increased acetylation at H4 and increased NF-kappaB @PROTEIN$ translocation to the nucleus in G93A mice, consistent with a therapeutic effect.	1
313	Riluzole/@COMPOUND$ administration increased acetylation at H4 and increased NF-kappaB @PROTEIN$ translocation to the nucleus in G93A mice, consistent with a therapeutic effect.	1
314	At 0.15 microM @COMPOUND$+), ((35)S) CaM bound to @PROTEIN$ with decreased affinity and binding enthalpy compared with RyR1.	0
315	At 0.15 microM @COMPOUND$+), ((35)S) @PROTEIN$ bound to RyR2 with decreased affinity and binding enthalpy compared with RyR1.	0
316	At 0.15 microM @COMPOUND$+), ((35)S) CaM bound to RyR2 with decreased affinity and binding enthalpy compared with @PROTEIN$.	0
317	The rates of ((35)S) CaM dissociation from RyR1 increased as the temperature was raised, whereas at 0.15 microM @COMPOUND$+) the rate from @PROTEIN$ was little affected.	0
318	The rates of ((35)S) CaM dissociation from @PROTEIN$ increased as the temperature was raised, whereas at 0.15 microM @COMPOUND$+) the rate from RyR2 was little affected.	0
319	The rates of ((35)S) @PROTEIN$ dissociation from RyR1 increased as the temperature was raised, whereas at 0.15 microM @COMPOUND$+) the rate from RyR2 was little affected.	0
320	The deduced amino acid sequence of Ai Lec was highly similar to those of the C-type @PROTEIN$ from other animals and contained a typical carbohydrate-recognition domain (CRD) of 131 residues, which has four conserved disulfide-bonded @COMPOUND$ residues that define the CRD and two additional cysteine residues at the amino terminus.	1
321	Reduction of intracellular @COMPOUND$+) levels abolished @PROTEIN$ reduction by HOG-LDL, as did pharmacological or genetic through calcium channel blockers or calcium chelator BAPTA or inhibition of NAD(P)H oxidase (with apocynin) or inhibition of calpain (calpain 1-specific siRNA).	1
322	Reduction of intracellular Ca(2+) levels abolished @PROTEIN$ reduction by HOG-LDL, as did pharmacological or genetic through calcium channel blockers or calcium chelator @COMPOUND$ or inhibition of NAD(P)H oxidase (with apocynin) or inhibition of calpain (calpain 1-specific siRNA).	1
323	Reduction of intracellular Ca(2+) levels abolished @PROTEIN$ reduction by HOG-LDL, as did pharmacological or genetic through calcium channel blockers or calcium chelator BAPTA or inhibition of NAD(P)H oxidase (with @COMPOUND$) or inhibition of calpain (calpain 1-specific siRNA).	0
324	We have recently shown that the antidepressant @COMPOUND$ enhances T cell proliferation and T(H)1 cytokine production in vivo, without changes on @PROTEIN$/CD8 subsets.	0
325	We found that @COMPOUND$ restored T cell proliferation and interleukin-2, @PROTEIN$ and tumor necrosis factor-alpha production by compensatory mechanisms.	1
326	We found that @COMPOUND$ restored T cell proliferation and interleukin-2, interferon-gamma and @PROTEIN$-alpha production by compensatory mechanisms.	1
327	We found that the acetylated @PROTEIN$ at @COMPOUND$ 9 and lysine 14 (H3K9/K14ac) is reduced in both the myelin basic protein (MBP) and proteolipid protein (PLP) genes of maturing oligodendroglial OL-1 cells, and furthermore, this temporally correlates with increases in MBP, PLP, and histone deacetylase (HDAC) 11 expression.	1
328	We found that the acetylated histone H3 at @COMPOUND$ 9 and lysine 14 (H3K9/K14ac) is reduced in both the myelin basic protein (@PROTEIN$) and proteolipid protein (PLP) genes of maturing oligodendroglial OL-1 cells, and furthermore, this temporally correlates with increases in MBP, PLP, and histone deacetylase (HDAC) 11 expression.	1
329	We found that the acetylated histone H3 at @COMPOUND$ 9 and lysine 14 (H3K9/K14ac) is reduced in both the myelin basic protein (MBP) and proteolipid protein (PLP) genes of maturing oligodendroglial OL-1 cells, and furthermore, this temporally correlates with increases in MBP, PLP, and @PROTEIN$ (HDAC) 11 expression.	0
330	We found that the acetylated histone H3 at @COMPOUND$ 9 and lysine 14 (H3K9/K14ac) is reduced in both the @PROTEIN$ (MBP) and proteolipid protein (PLP) genes of maturing oligodendroglial OL-1 cells, and furthermore, this temporally correlates with increases in MBP, PLP, and histone deacetylase (HDAC) 11 expression.	1
331	We found that the acetylated histone H3 at @COMPOUND$ 9 and lysine 14 (H3K9/K14ac) is reduced in both the myelin basic protein (MBP) and proteolipid protein (@PROTEIN$) genes of maturing oligodendroglial OL-1 cells, and furthermore, this temporally correlates with increases in MBP, PLP, and histone deacetylase (HDAC) 11 expression.	1
332	Oral administration of @COMPOUND$ remarkably prevented weight loss in the body and liver from DMN and inhibited the elevation of serum alanine transaminase (ALT), aspartate transaminase (@PROTEIN$), and total bilirubin levels.	1
333	Oral administration of morin remarkably prevented weight loss in the body and liver from DMN and inhibited the elevation of serum alanine transaminase (ALT), aspartate transaminase (@PROTEIN$), and total @COMPOUND$ levels.	0
334	@COMPOUND$ reduces induction of @PROTEIN$ and apoptosis in UVB-irradiated human skin independent of transcriptional controls.	1
335	We found that while OM24 treatment did not significantly affect UV-induced erythema and @COMPOUND$ dimer formation, OM24 treatment significantly reduced UV-induced @PROTEIN$ expression in keratinocytes.	0
336	Of various agents tested in HaCaT cell cultures, only @COMPOUND$ (10(-6) M) and staurosporine (2.5 x 10(-8) M) upregulated @PROTEIN$ mRNA and protein expression, whereas tumor promoters, hormones, or dexamethasone were without effect.	1
337	Of various agents tested in HaCaT cell cultures, only retinoic acid (10(-6) M) and @COMPOUND$ (2.5 x 10(-8) M) upregulated @PROTEIN$ mRNA and protein expression, whereas tumor promoters, hormones, or dexamethasone were without effect.	1
338	Of various agents tested in HaCaT cell cultures, only retinoic acid (10(-6) M) and staurosporine (2.5 x 10(-8) M) upregulated @PROTEIN$ mRNA and protein expression, whereas tumor promoters, hormones, or @COMPOUND$ were without effect.	0
339	By contrast, treatment of N2a cells with 1-10 microM @COMPOUND$ resulted in marked reductions in the expression of the axon growth-associated protein @PROTEIN$-43.	1
340	@COMPOUND$-treated cells also showed an increased expression of the heat shock protein @PROTEIN$ compared to controls.	1
341	In absence of stretch, we could activate @PROTEIN$ and deactivate GK1 by 1-oleoyl-2-acetyl-sn-glycerol (@COMPOUND$) and other amphipaths.	1
342	In absence of stretch, we could activate @PROTEIN$ and deactivate GK1 by @COMPOUND$ (OAG) and other amphipaths.	1
343	In absence of stretch, we could activate Gns and deactivate @PROTEIN$ by @COMPOUND$ (OAG) and other amphipaths.	1
344	In absence of stretch, we could activate Gns and deactivate @PROTEIN$ by 1-oleoyl-2-acetyl-sn-glycerol (@COMPOUND$) and other amphipaths.	1
345	Using enzyme-linked immunosorbent assays, we showed @COMPOUND$ to inhibit LPS-induced secretion of @PROTEIN$ and TNF-alpha.	1
346	Using enzyme-linked immunosorbent assays, we showed @COMPOUND$ to inhibit LPS-induced secretion of IL-6 and @PROTEIN$.	1
347	The inhibition of DMBA-carcinogenesis by GLN application was associated with increased arterial GLN and @COMPOUND$, elevated buccal mucosa GSH as well as induction of @PROTEIN$ and PARP, and inhibition of bcl-2.	0
348	The inhibition of DMBA-carcinogenesis by GLN application was associated with increased arterial GLN and @COMPOUND$, elevated buccal mucosa GSH as well as induction of bax and PARP, and inhibition of @PROTEIN$.	0
349	The inhibition of DMBA-carcinogenesis by GLN application was associated with increased arterial GLN and @COMPOUND$, elevated buccal mucosa GSH as well as induction of bax and @PROTEIN$, and inhibition of bcl-2.	0
350	Chemotaxis, @PROTEIN$ release and @COMPOUND$ anion production have been measured.	0
351	Results showed that MENT treatments increased @PROTEIN$ secretion and proliferation rate with a potency ranged between T and @COMPOUND$.	1
352	Results showed that @COMPOUND$ treatments increased @PROTEIN$ secretion and proliferation rate with a potency ranged between T and DHT.	1
353	The studies with @COMPOUND$ showed that in BPH and CaP cells, the conversion of T into DHT significantly contributes to its effect on the proliferation and @PROTEIN$ secretion, and corroborated the resistance of MENT to the 5-AR.	0
354	The studies with finasteride showed that in BPH and CaP cells, the conversion of T into DHT significantly contributes to its effect on the proliferation and @PROTEIN$ secretion, and corroborated the resistance of @COMPOUND$ to the 5-AR.	0
355	The studies with finasteride showed that in BPH and CaP cells, the conversion of T into @COMPOUND$ significantly contributes to its effect on the proliferation and @PROTEIN$ secretion, and corroborated the resistance of MENT to the 5-AR.	1
356	@COMPOUND$-containing bisphosphonates were found to inhibit @PROTEIN$-an essential enzyme in the cholesterol biosynthesis pathway, but their effect on cholesterol synthesis per se in the central nervous system (CNS) remains unknown.	0
357	Nitrogen-containing bisphosphonates were found to inhibit @PROTEIN$-an essential enzyme in the @COMPOUND$ biosynthesis pathway, but their effect on cholesterol synthesis per se in the central nervous system (CNS) remains unknown.	1
358	hsBAFF-upregulated intracellular free @COMPOUND$+) homeostasis regulates @PROTEIN$/2 activity and cell proliferation in B cells in vitro.	1
359	Using immunocytochemistry and Western blot analysis, we found that the activation of @PROTEIN$/2 due to hsBAFF was triggered by a (@COMPOUND$+))(i)-dependent pathway, leading to elevation of B cell proliferation.	1
360	This is supported by the findings that intracellular Ca(2+) chelator @COMPOUND$ attenuated phosphorylated @PROTEIN$/2 expression and cell proliferation in hsBAFF-stimulated B cells.	1
361	Taken together, the main finding of this study is that hsBAFF elicits higher but homeostatic (@COMPOUND$+))(i) levels, which regulates @PROTEIN$/2 activity and cell proliferation in in vitro B cells.	1
362	Serum l-@COMPOUND$ (l-KYN) concentrations, l-KYN/l-@PROTEIN$ ratio, and the level of IDO mRNA expression in ATLL cells were significantly increased in ATLL patients compared to those in healthy and HTLV-positive carrier subjects.	0
363	Serum l-kynurenine (l-@COMPOUND$) concentrations, l-KYN/l-@PROTEIN$ ratio, and the level of IDO mRNA expression in ATLL cells were significantly increased in ATLL patients compared to those in healthy and HTLV-positive carrier subjects.	0
364	Serum l-kynurenine (l-@COMPOUND$) concentrations, l-KYN/l-TRP ratio, and the level of @PROTEIN$ mRNA expression in ATLL cells were significantly increased in ATLL patients compared to those in healthy and HTLV-positive carrier subjects.	0
365	Serum l-@COMPOUND$ (l-KYN) concentrations, l-KYN/l-TRP ratio, and the level of @PROTEIN$ mRNA expression in ATLL cells were significantly increased in ATLL patients compared to those in healthy and HTLV-positive carrier subjects.	0
366	@COMPOUND$, a potent orally active angiogenesis inhibitor capable of inhibiting all known isoforms of Vascular Endothelial Growth Factor (@PROTEIN$) receptor, belongs to the class of aminophthalazines.	1
367	Recent evidence for toxic @COMPOUND$ (O(2)(-)) production by marine microalgae is afforded particular attention given that release of O(2)(-) anions can be exacerbated by the binding of @PROTEIN$ to the microalgal cell wall ; a novel model for grazing-activated chemical defence is proposed.	1
368	Activation of these receptors can inhibit @PROTEIN$-release in primary cultured corticotroph adenomas and compounds that target either sst (5) (@COMPOUND$, or SOM230) or D(2) (cabergoline) have shown significant efficacy in subsets of patients in recent clinical studies.	0
369	Activation of these receptors can inhibit @PROTEIN$-release in primary cultured corticotroph adenomas and compounds that target either sst (5) (pasireotide, or SOM230) or D(2) (@COMPOUND$) have shown significant efficacy in subsets of patients in recent clinical studies.	0
370	Activation of these receptors can inhibit @PROTEIN$-release in primary cultured corticotroph adenomas and compounds that target either sst (5) (pasireotide, or @COMPOUND$) or D(2) (cabergoline) have shown significant efficacy in subsets of patients in recent clinical studies.	0
371	Administration of @COMPOUND$ to DMH treated rats significantly decreased the tumor incidence, the number of aberrant crypt foci with simultaneous enhancement of tissue lipid peroxidation, GST, GPx, @PROTEIN$, and CAT activities.	1
372	Administration of @COMPOUND$ to DMH treated rats significantly decreased the tumor incidence, the number of aberrant crypt foci with simultaneous enhancement of tissue lipid peroxidation, @PROTEIN$, GPx, SOD, and CAT activities.	1
373	Administration of @COMPOUND$ to DMH treated rats significantly decreased the tumor incidence, the number of aberrant crypt foci with simultaneous enhancement of tissue lipid peroxidation, GST, GPx, SOD, and @PROTEIN$ activities.	1
374	Activation of interleukin-6/@PROTEIN$ in rat cholangiocyte proliferation induced by @COMPOUND$.	1
375	Activation of @PROTEIN$/STAT3 in rat cholangiocyte proliferation induced by @COMPOUND$.	1
376	To investigate the activation pathways triggered by @PROTEIN$, ESR spin-trapping techniques using N-tert-butyl-alpha-phenylnitrone (PBN) as spin trap followed by @COMPOUND$ extraction were employed to identify and quantify the free radical intermediates.	0
377	Methylation of these @COMPOUND$ sites may lead to reduced @PROTEIN$ expression in the lymphocytes of these former heroin addicts.	1
378	Two infants with elevated serum @PROTEIN$ had a decreased serum @COMPOUND$.	1
379	Altogether these changes offer a straightforward explanation for how following the addition of Ca(2+), the @COMPOUND$ could escape and become available for bioluminescence on Renilla @PROTEIN$.	1
380	Altogether these changes offer a straightforward explanation for how following the addition of @COMPOUND$+), the coelenterazine could escape and become available for bioluminescence on Renilla @PROTEIN$.	1
381	Adding @COMPOUND$ to the diet of the mice during the period of irradiation suppressed the activity and expression of @PROTEIN$ as well as the wrinkling and sagging formation.	1
382	Dietary @COMPOUND$ prevents the expression of @PROTEIN$, at least partly, by inhibiting photodynamic action involved in the formation of Chol-OOHs.	1
383	@PROTEIN$ gene polymorphisms and high levels of @COMPOUND$ are associated with a high degree of steatosis and fibrosis, conditions associated with a low sustained virological response (SVR) rate.	0
384	Besides the biogenesis of lysosome-related organelles complex 1 and dystrophin-associated protein complex, several molecules in the DTNBP1 network likely provide insight into the role of DTNBP1 in biological systems: @COMPOUND$, beta-estradiol, @PROTEIN$ and tumour necrosis factor.	0
385	Besides the biogenesis of lysosome-related organelles complex 1 and dystrophin-associated protein complex, several molecules in the @PROTEIN$ network likely provide insight into the role of DTNBP1 in biological systems: @COMPOUND$, beta-estradiol, calmodulin and tumour necrosis factor.	1
386	Besides the biogenesis of lysosome-related organelles complex 1 and dystrophin-associated protein complex, several molecules in the DTNBP1 network likely provide insight into the role of DTNBP1 in biological systems: retinoic acid, @COMPOUND$, @PROTEIN$ and tumour necrosis factor.	0
387	Besides the biogenesis of lysosome-related organelles complex 1 and dystrophin-associated protein complex, several molecules in the @PROTEIN$ network likely provide insight into the role of DTNBP1 in biological systems: retinoic acid, @COMPOUND$, calmodulin and tumour necrosis factor.	1
388	In prolonged OJ with LPS administration, hepatocyte apoptosis depending on @PROTEIN$ expression significantly increased in association with a decrease in @COMPOUND$ contents, thus resulting in liver necrapoptosis.	0
389	In this view, this study aimed at the investigating the use of a crude @PROTEIN$ preparation from onion solid by-products for oxidising @COMPOUND$, a widespread o-diphenol, whose various derivatives may occur in food industry wastes, such as olive mill waste waters.	1
390	@PROTEIN$ protein contains high glycine and @COMPOUND$, which concerns regulation and function of the matrix structure fiber.	1
391	@PROTEIN$ protein contains high @COMPOUND$ and tyrosine, which concerns regulation and function of the matrix structure fiber.	1
392	@COMPOUND$ levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli lipopolysaccharide plus @PROTEIN$ ; this response was concurrent with an increase in the expression of NOS2 (inducible nitric oxide synthase) and was inhibited by the (*)NO (nitric oxide) inhibitor L-NAME (N(G)-nitro-L-arginine methyl ester).	1
393	CLNO2 levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli lipopolysaccharide plus @PROTEIN$ ; this response was concurrent with an increase in the expression of NOS2 (inducible nitric oxide synthase) and was inhibited by the (*)NO (nitric oxide) inhibitor L-NAME (@COMPOUND$).	0
394	@COMPOUND$ levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli lipopolysaccharide plus interferon-gamma ; this response was concurrent with an increase in the expression of NOS2 (inducible @PROTEIN$) and was inhibited by the (*)NO (nitric oxide) inhibitor L-NAME (N(G)-nitro-L-arginine methyl ester).	1
395	CLNO2 levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli @COMPOUND$ plus interferon-gamma ; this response was concurrent with an increase in the expression of @PROTEIN$ (inducible nitric oxide synthase) and was inhibited by the (*)NO (nitric oxide) inhibitor L-NAME (N(G)-nitro-L-arginine methyl ester).	1
396	CLNO2 levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli lipopolysaccharide plus interferon-gamma ; this response was concurrent with an increase in the expression of @PROTEIN$ (inducible nitric oxide synthase) and was inhibited by the (*)NO (nitric oxide) inhibitor L-NAME (@COMPOUND$).	0
397	CLNO2 levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli @COMPOUND$ plus interferon-gamma ; this response was concurrent with an increase in the expression of NOS2 (inducible @PROTEIN$) and was inhibited by the (*)NO (nitric oxide) inhibitor L-NAME (N(G)-nitro-L-arginine methyl ester).	0
398	@COMPOUND$ levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli lipopolysaccharide plus interferon-gamma ; this response was concurrent with an increase in the expression of @PROTEIN$ (inducible nitric oxide synthase) and was inhibited by the (*)NO (nitric oxide) inhibitor L-NAME (N(G)-nitro-L-arginine methyl ester).	1
399	CLNO2 levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli @COMPOUND$ plus @PROTEIN$ ; this response was concurrent with an increase in the expression of NOS2 (inducible nitric oxide synthase) and was inhibited by the (*)NO (nitric oxide) inhibitor L-NAME (N(G)-nitro-L-arginine methyl ester).	0
400	CLNO2 levels were found to increase approximately 20-fold 24 h after macrophage activation with Escherichia coli lipopolysaccharide plus interferon-gamma ; this response was concurrent with an increase in the expression of NOS2 (inducible @PROTEIN$) and was inhibited by the (*)NO (nitric oxide) inhibitor L-NAME (@COMPOUND$).	0
401	@COMPOUND$-mediated ubiquitination regulates @PROTEIN$.	1
402	Short-acting @PROTEIN$ analogues, in comparison with regular human insulin (HRI), provide a greater control of postprandial @COMPOUND$, while their superiority on haemoglobin A1c (HbA1c) is controversial.	1
403	Short-acting insulin analogues, in comparison with regular human insulin (@PROTEIN$), provide a greater control of postprandial @COMPOUND$, while their superiority on haemoglobin A1c (HbA1c) is controversial.	1
404	Differentiated EBD cells in both monolayer and three-dimensional in vitro culture demonstrated fat granules by light microscopy, stained positive for lipids with @COMPOUND$, and expressed adipocyte-specific genes (lipoprotein @PROTEIN$ (LPL), peroxisome proliferator activated receptor gamma2, and adipocyte-specific fatty acid binding protein (alphaP2)).	0
405	Differentiated EBD cells in both monolayer and three-dimensional in vitro culture demonstrated fat granules by light microscopy, stained positive for lipids with @COMPOUND$, and expressed adipocyte-specific genes (lipoprotein lipase (LPL), peroxisome proliferator activated receptor gamma2, and adipocyte-specific @PROTEIN$ (alphaP2)).	0
406	Differentiated EBD cells in both monolayer and three-dimensional in vitro culture demonstrated fat granules by light microscopy, stained positive for lipids with @COMPOUND$, and expressed adipocyte-specific genes (lipoprotein lipase (@PROTEIN$), peroxisome proliferator activated receptor gamma2, and adipocyte-specific fatty acid binding protein (alphaP2)).	0
407	Differentiated EBD cells in both monolayer and three-dimensional in vitro culture demonstrated fat granules by light microscopy, stained positive for lipids with @COMPOUND$, and expressed adipocyte-specific genes (lipoprotein lipase (LPL), peroxisome proliferator activated receptor @PROTEIN$, and adipocyte-specific fatty acid binding protein (alphaP2)).	0
408	To compare expression of endometrial estrogen (ER) and progesterone (PR) receptors, beta(3)-integrin subunit, leukemia inhibitory factor (LIF), interleukin-6 (@PROTEIN$), and pinopodes in Indian women using @COMPOUND$ as a contraceptive with fertile and infertile subjects during the window of implantation.	1
409	To compare expression of endometrial estrogen (ER) and progesterone (PR) receptors, beta(3)-integrin subunit, leukemia inhibitory factor (LIF), @PROTEIN$ (IL-6), and pinopodes in Indian women using @COMPOUND$ as a contraceptive with fertile and infertile subjects during the window of implantation.	1
410	To compare expression of endometrial estrogen (ER) and progesterone (PR) receptors, beta(3)-integrin subunit, leukemia inhibitory factor (@PROTEIN$), interleukin-6 (IL-6), and pinopodes in Indian women using @COMPOUND$ as a contraceptive with fertile and infertile subjects during the window of implantation.	1
411	Inhibition of mitogen-activated protein kinase (MAPK) and @PROTEIN$ prevented the antiapoptotic effects of @COMPOUND$ and decreased chemotherapy-induced apoptosis.	1
412	Inhibition of mitogen-activated protein kinase (@PROTEIN$) and Akt prevented the antiapoptotic effects of @COMPOUND$ and decreased chemotherapy-induced apoptosis.	1
413	Inhibition of @PROTEIN$ (MAPK) and Akt prevented the antiapoptotic effects of @COMPOUND$ and decreased chemotherapy-induced apoptosis.	1
414	@COMPOUND$ up-regulated Akt-mediated antiapoptotic X-linked inhibitor of apoptosis protein and phosphorylated proapoptotic @PROTEIN$.	1
415	Enhancement of p53 expression in keratinocytes by the @COMPOUND$ apigenin is associated with RNA-binding protein @PROTEIN$.	0
416	Enhancement of @PROTEIN$ expression in keratinocytes by the @COMPOUND$ apigenin is associated with RNA-binding protein HuR.	0
417	Enhancement of p53 expression in keratinocytes by the bioflavonoid @COMPOUND$ is associated with @PROTEIN$ HuR.	0
418	Enhancement of p53 expression in keratinocytes by the bioflavonoid @COMPOUND$ is associated with RNA-binding protein @PROTEIN$.	1
419	Enhancement of @PROTEIN$ expression in keratinocytes by the bioflavonoid @COMPOUND$ is associated with RNA-binding protein HuR.	1
420	Enhancement of p53 expression in keratinocytes by the @COMPOUND$ apigenin is associated with @PROTEIN$ HuR.	0
421	We have reported previously that @COMPOUND$, a naturally occurring nonmutagenic flavonoid, increased wild-type @PROTEIN$ protein expression in the mouse keratinocyte 308 cell line by a mechanism involving p53 protein stabilization.	1
422	We have reported previously that apigenin, a naturally occurring nonmutagenic @COMPOUND$, increased wild-type @PROTEIN$ protein expression in the mouse keratinocyte 308 cell line by a mechanism involving p53 protein stabilization.	0
423	Instead, biosynthetic labeling showed that @COMPOUND$ increased nascent @PROTEIN$ protein synthesis by enhancing p53 translation.	1
424	Furthermore, @COMPOUND$ treatment increased the level of association of the RNA binding protein HuR with endogenous @PROTEIN$ mRNA.	1
425	Furthermore, @COMPOUND$ treatment increased the level of association of the RNA binding protein @PROTEIN$ with endogenous p53 mRNA.	1
426	Furthermore, @COMPOUND$ treatment increased the level of association of the @PROTEIN$ HuR with endogenous p53 mRNA.	0
427	@COMPOUND$ treatment also augmented @PROTEIN$ translocation into the cytoplasm.	1
428	Overall, these findings indicate that, in addition to modulating @PROTEIN$ protein stability, one of the mechanisms by which @COMPOUND$ induces p53 protein expression is enhancement of translation through the RNA binding protein HuR.	1
429	Overall, these findings indicate that, in addition to modulating p53 protein stability, one of the mechanisms by which @COMPOUND$ induces p53 protein expression is enhancement of translation through the RNA binding protein @PROTEIN$.	1
430	Overall, these findings indicate that, in addition to modulating p53 protein stability, one of the mechanisms by which @COMPOUND$ induces p53 protein expression is enhancement of translation through the @PROTEIN$ HuR.	0
431	@COMPOUND$ prevents acute liver damage after massive hepatectomy in rats through suppression of a CXC chemokine @PROTEIN$ and induction of heat shock proteins.	1
432	ALK2 (R206H) with @PROTEIN$ or Smad5 induced osteoblastic differentiation that could be inhibited by Smad7 or @COMPOUND$.	1
433	ALK2 (R206H) with Smad1 or Smad5 induced osteoblastic differentiation that could be inhibited by @PROTEIN$ or @COMPOUND$.	0
434	ALK2 (R206H) with Smad1 or @PROTEIN$ induced osteoblastic differentiation that could be inhibited by Smad7 or @COMPOUND$.	1
435	@PROTEIN$ (R206H) with Smad1 or Smad5 induced osteoblastic differentiation that could be inhibited by Smad7 or @COMPOUND$.	1
436	Studies suggest that @PROTEIN$ activation in osteoblasts is the underlying cause of glucocorticoid- and estrogen deficiency-mediated osteoporosis, and at least partially underlies the teratogenic effects of @COMPOUND$ on limb development.	1
437	Rat dicarboxylate transporter (@PROTEIN$), expressed in renal tubular epithelial cells, plays a key role in regulating blood and urinary @COMPOUND$ level by reabsorbing citrate from the lumen.	1
438	Two related polytopic @PROTEIN$ of the major facilitator family, NarK and NarU, catalyse @COMPOUND$ uptake, nitrite export and nitrite uptake across the Escherichia coli cytoplasmic membrane by an unknown mechanism.	0
439	Two related polytopic membrane proteins of the major facilitator family, NarK and @PROTEIN$, catalyse @COMPOUND$ uptake, nitrite export and nitrite uptake across the Escherichia coli cytoplasmic membrane by an unknown mechanism.	1
440	Two related polytopic membrane proteins of the major facilitator family, @PROTEIN$ and NarU, catalyse @COMPOUND$ uptake, nitrite export and nitrite uptake across the Escherichia coli cytoplasmic membrane by an unknown mechanism.	1
441	Intracellular interleukin-4 (Th2 cytokine) and @PROTEIN$ (Th1 cytokine) production was assessed in CD4+ T lymphocytes activated by phorbol 12-myristate 13-acetate and @COMPOUND$ using flow cytometry.	1
442	Intracellular interleukin-4 (Th2 cytokine) and interferon-gamma (@PROTEIN$ cytokine) production was assessed in CD4+ T lymphocytes activated by @COMPOUND$ and ionomycin using flow cytometry.	1
443	Intracellular interleukin-4 (Th2 cytokine) and @PROTEIN$ (Th1 cytokine) production was assessed in CD4+ T lymphocytes activated by @COMPOUND$ and ionomycin using flow cytometry.	1
444	Intracellular interleukin-4 (Th2 cytokine) and interferon-gamma (@PROTEIN$ cytokine) production was assessed in CD4+ T lymphocytes activated by phorbol 12-myristate 13-acetate and @COMPOUND$ using flow cytometry.	1
445	@PROTEIN$ is important to this response because it increases @COMPOUND$ uptake.	1
446	Biological testing of the compound demonstrated a significant antidiabetic activity by reducing the elevated blood glucose levels and restoring the @PROTEIN$ levels in @COMPOUND$-induced diabetic rats.	0
447	Biological testing of the compound demonstrated a significant antidiabetic activity by reducing the elevated blood @COMPOUND$ levels and restoring the @PROTEIN$ levels in streptozotocin-induced diabetic rats.	0
448	E(2) increased the expression of @PROTEIN$ and caveolin-2 mRNA and proteins, but pre-treatment with @COMPOUND$ (an estrogen receptor (ER) antagonist) inhibited E(2)-induced increase in caveolin-1 and caveolin-2 proteins expression.	1
449	E(2) increased the expression of caveolin-1 and @PROTEIN$ mRNA and proteins, but pre-treatment with @COMPOUND$ (an estrogen receptor (ER) antagonist) inhibited E(2)-induced increase in caveolin-1 and caveolin-2 proteins expression.	1
450	Phospho-@PROTEIN$ was significantly blocked by @COMPOUND$ or pyrazolopyrimidine 2 (PP2 ; a Src-kinase inhibitor).	1
451	Phospho-@PROTEIN$ was significantly blocked by ICI 182,780 or @COMPOUND$ 2 (PP2 ; a Src-kinase inhibitor).	1
452	LY 294002 (a PI3K inhibitor) or PD 98059 (an ERK1/2 inhibitor) prevented E(2)-induced increase in @PROTEIN$ expression and the accompanying ((3)H)-@COMPOUND$ incorporation.	1
453	LY 294002 (a PI3K inhibitor) or @COMPOUND$ (an ERK1/2 inhibitor) prevented E(2)-induced increase in @PROTEIN$ expression and the accompanying ((3)H)-thymidine incorporation.	1
454	@COMPOUND$ (a PI3K inhibitor) or PD 98059 (an ERK1/2 inhibitor) prevented E(2)-induced increase in @PROTEIN$ expression and the accompanying ((3)H)-thymidine incorporation.	1
455	Furthermore, inhibition of caveolin-1 expression using a caveolin-1 siRNA significantly attenuated E(2)-induced up-regulation of proto-oncogenes, @PROTEIN$, ((3)H)-@COMPOUND$ incorporation, overall cell number, and percent of the cell population in S phase, while mediating a concomitant increase in the G0/G1 population.	0
456	During the early response in AR, @COMPOUND$ has been found to be the most abundant mediator and it is associated with many symptoms of this disease mediated through the @PROTEIN$.	1
457	During the incubation of @COMPOUND$ with para-hydroquinones using @PROTEIN$ as biocatalyst, one or two main products were formed.	1
458	Arginine-specific @PROTEIN$ (Art) catalyzes the mono-ADP-ribosylation, in which it transfers a single ADP-ribose moiety of NAD to the @COMPOUND$ residue(s) of target proteins, and may regulate the function of the proteins or peptides in cellular processes.	1
459	@COMPOUND$-specific @PROTEIN$ (Art) catalyzes the mono-ADP-ribosylation, in which it transfers a single ADP-ribose moiety of NAD to the arginine residue(s) of target proteins, and may regulate the function of the proteins or peptides in cellular processes.	1
460	Arginine-specific @PROTEIN$ (Art) catalyzes the mono-ADP-ribosylation, in which it transfers a single ADP-ribose moiety of @COMPOUND$ to the arginine residue(s) of target proteins, and may regulate the function of the proteins or peptides in cellular processes.	1
461	Solamargine induces apoptosis and enhances susceptibility to trastuzumab and @COMPOUND$ in breast cancer cells with low or high expression levels of HER2/@PROTEIN$.	0
462	@COMPOUND$ induces apoptosis and enhances susceptibility to trastuzumab and epirubicin in breast cancer cells with low or high expression levels of @PROTEIN$/neu.	0
463	Solamargine induces apoptosis and enhances susceptibility to trastuzumab and @COMPOUND$ in breast cancer cells with low or high expression levels of @PROTEIN$/neu.	0
464	@COMPOUND$ induces apoptosis and enhances susceptibility to trastuzumab and epirubicin in breast cancer cells with low or high expression levels of HER2/@PROTEIN$.	0
465	SM (@COMPOUND$), a major steroidal alkaloid glycoside purified from Solanum incanum, triggered apoptosis of breast cancer cells (MCF-7 and SK-BR-3 cells) and non-cancerous breast epithelial cells (HBL-100 cells) within 3 h. To extend the application of trastuzumab in breast cancer patients, the regulation of @PROTEIN$/neu expression by SM was investigated.	0
466	SM (solamargine), a major @COMPOUND$ glycoside purified from Solanum incanum, triggered apoptosis of breast cancer cells (MCF-7 and SK-BR-3 cells) and non-cancerous breast epithelial cells (HBL-100 cells) within 3 h. To extend the application of trastuzumab in breast cancer patients, the regulation of HER2/@PROTEIN$ expression by SM was investigated.	0
467	SM (@COMPOUND$), a major steroidal alkaloid glycoside purified from Solanum incanum, triggered apoptosis of breast cancer cells (MCF-7 and SK-BR-3 cells) and non-cancerous breast epithelial cells (HBL-100 cells) within 3 h. To extend the application of trastuzumab in breast cancer patients, the regulation of HER2/@PROTEIN$ expression by SM was investigated.	0
468	SM (solamargine), a major @COMPOUND$ glycoside purified from Solanum incanum, triggered apoptosis of breast cancer cells (MCF-7 and SK-BR-3 cells) and non-cancerous breast epithelial cells (HBL-100 cells) within 3 h. To extend the application of trastuzumab in breast cancer patients, the regulation of @PROTEIN$/neu expression by SM was investigated.	0
469	The aim of this phase 0 study was to investigate whether @COMPOUND$ passes the blood-tumor barrier, and is phosphorylated in the tumor by @PROTEIN$ (dCK) to gemcitabine nucleotides in order to enable radiosensitization, and whether it is deaminated by deoxycytidine deaminase (dCDA) to dFdU.	1
470	The aim of this phase 0 study was to investigate whether @COMPOUND$ passes the blood-tumor barrier, and is phosphorylated in the tumor by deoxycytidine kinase (@PROTEIN$) to gemcitabine nucleotides in order to enable radiosensitization, and whether it is deaminated by deoxycytidine deaminase (dCDA) to dFdU.	1
471	Serum @COMPOUND$ (E2) levels were not altered at any time point after @PROTEIN$, demonstrating that the increased KiSS-1 expression observed was not caused by an elevation in E2.	0
472	@COMPOUND$ replacement to euglycemia causes hypoxia, acidosis, and decreased @PROTEIN$ secretion in fetal sheep with intrauterine growth restriction.	1
473	@COMPOUND$ stimulated @PROTEIN$ secretion (GSIS) was lower in the Glu group.	1
474	These data confirm that endogenous miR-34a regulates @PROTEIN$ levels and supports the notion that miR-34a contributes to the effects of @COMPOUND$ and VPA on GRM7.	1
475	Here, we found that the addition of glucocorticoids, such as dexamethasone and @COMPOUND$, to cultured human keratinocytes increased their @PROTEIN$ gene expression.	1
476	Here, we found that the addition of glucocorticoids, such as @COMPOUND$ and cortisol, to cultured human keratinocytes increased their @PROTEIN$ gene expression.	1
477	Gene expression of mitogen-activated protein kinase (@PROTEIN$) phosphatase-1 was also increased by the addition of @COMPOUND$.	1
478	Osteointegration of @COMPOUND$ or its alloy with bone can be greatly improved by calcium phosphate coatings, and further enhanced by an extracellular @PROTEIN$ layer such as collagen.	1
479	Osteointegration of titanium or its alloy with bone can be greatly improved by @COMPOUND$ coatings, and further enhanced by an extracellular @PROTEIN$ layer such as collagen.	0
480	Although the overall amino acid identity between @PROTEIN$ and the LeuT(Aa) is only 17%, it increases to above 50% in the first shell of the putative 5-HT binding site, allowing de novo computational docking of @COMPOUND$ derivatives in atomic detail.	0
481	The magnitude of autophagosome formation is tightly regulated by intracellular and extracellular amino acid concentrations and @COMPOUND$ levels via signaling pathways that include the nutrient sensing kinase @PROTEIN$.	1
482	Intracellular concentrations of @COMPOUND$+) modulate the strength of signal and alter the outcomes of cytotoxic T-lymphocyte antigen-4 (CD152)-@PROTEIN$/CD86 interactions in CD4 (+) T lymphocytes.	1
483	Intracellular concentrations of @COMPOUND$+) modulate the strength of signal and alter the outcomes of cytotoxic T-lymphocyte antigen-4 (CD152)-CD80/@PROTEIN$ interactions in CD4 (+) T lymphocytes.	1
484	Intracellular concentrations of @COMPOUND$+) modulate the strength of signal and alter the outcomes of cytotoxic T-lymphocyte @PROTEIN$ (CD152)-CD80/CD86 interactions in CD4 (+) T lymphocytes.	1
485	Intracellular concentrations of @COMPOUND$+) modulate the strength of signal and alter the outcomes of cytotoxic T-lymphocyte antigen-4 (@PROTEIN$)-CD80/CD86 interactions in CD4 (+) T lymphocytes.	1
486	During activation with @COMPOUND$ and low amounts of I, intracellular concentrations of calcium ((Ca(2+))(i)) were greatly reduced upon CTLA-4-@PROTEIN$/CD86 blockade.	1
487	During activation with PMA and low amounts of I, intracellular concentrations of calcium ((@COMPOUND$+))(i)) were greatly reduced upon CTLA-4-CD80/@PROTEIN$ blockade.	1
488	During activation with @COMPOUND$ and low amounts of I, intracellular concentrations of calcium ((Ca(2+))(i)) were greatly reduced upon CTLA-4-CD80/@PROTEIN$ blockade.	1
489	During activation with @COMPOUND$ and low amounts of I, intracellular concentrations of calcium ((Ca(2+))(i)) were greatly reduced upon @PROTEIN$-CD80/CD86 blockade.	1
490	During activation with PMA and low amounts of I, intracellular concentrations of calcium ((@COMPOUND$+))(i)) were greatly reduced upon CTLA-4-@PROTEIN$/CD86 blockade.	1
491	During activation with PMA and low amounts of I, intracellular concentrations of calcium ((@COMPOUND$+))(i)) were greatly reduced upon @PROTEIN$-CD80/CD86 blockade.	1
492	Further experiments demonstrated that CTLA-4-@PROTEIN$/CD86 interactions reduced cell cycling upon activation with @COMPOUND$ and high amounts of I or TG (high SOS) but the opposite occurred with PMA and low amounts of I or TG (low SOS).	1
493	Further experiments demonstrated that CTLA-4-@PROTEIN$/CD86 interactions reduced cell cycling upon activation with PMA and high amounts of I or TG (high @COMPOUND$) but the opposite occurred with PMA and low amounts of I or TG (low SOS).	1
494	Further experiments demonstrated that @PROTEIN$-CD80/CD86 interactions reduced cell cycling upon activation with PMA and high amounts of I or TG (high @COMPOUND$) but the opposite occurred with PMA and low amounts of I or TG (low SOS).	1
495	Further experiments demonstrated that CTLA-4-CD80/@PROTEIN$ interactions reduced cell cycling upon activation with @COMPOUND$ and high amounts of I or TG (high SOS) but the opposite occurred with PMA and low amounts of I or TG (low SOS).	1
496	Further experiments demonstrated that @PROTEIN$-CD80/CD86 interactions reduced cell cycling upon activation with @COMPOUND$ and high amounts of I or TG (high SOS) but the opposite occurred with PMA and low amounts of I or TG (low SOS).	1
497	Further experiments demonstrated that CTLA-4-CD80/@PROTEIN$ interactions reduced cell cycling upon activation with PMA and high amounts of I or TG (high @COMPOUND$) but the opposite occurred with PMA and low amounts of I or TG (low SOS).	1
498	We found that postovulatory administration of 1.5 mg of @COMPOUND$ to women with a subsequent or existing early pregnancy did not affect the immunohistochemical expressions of @PROTEIN$ (ER (alpha), ER (beta)), P receptors (PR(B), PR(A+B)), androgen receptor (AR), or proliferation index Ki67 in the first-trimester decidua and chorionic villi.	0
499	We found that postovulatory administration of 1.5 mg of @COMPOUND$ to women with a subsequent or existing early pregnancy did not affect the immunohistochemical expressions of estrogen receptors (ER (alpha), ER (beta)), P receptors (PR(B), PR(A+B)), @PROTEIN$ (AR), or proliferation index Ki67 in the first-trimester decidua and chorionic villi.	0
500	High-level toxin production occurred after detectable spore germination in all experiments except those with C. difficile PCR ribotype 027 and @COMPOUND$, in which marked @PROTEIN$ production preceded detectable germination, which coincided with isolate recovery on fluoroquinolone-containing medium.	0
501	Furthermore, @PROTEIN$ overexpression reduced @COMPOUND$ anion generation after H/R, whereas glutathione levels were significantly improved compared with WT controls.	1
502	Furthermore, @PROTEIN$ overexpression reduced superoxide anion generation after H/R, whereas @COMPOUND$ levels were significantly improved compared with WT controls.	1
503	Our previous studies have shown that @COMPOUND$ (5-HT) altered under diabetic condition was accompanied by alterations of protein kinase C-alpha (@PROTEIN$) and CaMKII, and those alterations were reversed after insulin administration.	1
504	Our previous studies have shown that @COMPOUND$ (5-HT) altered under diabetic condition was accompanied by alterations of protein kinase C-alpha (PKC-alpha) and CaMKII, and those alterations were reversed after @PROTEIN$ administration.	1
505	Our previous studies have shown that serotonin (@COMPOUND$) altered under diabetic condition was accompanied by alterations of protein kinase C-alpha (@PROTEIN$) and CaMKII, and those alterations were reversed after insulin administration.	1
506	Our previous studies have shown that serotonin (@COMPOUND$) altered under diabetic condition was accompanied by alterations of protein kinase C-alpha (PKC-alpha) and @PROTEIN$, and those alterations were reversed after insulin administration.	1
507	Our previous studies have shown that serotonin (@COMPOUND$) altered under diabetic condition was accompanied by alterations of @PROTEIN$-alpha (PKC-alpha) and CaMKII, and those alterations were reversed after insulin administration.	1
508	Our previous studies have shown that serotonin (@COMPOUND$) altered under diabetic condition was accompanied by alterations of protein kinase C-alpha (PKC-alpha) and CaMKII, and those alterations were reversed after @PROTEIN$ administration.	1
509	Our previous studies have shown that @COMPOUND$ (5-HT) altered under diabetic condition was accompanied by alterations of @PROTEIN$-alpha (PKC-alpha) and CaMKII, and those alterations were reversed after insulin administration.	1
510	Our previous studies have shown that @COMPOUND$ (5-HT) altered under diabetic condition was accompanied by alterations of protein kinase C-alpha (PKC-alpha) and @PROTEIN$, and those alterations were reversed after insulin administration.	1
511	The current study showed that alloxan-induced diabetic animals revealed hyperglycemia and was associated with an increase in the content of @COMPOUND$, @PROTEIN$ expression and PKC 0.05) simultaneously in striatum (ST), midbrain (MB), pons medulla (PM), cerebellum (CB), and cerebral cortex (CCX) from 7 days to 60 days.	0
512	The current study showed that @COMPOUND$-induced diabetic animals revealed hyperglycemia and was associated with an increase in the content of 5-HT, PKC-alpha expression and PKC 0.05) simultaneously in striatum (ST), midbrain (MB), @PROTEIN$ medulla (PM), cerebellum (CB), and cerebral cortex (CCX) from 7 days to 60 days.	0
513	The current study showed that alloxan-induced diabetic animals revealed hyperglycemia and was associated with an increase in the content of @COMPOUND$, @PROTEIN$-alpha expression and PKC 0.05) simultaneously in striatum (ST), midbrain (MB), pons medulla (PM), cerebellum (CB), and cerebral cortex (CCX) from 7 days to 60 days.	0
514	The current study showed that alloxan-induced diabetic animals revealed hyperglycemia and was associated with an increase in the content of @COMPOUND$, PKC-alpha expression and PKC 0.05) simultaneously in striatum (ST), midbrain (MB), @PROTEIN$ medulla (PM), cerebellum (CB), and cerebral cortex (CCX) from 7 days to 60 days.	0
515	The current study showed that @COMPOUND$-induced diabetic animals revealed hyperglycemia and was associated with an increase in the content of 5-HT, @PROTEIN$ expression and PKC 0.05) simultaneously in striatum (ST), midbrain (MB), pons medulla (PM), cerebellum (CB), and cerebral cortex (CCX) from 7 days to 60 days.	1
516	The current study showed that @COMPOUND$-induced diabetic animals revealed hyperglycemia and was associated with an increase in the content of 5-HT, @PROTEIN$-alpha expression and PKC 0.05) simultaneously in striatum (ST), midbrain (MB), pons medulla (PM), cerebellum (CB), and cerebral cortex (CCX) from 7 days to 60 days.	1
517	Although the @COMPOUND$ levels in hippocampus (HC) and hypothalamus (HT) were not altered, the @PROTEIN$ expression and PKC 0.05) in level in HC.	0
518	Although the @COMPOUND$ levels in hippocampus (HC) and hypothalamus (HT) were not altered, the @PROTEIN$-alpha expression and PKC 0.05) in level in HC.	0
519	Purification, characterization, and preliminary X-ray diffraction analysis of a @COMPOUND$-specific @PROTEIN$ from Cymbosema roseum seeds.	1
520	Here, we report the purification, partial primary structure, carbohydrate affinity characterization, crystallization, and preliminary X-ray diffraction analysis of a @COMPOUND$-specific @PROTEIN$ from Cymbosema roseum seeds (CRLII).	1
521	The @COMPOUND$ (the final product of ATP hydrolysis by @PROTEIN$), have a recognized neuroprotective actions in the central nervous system (CNS) in pathological conditions.	1
522	Inhibition of apoptotic signaling and neointimal hyperplasia by @COMPOUND$ and @PROTEIN$ following vascular injury.	1
523	Repeated injections of arsenic trioxide induced oxidative stress and hepatotoxicity in mice as revealed from elevated levels of glutamate oxaloacetate transaminases, glutamate pyruvate transaminases, acid and alkaline phosphatases, lipid peroxidation along with reduction of @PROTEIN$, catalase, @COMPOUND$ content, glutathione reductase and succinate dehydrogenase activities.	0
524	Repeated injections of arsenic trioxide induced oxidative stress and hepatotoxicity in mice as revealed from elevated levels of glutamate oxaloacetate transaminases, glutamate pyruvate transaminases, acid and @PROTEIN$, lipid peroxidation along with reduction of superoxide dismutase, catalase, @COMPOUND$ content, glutathione reductase and succinate dehydrogenase activities.	0
525	Repeated injections of arsenic trioxide induced oxidative stress and hepatotoxicity in mice as revealed from elevated levels of glutamate oxaloacetate transaminases, glutamate pyruvate transaminases, acid and alkaline phosphatases, lipid peroxidation along with reduction of superoxide dismutase, @PROTEIN$, @COMPOUND$ content, glutathione reductase and succinate dehydrogenase activities.	0
526	Repeated injections of arsenic trioxide induced oxidative stress and hepatotoxicity in mice as revealed from elevated levels of glutamate oxaloacetate transaminases, glutamate pyruvate transaminases, acid and alkaline phosphatases, lipid peroxidation along with reduction of superoxide dismutase, catalase, @COMPOUND$ content, @PROTEIN$ and succinate dehydrogenase activities.	0
527	Hepatoprotective potential of vitamin C was indicated by its ability to restore @COMPOUND$, SOD, @PROTEIN$, AcP, AlkP and GRD levels towards near normal.	0
528	Hepatoprotective potential of vitamin C was indicated by its ability to restore @COMPOUND$, @PROTEIN$, CAT, AcP, AlkP and GRD levels towards near normal.	0
529	Hepatoprotective potential of vitamin C was indicated by its ability to restore @COMPOUND$, SOD, CAT, @PROTEIN$, AlkP and GRD levels towards near normal.	0
530	Hepatoprotective potential of vitamin C was indicated by its ability to restore @COMPOUND$, SOD, CAT, AcP, AlkP and @PROTEIN$ levels towards near normal.	0
531	Under optimum conditions, the fluorescence intensity of @PROTEIN$-GNPs is linearly proportional to @COMPOUND$ concentration from 6.0x10(-8)mol/L to 8.0x10(-6)mol/L with a detection limit of 1.0x10(-8)mol/L.	1
532	Among the Gram-negative bacteria, 100% of the Escherichia coli isolates (including extended spectrum @PROTEIN$ (ESBL)-producers) were @COMPOUND$-susceptible, while about 10% of the Enterobacter cloacae and Klebsiella pneumoniae isolates were resistant.	1
533	No relationships were observed among mercury, selenium, and several other neurochemical biomarkers (dopamine-2, @COMPOUND$ type A, muscarinic cholinergic, and nicotinic cholinergic receptors; @PROTEIN$ and monoamine oxidase enzymes).	0
534	No relationships were observed among mercury, @COMPOUND$, and several other neurochemical biomarkers (dopamine-2, gamma-aminobutyric acid type A, muscarinic cholinergic, and nicotinic cholinergic receptors; @PROTEIN$ and monoamine oxidase enzymes).	0
535	No relationships were observed among mercury, selenium, and several other neurochemical biomarkers (@COMPOUND$-2, gamma-aminobutyric acid type A, muscarinic cholinergic, and nicotinic cholinergic receptors; @PROTEIN$ and monoamine oxidase enzymes).	0
536	No relationships were observed among mercury, @COMPOUND$, and several other neurochemical biomarkers (dopamine-2, gamma-aminobutyric acid type A, muscarinic cholinergic, and nicotinic cholinergic receptors; cholinesterase and @PROTEIN$ enzymes).	0
537	No relationships were observed among mercury, selenium, and several other neurochemical biomarkers (@COMPOUND$-2, gamma-aminobutyric acid type A, muscarinic cholinergic, and nicotinic cholinergic receptors; cholinesterase and @PROTEIN$ enzymes).	0
538	No relationships were observed among mercury, selenium, and several other neurochemical biomarkers (dopamine-2, @COMPOUND$ type A, muscarinic cholinergic, and nicotinic cholinergic receptors; cholinesterase and @PROTEIN$ enzymes).	0
539	No relationships were observed among @COMPOUND$, selenium, and several other neurochemical biomarkers (dopamine-2, gamma-aminobutyric acid type A, muscarinic cholinergic, and nicotinic cholinergic receptors; cholinesterase and @PROTEIN$ enzymes).	0
540	No relationships were observed among @COMPOUND$, selenium, and several other neurochemical biomarkers (dopamine-2, gamma-aminobutyric acid type A, muscarinic cholinergic, and nicotinic cholinergic receptors; @PROTEIN$ and monoamine oxidase enzymes).	0
541	Treatment with @COMPOUND$ resulted in dose- and time-dependent inhibition of growth of BeWo cells with IC(50) values of 2.01 and 1.19 microM for 7 and 24 h respectively, accompanied by downregulation of @PROTEIN$.	1
542	Obesity increases @PROTEIN$ resistance and @COMPOUND$ intolerance and also exacerbates metabolic abnormalities present in type 2 diabetes.	0
543	Crustacean hyperglycemic hormone (@PROTEIN$) not only plays an important role in the modulation of hemolymph @COMPOUND$ level but also functions in other biological events including molting, reproduction and stress response.	1
544	@PROTEIN$ (CHH) not only plays an important role in the modulation of hemolymph @COMPOUND$ level but also functions in other biological events including molting, reproduction and stress response.	1
545	We demonstrate for the first time that several developmental stages of the human parasite Schistosoma mansoni express @PROTEIN$, which is responsible for the hydrolysis of l-@COMPOUND$ to l-ornithine and urea.	1
546	We demonstrate for the first time that several developmental stages of the human parasite Schistosoma mansoni express @PROTEIN$, which is responsible for the hydrolysis of l-arginine to l-ornithine and @COMPOUND$.	1
547	We demonstrate for the first time that several developmental stages of the human parasite Schistosoma mansoni express @PROTEIN$, which is responsible for the hydrolysis of l-arginine to @COMPOUND$ and urea.	1
548	If no pretreatment applied, hydrolyses of the textiles by cellulase and @PROTEIN$ for 24 h followed by simultaneous saccharification and fermentation (SSF) in 4 days, resulted in 0.140-0.145 g @COMPOUND$/g textiles, which was 25-26% of the corresponding theoretical yield.	1
549	If no pretreatment applied, hydrolyses of the textiles by @PROTEIN$ and beta-glucosidase for 24 h followed by simultaneous saccharification and fermentation (SSF) in 4 days, resulted in 0.140-0.145 g @COMPOUND$/g textiles, which was 25-26% of the corresponding theoretical yield.	1
550	Angiotensin II (@PROTEIN$) stimulation of water and @COMPOUND$ intake is a classic model of the behavioural effects of hormones.	1
551	@PROTEIN$ (AngII) stimulation of water and @COMPOUND$ intake is a classic model of the behavioural effects of hormones.	1
552	Previous studies support the hypotheses that @PROTEIN$ is involved in AngII-induced water, but not @COMPOUND$ intake and that MAP kinase plays a role in NaCl consumption, but not water intake, after injection of AngII.	0
553	Pretreatment with the PKC inhibitor chelerythrine attenuated @PROTEIN$-induced water intake, but @COMPOUND$ intake was unaffected.	0
554	Pretreatment with the PKC inhibitor @COMPOUND$ attenuated @PROTEIN$-induced water intake, but NaCl intake was unaffected.	1
555	In contrast, pretreatment with U0126, a MAP kinase inhibitor, had no effect on @PROTEIN$-induced water intake, but attenuated @COMPOUND$ intake.	0
556	Transitions in the @COMPOUND$ microenvironment and secondary structure of two monocot @PROTEIN$ from Sauromatum guttatum and Arisaema tortuosum under different denaturing conditions were studied by steady state and time resolved fluorescence and CD spectroscopy.	0
557	The @PROTEIN$ exist as tetramers with a single @COMPOUND$ residue estimated per monomer, present in a polar environment.	1
558	Similarly, both the @PROTEIN$ showed a drastic loss of secondary structure in 5 M Gdn-@COMPOUND$ or 6 M Urea or at pH 2.0 and below.	1
559	Similarly, both the @PROTEIN$ showed a drastic loss of secondary structure in 5 M Gdn-HCl or 6 M @COMPOUND$ or at pH 2.0 and below.	1
560	Similarly, both the @PROTEIN$ showed a drastic loss of secondary structure in 5 M @COMPOUND$-HCl or 6 M Urea or at pH 2.0 and below.	1
561	Phosphorylation of insulin receptor substrate (@PROTEIN$) proteins on @COMPOUND$ residues has emerged as a key step in these control processes under both physiological and pathological conditions.	1
562	Phosphorylation of @PROTEIN$ substrate (IRS) proteins on @COMPOUND$ residues has emerged as a key step in these control processes under both physiological and pathological conditions.	1
563	The progressive ankylosis gene (ank) is a @PROTEIN$ that transports intracellular @COMPOUND$ to the extracellular milieu.	1
564	However, @COMPOUND$ was equally effective in @PROTEIN$alpha1(-/-) and wild-type animals, suggesting additional AMPK-independent action of phenformin.	0
565	These evoked expressions at both molecular and cellular levels were significantly inhibited after TRPV(1) receptors were blocked by 5'-iodoresiniferatoxin (5 microg) or @PROTEIN$ was inhibited by @COMPOUND$ chloride (5 microg).	1
566	These evoked expressions at both molecular and cellular levels were significantly inhibited after TRPV(1) receptors were blocked by @COMPOUND$ (5 microg) or @PROTEIN$ was inhibited by chelerythrine chloride (5 microg).	0
567	These evoked expressions at both molecular and cellular levels were significantly inhibited after TRPV(1) receptors were blocked by 5'-iodoresiniferatoxin (5 microg) or @PROTEIN$ was inhibited by chelerythrine @COMPOUND$ (5 microg).	1
568	Associated with the mitochondrial permeabilization, PdC also induced the release of @PROTEIN$, which is sensitive to inhibition by @COMPOUND$.	1
569	Here we report identification of the first three in vivo non-histone protein substrates of @COMPOUND$ propionylation in eukaryotic cells: p53, p300, and @PROTEIN$.	1
570	Here we report identification of the first three in vivo non-histone protein substrates of @COMPOUND$ propionylation in eukaryotic cells: @PROTEIN$, p300, and CREB-binding protein.	1
571	Here we report identification of the first three in vivo non-histone protein substrates of @COMPOUND$ propionylation in eukaryotic cells: p53, @PROTEIN$, and CREB-binding protein.	1
572	@PROTEIN$ was able to perform autopropionylation on @COMPOUND$ residues in cells.	1
573	@COMPOUND$ (GSH), catalase (@PROTEIN$), and malondialdehyde (MDA) activities in blood were measured.	0
574	Glutathione (@COMPOUND$), catalase (@PROTEIN$), and malondialdehyde (MDA) activities in blood were measured.	0
575	Glutathione (GSH), catalase (@PROTEIN$), and @COMPOUND$ (MDA) activities in blood were measured.	0
576	Glutathione (@COMPOUND$), @PROTEIN$ (CAT), and malondialdehyde (MDA) activities in blood were measured.	0
577	Glutathione (GSH), @PROTEIN$ (CAT), and @COMPOUND$ (MDA) activities in blood were measured.	0
578	@COMPOUND$ (GSH), @PROTEIN$ (CAT), and malondialdehyde (MDA) activities in blood were measured.	0
579	Catalase, myeloperoxidase (@PROTEIN$), glutathione peroxidase (GSH-Px), glutathione reductase (GR), @COMPOUND$, and nitric oxide (NO) activities were measured from tissue samples.	0
580	Catalase, myeloperoxidase (MPO), glutathione peroxidase (GSH-Px), @PROTEIN$ (GR), malondialdehyde, and @COMPOUND$ (NO) activities were measured from tissue samples.	0
581	@PROTEIN$, myeloperoxidase (MPO), glutathione peroxidase (GSH-Px), glutathione reductase (GR), malondialdehyde, and @COMPOUND$ (NO) activities were measured from tissue samples.	0
582	Catalase, myeloperoxidase (MPO), @PROTEIN$ (GSH-Px), glutathione reductase (GR), @COMPOUND$, and nitric oxide (NO) activities were measured from tissue samples.	0
583	Catalase, myeloperoxidase (MPO), @PROTEIN$ (GSH-Px), glutathione reductase (GR), malondialdehyde, and @COMPOUND$ (NO) activities were measured from tissue samples.	0
584	@PROTEIN$, myeloperoxidase (MPO), glutathione peroxidase (GSH-Px), glutathione reductase (GR), @COMPOUND$, and nitric oxide (NO) activities were measured from tissue samples.	0
585	Catalase, myeloperoxidase (MPO), glutathione peroxidase (GSH-Px), @PROTEIN$ (GR), @COMPOUND$, and nitric oxide (NO) activities were measured from tissue samples.	0
586	Catalase, myeloperoxidase (@PROTEIN$), glutathione peroxidase (GSH-Px), glutathione reductase (GR), malondialdehyde, and @COMPOUND$ (NO) activities were measured from tissue samples.	0
587	The present study was undertaken to test the hypothesis that PPARalpha activator @COMPOUND$ plays a key role in left ventricular hypertrophic remodelling via the formation of c-@PROTEIN$/c-jun heterodimers in spontaneous hypertensive rats (SHRs).	1
588	The present study was undertaken to test the hypothesis that PPARalpha activator @COMPOUND$ plays a key role in left ventricular hypertrophic remodelling via the formation of c-fos/c-@PROTEIN$ heterodimers in spontaneous hypertensive rats (SHRs).	1
589	This study is aimed to investigate the effects of @COMPOUND$ (TEGDMA) and 2-hydroxyethyl methacrylate (HEMA) on expression of @PROTEIN$ (COX-2) and inducible nitric oxide synthase (iNOS) in cultured murine macrophage cell line RAW 264.7.	1
590	This study is aimed to investigate the effects of @COMPOUND$ (TEGDMA) and 2-hydroxyethyl methacrylate (HEMA) on expression of cyclooxygenase-2 (@PROTEIN$) and inducible nitric oxide synthase (iNOS) in cultured murine macrophage cell line RAW 264.7.	1
591	This study is aimed to investigate the effects of @COMPOUND$ (TEGDMA) and 2-hydroxyethyl methacrylate (HEMA) on expression of cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (@PROTEIN$) in cultured murine macrophage cell line RAW 264.7.	1
592	This study is aimed to investigate the effects of triethyleneglycol dimethacrylate (TEGDMA) and @COMPOUND$ (HEMA) on expression of cyclooxygenase-2 (COX-2) and inducible @PROTEIN$ (iNOS) in cultured murine macrophage cell line RAW 264.7.	1
593	This study is aimed to investigate the effects of triethyleneglycol dimethacrylate (TEGDMA) and @COMPOUND$ (HEMA) on expression of cyclooxygenase-2 (@PROTEIN$) and inducible nitric oxide synthase (iNOS) in cultured murine macrophage cell line RAW 264.7.	1
594	This study is aimed to investigate the effects of triethyleneglycol dimethacrylate (TEGDMA) and @COMPOUND$ (HEMA) on expression of cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (@PROTEIN$) in cultured murine macrophage cell line RAW 264.7.	1
595	This study is aimed to investigate the effects of @COMPOUND$ (TEGDMA) and 2-hydroxyethyl methacrylate (HEMA) on expression of cyclooxygenase-2 (COX-2) and inducible @PROTEIN$ (iNOS) in cultured murine macrophage cell line RAW 264.7.	1
596	This study is aimed to investigate the effects of triethyleneglycol dimethacrylate (TEGDMA) and @COMPOUND$ (HEMA) on expression of @PROTEIN$ (COX-2) and inducible nitric oxide synthase (iNOS) in cultured murine macrophage cell line RAW 264.7.	1
597	Intracellular production of @PROTEIN$ and IL-2 after stimulation with phorbol myristate/@COMPOUND$ was flowcytometrically measured in CD4 (+) T cells from peripheral blood (PB) and cerebrospinal fluid (CSF) of 29 patients with multiple sclerosis (MS), and 16 with other inflammatory and 41 with other non-inflammatory neurological diseases.	1
598	Intracellular production of TNFalpha and @PROTEIN$ after stimulation with @COMPOUND$ myristate/ionomycin was flowcytometrically measured in CD4 (+) T cells from peripheral blood (PB) and cerebrospinal fluid (CSF) of 29 patients with multiple sclerosis (MS), and 16 with other inflammatory and 41 with other non-inflammatory neurological diseases.	1
599	Intracellular production of @PROTEIN$ and IL-2 after stimulation with @COMPOUND$ myristate/ionomycin was flowcytometrically measured in CD4 (+) T cells from peripheral blood (PB) and cerebrospinal fluid (CSF) of 29 patients with multiple sclerosis (MS), and 16 with other inflammatory and 41 with other non-inflammatory neurological diseases.	1
600	Intracellular production of TNFalpha and @PROTEIN$ after stimulation with phorbol myristate/@COMPOUND$ was flowcytometrically measured in CD4 (+) T cells from peripheral blood (PB) and cerebrospinal fluid (CSF) of 29 patients with multiple sclerosis (MS), and 16 with other inflammatory and 41 with other non-inflammatory neurological diseases.	1
601	Intracellular production of @PROTEIN$ and IL-2 after stimulation with phorbol @COMPOUND$/ionomycin was flowcytometrically measured in CD4 (+) T cells from peripheral blood (PB) and cerebrospinal fluid (CSF) of 29 patients with multiple sclerosis (MS), and 16 with other inflammatory and 41 with other non-inflammatory neurological diseases.	1
602	Intracellular production of TNFalpha and @PROTEIN$ after stimulation with phorbol @COMPOUND$/ionomycin was flowcytometrically measured in CD4 (+) T cells from peripheral blood (PB) and cerebrospinal fluid (CSF) of 29 patients with multiple sclerosis (MS), and 16 with other inflammatory and 41 with other non-inflammatory neurological diseases.	1
603	The vasodilating effect of @COMPOUND$ and dorzolamide involves mechanisms other than @PROTEIN$ inhibition.	0
604	The vasodilating effect of acetazolamide and @COMPOUND$ involves mechanisms other than @PROTEIN$ inhibition.	0
605	The optimal condition for the labeling of cypate to @PROTEIN$ was 4 h reaction duration at 4 degrees C and pH 8.5 under catalysis by HOBt/@COMPOUND$.	1
606	The optimal condition for the labeling of cypate to @PROTEIN$ was 4 h reaction duration at 4 degrees C and pH 8.5 under catalysis by @COMPOUND$/HBTU.	1
607	The @PROTEIN$-deficient mouse, which develops atherosclerotic lesions rapidly when fed @COMPOUND$, was used to determine the ability of dried plums to reduce atherosclerosis.	0
608	Urinary @COMPOUND$-reactive substances (TBARS) excretion and serum amyloid P-component (@PROTEIN$) were measured as indicators of oxidative stress and inflammation, respectively.	0
609	Urinary @COMPOUND$-reactive substances (TBARS) excretion and @PROTEIN$ (SAP) were measured as indicators of oxidative stress and inflammation, respectively.	0
610	The inhibitors include mitogen-inducible gene-6 (@PROTEIN$)/receptor-associated late transducer (RALT)/Gene 33, fibroblast growth factor receptor substrate 2beta (FRS2beta)/suc1-associated neurotrophic factor target-2 (SNT-2)/FRS3, suppressor of cytokine signaling 3 (SOCS3)/SOCS4/SOCS5, and @COMPOUND$-rich repeats and immunoglobulin-like domains 1 (LRIG1).	0
611	The inhibitors include mitogen-inducible gene-6 (Mig-6)/receptor-associated late transducer (RALT)/Gene 33, fibroblast growth factor receptor substrate 2beta (FRS2beta)/suc1-associated neurotrophic factor target-2 (SNT-2)/FRS3, suppressor of cytokine signaling 3 (SOCS3)/SOCS4/SOCS5, and @COMPOUND$-rich repeats and immunoglobulin-like domains 1 (@PROTEIN$).	0
612	The inhibitors include mitogen-inducible gene-6 (Mig-6)/receptor-associated late transducer (RALT)/Gene 33, fibroblast growth factor receptor substrate 2beta (FRS2beta)/suc1-associated neurotrophic factor target-2 (SNT-2)/FRS3, suppressor of cytokine signaling 3 (SOCS3)/@PROTEIN$/SOCS5, and @COMPOUND$-rich repeats and immunoglobulin-like domains 1 (LRIG1).	0
613	The inhibitors include mitogen-inducible gene-6 (Mig-6)/receptor-associated late transducer (RALT)/Gene 33, fibroblast growth factor receptor substrate 2beta (FRS2beta)/suc1-associated neurotrophic factor target-2 (SNT-2)/FRS3, suppressor of cytokine signaling 3 (SOCS3)/SOCS4/@PROTEIN$, and @COMPOUND$-rich repeats and immunoglobulin-like domains 1 (LRIG1).	0
614	The inhibitors include mitogen-inducible gene-6 (Mig-6)/receptor-associated late transducer (RALT)/Gene 33, fibroblast growth factor receptor substrate 2beta (FRS2beta)/suc1-associated neurotrophic factor target-2 (SNT-2)/FRS3, @PROTEIN$ (SOCS3)/SOCS4/SOCS5, and @COMPOUND$-rich repeats and immunoglobulin-like domains 1 (LRIG1).	0
615	The inhibitors include mitogen-inducible gene-6 (Mig-6)/receptor-associated late transducer (RALT)/Gene 33, fibroblast growth factor receptor substrate 2beta (FRS2beta)/suc1-associated neurotrophic factor target-2 (@PROTEIN$)/FRS3, suppressor of cytokine signaling 3 (SOCS3)/SOCS4/SOCS5, and @COMPOUND$-rich repeats and immunoglobulin-like domains 1 (LRIG1).	0
616	The inhibitors include mitogen-inducible gene-6 (Mig-6)/receptor-associated late transducer (RALT)/Gene 33, fibroblast growth factor receptor substrate 2beta (FRS2beta)/suc1-associated neurotrophic factor target-2 (SNT-2)/@PROTEIN$, suppressor of cytokine signaling 3 (SOCS3)/SOCS4/SOCS5, and @COMPOUND$-rich repeats and immunoglobulin-like domains 1 (LRIG1).	0
617	The inhibitors include mitogen-inducible gene-6 (Mig-6)/receptor-associated late transducer (RALT)/Gene 33, fibroblast growth factor receptor substrate 2beta (FRS2beta)/@PROTEIN$ (SNT-2)/FRS3, suppressor of cytokine signaling 3 (SOCS3)/SOCS4/SOCS5, and @COMPOUND$-rich repeats and immunoglobulin-like domains 1 (LRIG1).	0
618	The inhibitors include mitogen-inducible gene-6 (Mig-6)/receptor-associated late transducer (RALT)/Gene 33, fibroblast growth factor receptor substrate 2beta (FRS2beta)/suc1-associated neurotrophic factor target-2 (SNT-2)/FRS3, suppressor of cytokine signaling 3 (@PROTEIN$)/SOCS4/SOCS5, and @COMPOUND$-rich repeats and immunoglobulin-like domains 1 (LRIG1).	0
619	The inhibitors include mitogen-inducible gene-6 (Mig-6)/receptor-associated late transducer (RALT)/Gene 33, fibroblast growth factor receptor substrate 2beta (@PROTEIN$)/suc1-associated neurotrophic factor target-2 (SNT-2)/FRS3, suppressor of cytokine signaling 3 (SOCS3)/SOCS4/SOCS5, and @COMPOUND$-rich repeats and immunoglobulin-like domains 1 (LRIG1).	0
620	There are no controlled trials comparing @PROTEIN$ and @COMPOUND$ efficacy and therapeutic mechanisms in psoriasis.	0
621	Inhibition of human poly(A)-specific @PROTEIN$ (PARN) by @COMPOUND$ nucleotides: kinetic analysis.	1
622	Inhibition of human poly(A)-specific ribonuclease (@PROTEIN$) by @COMPOUND$ nucleotides: kinetic analysis.	1
623	The aqueous extract was found to be more effective than @COMPOUND$, a classical anticarcinogenic drug, with respect to its action on antioxidant enzymes and @PROTEIN$ in the liver of mice with developing lymphomas.	1
624	The picture of signalling mechanisms underlying the wound-regulated FAD7 expression, and potential roles of @PROTEIN$ proteins as attenuators of wound-induced @COMPOUND$ biosynthesis, are discussed.	0
625	The picture of signalling mechanisms underlying the wound-regulated @PROTEIN$ expression, and potential roles of CPL proteins as attenuators of wound-induced @COMPOUND$ biosynthesis, are discussed.	0
626	An oncogenetic tree model was built using data on mutations of TP53, KRAS2, APC, and @PROTEIN$ genes, methylation at @COMPOUND$ sites of MLH1 and TP16 genes, methylation in tumor (MINT) markers, and microsatellite instability (MSI) for 971 colon tumors from a population-based series.	0
627	An oncogenetic tree model was built using data on mutations of TP53, KRAS2, @PROTEIN$, and BRAF genes, methylation at @COMPOUND$ sites of MLH1 and TP16 genes, methylation in tumor (MINT) markers, and microsatellite instability (MSI) for 971 colon tumors from a population-based series.	0
628	An oncogenetic tree model was built using data on mutations of TP53, KRAS2, APC, and BRAF genes, methylation at @COMPOUND$ sites of @PROTEIN$ and TP16 genes, methylation in tumor (MINT) markers, and microsatellite instability (MSI) for 971 colon tumors from a population-based series.	1
629	An oncogenetic tree model was built using data on mutations of TP53, @PROTEIN$, APC, and BRAF genes, methylation at @COMPOUND$ sites of MLH1 and TP16 genes, methylation in tumor (MINT) markers, and microsatellite instability (MSI) for 971 colon tumors from a population-based series.	0
630	An oncogenetic tree model was built using data on mutations of @PROTEIN$, KRAS2, APC, and BRAF genes, methylation at @COMPOUND$ sites of MLH1 and TP16 genes, methylation in tumor (MINT) markers, and microsatellite instability (MSI) for 971 colon tumors from a population-based series.	0
631	We characterized this selenoprotein @PROTEIN$ which had a single Sec residue at the catalytic site but no @COMPOUND$ (Cys) residues in the protein sequence.	0
632	@PROTEIN$ activity and @COMPOUND$ levels may therefore be altered in 22q11DS individuals.	0
633	@PROTEIN$ (158) genotype and plasma @COMPOUND$ levels were determined in the 22q11DS children.	0
634	Of the 37 E. coli isolated from diarrhoeic calves, @COMPOUND$ (18.9%), F41 (18.9%), heat-stable enterotoxin a (STa) (18.9%), Shiga @PROTEIN$ (Stx1; 13.5%) and Shiga toxin 2 (Stx2 ; 5.4%) and intimin (8.1%) genes were identified by multiplex PCR.	0
635	Of the 37 E. coli isolated from diarrhoeic calves, @COMPOUND$ (18.9%), F41 (18.9%), heat-stable enterotoxin a (STa) (18.9%), Shiga toxin 1 (Stx1; 13.5%) and Shiga toxin 2 (@PROTEIN$ ; 5.4%) and intimin (8.1%) genes were identified by multiplex PCR.	0
636	Of the 37 E. coli isolated from diarrhoeic calves, K99 (18.9%), @COMPOUND$ (18.9%), heat-stable enterotoxin a (STa) (18.9%), Shiga toxin 1 (Stx1; 13.5%) and Shiga toxin 2 (Stx2 ; 5.4%) and @PROTEIN$ (8.1%) genes were identified by multiplex PCR.	0
637	Of the 37 E. coli isolated from diarrhoeic calves, K99 (18.9%), @COMPOUND$ (18.9%), heat-stable enterotoxin a (STa) (18.9%), Shiga @PROTEIN$ (Stx1; 13.5%) and Shiga toxin 2 (Stx2 ; 5.4%) and intimin (8.1%) genes were identified by multiplex PCR.	0
638	Of the 37 E. coli isolated from diarrhoeic calves, @COMPOUND$ (18.9%), F41 (18.9%), heat-stable @PROTEIN$ a (STa) (18.9%), Shiga toxin 1 (Stx1; 13.5%) and Shiga toxin 2 (Stx2 ; 5.4%) and intimin (8.1%) genes were identified by multiplex PCR.	0
639	Of the 37 E. coli isolated from diarrhoeic calves, K99 (18.9%), @COMPOUND$ (18.9%), heat-stable enterotoxin a (STa) (18.9%), Shiga toxin 1 (Stx1; 13.5%) and Shiga toxin 2 (Stx2 ; 5.4%) and intimin (8.1%) genes were identified by multiplex @PROTEIN$.	0
640	Of the 37 E. coli isolated from diarrhoeic calves, @COMPOUND$ (18.9%), F41 (18.9%), heat-stable enterotoxin a (STa) (18.9%), Shiga toxin 1 (Stx1; 13.5%) and Shiga toxin 2 (Stx2 ; 5.4%) and intimin (8.1%) genes were identified by multiplex @PROTEIN$.	0
641	Of the 37 E. coli isolated from diarrhoeic calves, K99 (18.9%), @COMPOUND$ (18.9%), heat-stable @PROTEIN$ a (STa) (18.9%), Shiga toxin 1 (Stx1; 13.5%) and Shiga toxin 2 (Stx2 ; 5.4%) and intimin (8.1%) genes were identified by multiplex PCR.	0
642	Of the 37 E. coli isolated from diarrhoeic calves, K99 (18.9%), @COMPOUND$ (18.9%), heat-stable enterotoxin a (STa) (18.9%), Shiga toxin 1 (Stx1; 13.5%) and Shiga toxin 2 (@PROTEIN$ ; 5.4%) and intimin (8.1%) genes were identified by multiplex PCR.	0
643	Of the 37 E. coli isolated from diarrhoeic calves, @COMPOUND$ (18.9%), F41 (18.9%), heat-stable enterotoxin a (STa) (18.9%), Shiga toxin 1 (Stx1; 13.5%) and Shiga toxin 2 (Stx2 ; 5.4%) and @PROTEIN$ (8.1%) genes were identified by multiplex PCR.	0
644	Of the 18 E. coli isolated from healthy calves, @COMPOUND$ (16.6%) and intimin (55.5%) genes were identified by @PROTEIN$.	0
645	Of the 18 E. coli isolated from healthy calves, @COMPOUND$ (16.6%) and @PROTEIN$ (55.5%) genes were identified by PCR.	0
646	@COMPOUND$, F41, STa, Stx1 and @PROTEIN$ were found as the most common virulence gene markers of E. coli strains isolated from calves with diarrhoea.	0
647	K99, @COMPOUND$, STa, Stx1 and @PROTEIN$ were found as the most common virulence gene markers of E. coli strains isolated from calves with diarrhoea.	0
648	Treatment with @COMPOUND$, but not equimolar mannitol or 3-O-methyl glucose, resulted in phosphorylation and activation of TNF-alpha converting enzyme (TACE) (@PROTEIN$), which were attenuated by sorbinil or AR-specific small interference RNA.	1
649	Treatment with HG, but not equimolar @COMPOUND$ or 3-O-methyl glucose, resulted in phosphorylation and activation of @PROTEIN$ (TACE) (ADAM17), which were attenuated by sorbinil or AR-specific small interference RNA.	0
650	Treatment with HG, but not equimolar mannitol or 3-O-methyl @COMPOUND$, resulted in phosphorylation and activation of TNF-alpha converting enzyme (@PROTEIN$) (ADAM17), which were attenuated by sorbinil or AR-specific small interference RNA.	0
651	Treatment with HG, but not equimolar mannitol or 3-O-methyl glucose, resulted in phosphorylation and activation of @PROTEIN$ (TACE) (ADAM17), which were attenuated by @COMPOUND$ or AR-specific small interference RNA.	1
652	Treatment with @COMPOUND$, but not equimolar mannitol or 3-O-methyl glucose, resulted in phosphorylation and activation of @PROTEIN$ (TACE) (ADAM17), which were attenuated by sorbinil or AR-specific small interference RNA.	1
653	Treatment with HG, but not equimolar @COMPOUND$ or 3-O-methyl glucose, resulted in phosphorylation and activation of TNF-alpha converting enzyme (TACE) (@PROTEIN$), which were attenuated by sorbinil or AR-specific small interference RNA.	0
654	Treatment with HG, but not equimolar mannitol or 3-O-methyl glucose, resulted in phosphorylation and activation of TNF-alpha converting enzyme (TACE) (@PROTEIN$), which were attenuated by @COMPOUND$ or AR-specific small interference RNA.	1
655	Treatment with HG, but not equimolar mannitol or 3-O-methyl @COMPOUND$, resulted in phosphorylation and activation of @PROTEIN$ (TACE) (ADAM17), which were attenuated by sorbinil or AR-specific small interference RNA.	0
656	Treatment with @COMPOUND$, but not equimolar mannitol or 3-O-methyl glucose, resulted in phosphorylation and activation of TNF-alpha converting enzyme (@PROTEIN$) (ADAM17), which were attenuated by sorbinil or AR-specific small interference RNA.	1
657	Treatment with HG, but not equimolar mannitol or 3-O-methyl glucose, resulted in phosphorylation and activation of TNF-alpha converting enzyme (@PROTEIN$) (ADAM17), which were attenuated by @COMPOUND$ or AR-specific small interference RNA.	1
658	Treatment with HG, but not equimolar mannitol or 3-O-methyl @COMPOUND$, resulted in phosphorylation and activation of TNF-alpha converting enzyme (TACE) (@PROTEIN$), which were attenuated by sorbinil or AR-specific small interference RNA.	0
659	Treatment with HG, but not equimolar @COMPOUND$ or 3-O-methyl glucose, resulted in phosphorylation and activation of TNF-alpha converting enzyme (@PROTEIN$) (ADAM17), which were attenuated by sorbinil or AR-specific small interference RNA.	0
660	These results indicate that @COMPOUND$-induced TNF-alpha shedding could be attributed to @PROTEIN$ activation, which is regulated, in part, by PKC-delta and AR.	1
661	These results indicate that @COMPOUND$-induced @PROTEIN$ shedding could be attributed to TACE activation, which is regulated, in part, by PKC-delta and AR.	1
662	These results indicate that @COMPOUND$-induced TNF-alpha shedding could be attributed to TACE activation, which is regulated, in part, by @PROTEIN$ and AR.	0
663	The dark side of @COMPOUND$ deficiency: II. Type 2 diabetes and @PROTEIN$ resistance.	1
664	A considerable body of evidence exists suggesting a link among reduced @COMPOUND$ plasma levels, type 2 diabetes (T2D), and @PROTEIN$ resistance (IR).	1
665	Androgen therapy of hypogonadal men improves @PROTEIN$ sensitivity, fasting @COMPOUND$, and HbA1c levels.	0
666	Radioisotopic localization of (90) @COMPOUND$-ibritumomab tiuxetan in patients with @PROTEIN$+ non-Hodgkin's lymphoma.	1
667	@PROTEIN$-diminished arginine and indolamine 2,3-dioxygenase-diminished tryptophan) or @COMPOUND$ (NO) production.	0
668	@PROTEIN$-diminished @COMPOUND$ and indolamine 2,3-dioxygenase-diminished tryptophan) or nitric oxide (NO) production.	1
669	@PROTEIN$-diminished arginine and indolamine 2,3-dioxygenase-diminished @COMPOUND$) or nitric oxide (NO) production.	0
670	These include typical G-protein (Galphaq/11)-coupled cascades, such as activation of phospholipase C (PLC), and subsequent accumulation of inositol-(1,4,5)-triphosphate (IP3), intracellular @COMPOUND$+) mobilization, and activation of @PROTEIN$.	0
671	Polymorphism in the @PROTEIN$ gene, plasma lipoprotein(a), cardiovascular disease, and low-dose @COMPOUND$ therapy.	0
672	We investigated whether this allele was associated with elevated @PROTEIN$ and cardiovascular risk in the Women's Health Study, a randomized trial of low-dose @COMPOUND$, and whether aspirin reduced cardiovascular risk in minor allele carriers.	0
673	@COMPOUND$-mediated inflammation and @PROTEIN$ resistance in human adipocytes are attenuated by resveratrol.	0
674	Conjugated linoleic acid-mediated inflammation and @PROTEIN$ resistance in human adipocytes are attenuated by @COMPOUND$.	1
675	Inflammation plays a role in trans-10, cis-12 (10,12)-@COMPOUND$ (CLA)-mediated delipidation and @PROTEIN$ resistance in adipocytes.	0
676	Given the anti-inflammatory role of @COMPOUND$ (RSV), we hypothesized that RSV would attenuate inflammation and @PROTEIN$ resistance caused by 10,12 CLA in human adipocytes.	1
677	Wheat germ @PROTEIN$ had a high activity and enantioselectivity only in n-hexane with a high initial water activity (alpha(w) = 0.97), especially with @COMPOUND$ (C 32%, E &gt; 200).	1
678	We recently reported @COMPOUND$ (Hcy)-induced @PROTEIN$-phosphorylation was suppressed by pertussis toxin (PTX), which suggested the involvement of GPCRs in initiating signal transduction.	1
679	Possible binding site for the substrate, prostaglandin H(2) (@COMPOUND$)), was identified by systematically probing the refined molecular structure of @PROTEIN$.	1
680	Bevacizumab (Avastin), ranibizumab (Lucentis) and pegaptanib sodium (@COMPOUND$) are anti-@PROTEIN$ medications that have been used in the treatment of CNV.	1
681	Bevacizumab (Avastin), ranibizumab (Lucentis) and @COMPOUND$ (Macugen) are anti-@PROTEIN$ medications that have been used in the treatment of CNV.	1
682	Some of the peptide derivatives inhibited @PROTEIN$-mediated uptake of ((3)H) @COMPOUND$-Sar.	1
683	Following an oral @COMPOUND$ challenge, there was a weak trend for glucose-stimulated @PROTEIN$ release to be increased in the offspring of dams fed the folate-deficient diet.	1
684	Association between serum retinol-binding @PROTEIN$ and small dense low-density lipoprotein @COMPOUND$ levels in young adult women.	1
685	Adult female X. laevis were injected three times at weekly intervals with the hapten-carrier complex, trinitrophenylated bovine @PROTEIN$ (@COMPOUND$-BSA).	1
686	Adult female X. laevis were injected three times at weekly intervals with the hapten-carrier complex, trinitrophenylated bovine serum albumin (@COMPOUND$-@PROTEIN$).	1
687	By using the system, we obtained four event timing data sets (stimulation by @PROTEIN$ with and without @COMPOUND$ at the concentrations of 0.01, 0.1, and 1 microM).	0
688	Low-density lipoprotein @COMPOUND$ and non-@PROTEIN$ cholesterol and the incidence of cardiovascular disease in an urban Japanese cohort study: The Suita study.	0
689	Only a small number of population-based cohort studies have directly compared the predictive value of low-density lipoprotein @COMPOUND$ (LDL-C) and non-@PROTEIN$ cholesterol (non-HDLC) for coronary artery disease in Asian populations, such as Japan.	0
690	Finally, we show that Vcx1 helps return cytosolic @COMPOUND$+) toward resting levels after shock with high extracellular Ca(2+) much more effectively than @PROTEIN$ and that calcineurin, a protein phosphatase regulator of Vcx1 and Pmc1, had no detectable effects on these factors within the first few minutes of its activation.	0
691	Transgene optimization significantly improves SIN vector titers, @PROTEIN$ expression and reconstitution of @COMPOUND$ production in X-CGD cells.	0
692	@PROTEIN$ is also important in the regulation of @COMPOUND$ signaling, a second messenger implicated in learning, memory, and mood.	1
693	SNs and SMs were exposed to macrophages with and without addition of @COMPOUND$ (LPS), a positive inducer of tumor necrosis factor-alpha (TNF-alpha), interleukin 6 (@PROTEIN$), and nitric oxide (NO).	1
694	SNs and SMs were exposed to macrophages with and without addition of endotoxin lipopolysaccharide (LPS), a positive inducer of tumor necrosis factor-alpha (TNF-alpha), @PROTEIN$ (IL-6), and @COMPOUND$ (NO).	0
695	SNs and SMs were exposed to macrophages with and without addition of endotoxin lipopolysaccharide (LPS), a positive inducer of @PROTEIN$-alpha (TNF-alpha), interleukin 6 (IL-6), and @COMPOUND$ (NO).	0
696	SNs and SMs were exposed to macrophages with and without addition of endotoxin lipopolysaccharide (LPS), a positive inducer of tumor necrosis factor-alpha (@PROTEIN$), interleukin 6 (IL-6), and @COMPOUND$ (NO).	0
697	SNs and SMs were exposed to macrophages with and without addition of @COMPOUND$ (LPS), a positive inducer of tumor necrosis factor-alpha (@PROTEIN$), interleukin 6 (IL-6), and nitric oxide (NO).	1
698	SNs and SMs were exposed to macrophages with and without addition of @COMPOUND$ (LPS), a positive inducer of tumor necrosis factor-alpha (TNF-alpha), @PROTEIN$ (IL-6), and nitric oxide (NO).	1
699	SNs and SMs were exposed to macrophages with and without addition of endotoxin lipopolysaccharide (LPS), a positive inducer of tumor necrosis factor-alpha (TNF-alpha), interleukin 6 (@PROTEIN$), and @COMPOUND$ (NO).	0
700	SNs and SMs were exposed to macrophages with and without addition of @COMPOUND$ (LPS), a positive inducer of @PROTEIN$-alpha (TNF-alpha), interleukin 6 (IL-6), and nitric oxide (NO).	1
701	Silencing of @PROTEIN$, the key entry-point enzyme for @COMPOUND$ biosynthesis led to flavonoid-deficient roots.	1
702	They potentiate @COMPOUND$-induced @PROTEIN$ secretion and may be responsible for up to 70% of postprandial insulin secretion.	1
703	However, in supraphysiological doses, @PROTEIN$ administration may completely normalize beta as well as alpha cell sensitivity to @COMPOUND$.	1
704	Unlike @COMPOUND$, Cystatin C (@PROTEIN$) is believed to be independent of body composition in both adults and children.	0
705	Unlike @COMPOUND$, @PROTEIN$ C (CysC) is believed to be independent of body composition in both adults and children.	0
706	Thereafter we determined that hCG effect could be partially blocked by pharmacologic inhibition of @PROTEIN$ pathway with 50 microM @COMPOUND$ but not by the inhibition of the phosphatidylinositol 3-kinase pathway with 0.1 microm wortmannin.	1
707	Thereafter we determined that hCG effect could be partially blocked by pharmacologic inhibition of @PROTEIN$ pathway with 50 microM PD98059 but not by the inhibition of the phosphatidylinositol 3-kinase pathway with 0.1 microm @COMPOUND$.	0
708	In this study, the degradation of @PROTEIN$- and R-@COMPOUND$ under anaerobic conditions was studied.	0
709	Regulation of muscle protein degradation, not synthesis, by dietary @COMPOUND$ in rats fed @PROTEIN$-deficient diet.	0
710	This study was designed to determine the effect of molsidomine (MO), a precursor of @COMPOUND$ (NO) donor, on hypoxia inducible factor alpha (@PROTEIN$) and Sonic hedgehog (Shh) levels considered to be involved in the development of testes ischemia/reperfusion (I-R) injury.	1
711	This study was designed to determine the effect of @COMPOUND$ (MO), a precursor of nitric oxide (NO) donor, on hypoxia inducible factor alpha (@PROTEIN$) and Sonic hedgehog (Shh) levels considered to be involved in the development of testes ischemia/reperfusion (I-R) injury.	1
712	The @COMPOUND$/@PROTEIN$ (PKA) signaling cascade is crucial for synaptic plasticity in a wide variety of species.	1
713	In the present study, we have investigated the effect of @PROTEIN$ on ABCA1 expression and @COMPOUND$ efflux in THP-1 macrophage-derived foam cells.	1
714	In the present study, we have investigated the effect of IFN-gamma on @PROTEIN$ expression and @COMPOUND$ efflux in THP-1 macrophage-derived foam cells.	0
715	Every 12 weeks intestinal permeability (@COMPOUND$/mannitol ratio), haemoglobin, plasma albumin, alpha-1-acid @PROTEIN$, IgG and Giardia-specific IgM (GSIgM) and eggs of the three common geohelminths and G. intestinalis cysts were determined.	0
716	Every 12 weeks intestinal permeability (lactulose/@COMPOUND$ ratio), haemoglobin, plasma albumin, @PROTEIN$-acid glycoprotein, IgG and Giardia-specific IgM (GSIgM) and eggs of the three common geohelminths and G. intestinalis cysts were determined.	0
717	Every 12 weeks intestinal permeability (@COMPOUND$/mannitol ratio), haemoglobin, plasma albumin, @PROTEIN$-acid glycoprotein, IgG and Giardia-specific IgM (GSIgM) and eggs of the three common geohelminths and G. intestinalis cysts were determined.	0
718	Every 12 weeks intestinal permeability (lactulose/@COMPOUND$ ratio), haemoglobin, plasma albumin, alpha-1-acid @PROTEIN$, IgG and Giardia-specific IgM (GSIgM) and eggs of the three common geohelminths and G. intestinalis cysts were determined.	0
719	Pathways involved in the hydrolysis of nitrile pollutants (aliphatic nitriles, @COMPOUND$ analogues) and the corresponding enzymes (@PROTEIN$, nitrile hydratase) are described in detail.	1
720	In hypersensitive alpha4L9'A mice, injections of a low dose of @COMPOUND$ (0.1 mg/kg) led to strong c-@PROTEIN$ expression in only the ventrolateral region of the MHb, but not in the MHb of wild-type (WT) mice.	1
721	These effects were probably associated with the increase of intracellular @COMPOUND$ in mitochondrial signaling pathway which attributed to the down-regulation of @PROTEIN$ (SOD).	1
722	These effects were probably associated with the increase of intracellular @COMPOUND$ in mitochondrial signaling pathway which attributed to the down-regulation of superoxide dismutase (@PROTEIN$).	1
723	This study confirmed QTL previously identified for pH except those on @PROTEIN$, 11, 12, and X, and found 11 new 5% genome-wise significant QTL for @COMPOUND$-related traits.	0
724	Whole blood and plasma were analyzed for total Se, @PROTEIN$ activity in whole blood (GPX-1) and plasma, and thyroid hormones (thyroxine and @COMPOUND$) in plasma.	0
725	Whole blood and plasma were analyzed for total Se, @PROTEIN$ activity in whole blood (GPX-1) and plasma, and thyroid hormones (@COMPOUND$ and triiodothyronine) in plasma.	0
726	Whole blood and plasma were analyzed for total Se, glutathione peroxidase activity in whole blood (@PROTEIN$) and plasma, and thyroid hormones (thyroxine and @COMPOUND$) in plasma.	0
727	Whole blood and plasma were analyzed for total Se, glutathione peroxidase activity in whole blood (@PROTEIN$) and plasma, and thyroid hormones (@COMPOUND$ and triiodothyronine) in plasma.	0
728	In vivo administration of a synthetic phospholipid, named hereafter phospho-ceramide analogue-1 (PCERA-1), was previously found to suppress @COMPOUND$ (LPS)-induced @PROTEIN$ blood levels.	1
729	In conclusion, the anti-inflammatory activity of PCERA-1 seems to be mediated by a cell membrane receptor, upstream of @COMPOUND$ production, and eventually TNF-alpha suppression and @PROTEIN$ induction.	0
730	In conclusion, the anti-inflammatory activity of PCERA-1 seems to be mediated by a cell membrane receptor, upstream of @COMPOUND$ production, and eventually @PROTEIN$ suppression and IL-10 induction.	0
731	Depletion of tungsten and/or molybdenum, however, did not affect the growth of the pure culture of S. fumaroxidans on @COMPOUND$ plus fumarate significantly, although the specific activities of @PROTEIN$ and especially formate dehydrogenase were influenced by the absence of Mo and W. This indicates that the organism has a low W or Mo requirement under these conditions.	0
732	Depletion of tungsten and/or molybdenum, however, did not affect the growth of the pure culture of S. fumaroxidans on @COMPOUND$ plus fumarate significantly, although the specific activities of hydrogenase and especially @PROTEIN$ were influenced by the absence of Mo and W. This indicates that the organism has a low W or Mo requirement under these conditions.	0
733	Depletion of tungsten and/or molybdenum, however, did not affect the growth of the pure culture of S. fumaroxidans on propionate plus @COMPOUND$ significantly, although the specific activities of @PROTEIN$ and especially formate dehydrogenase were influenced by the absence of Mo and W. This indicates that the organism has a low W or Mo requirement under these conditions.	0
734	Depletion of tungsten and/or molybdenum, however, did not affect the growth of the pure culture of S. fumaroxidans on propionate plus @COMPOUND$ significantly, although the specific activities of hydrogenase and especially @PROTEIN$ were influenced by the absence of Mo and W. This indicates that the organism has a low W or Mo requirement under these conditions.	0
735	Our results suggest a more prominent role for H2 as electron carrier in the syntrophic conversion of @COMPOUND$, when the essential trace metals W and Mo for the functioning of @PROTEIN$ are depleted.	1
736	Previous studies have demonstrated an association between genetic polymorphisms of the mu opioid receptor gene (@PROTEIN$) and response to @COMPOUND$ treatment.	1
737	Based on the preclinical evidence of @PROTEIN$ I (Topo-1) upregulation by @COMPOUND$ (MMC) and decreased NF-kappaB activation by celecoxib, we evaluated combinations of irinotecan/MMC and irinotecan/MMC/celecoxib in patients with advanced solid malignancies.	1
738	Sixty-one percent of the isolates were @PROTEIN$ producers, which explains the poor activity of @COMPOUND$.	1
739	Infusion of each receptor antagonist alone similarly reduced basal unstressed volume and blood flow in @PROTEIN$-treated CHF patients, but not in healthy volunteers or @COMPOUND$-treated CHF patients.	0
740	In @COMPOUND$-treated heart failure, venous responses to @PROTEIN$ are preserved but arterial responses are reduced compared with healthy controls.	0
741	High @COMPOUND$ attenuates VEGF expression in rat multipotent adult progenitor cells in association with inhibition of JAK2/@PROTEIN$ signalling.	0
742	High @COMPOUND$ attenuates VEGF expression in rat multipotent adult progenitor cells in association with inhibition of @PROTEIN$/STAT3 signalling.	0
743	High @COMPOUND$ attenuates @PROTEIN$ expression in rat multipotent adult progenitor cells in association with inhibition of JAK2/STAT3 signalling.	1
744	This study was to investigate the effect of high @COMPOUND$ (HG) on vascular endothelial growth factor (VEGF) expression in bone marrow stem cells and JAK2/@PROTEIN$-3 signalling.	0
745	This study was to investigate the effect of high @COMPOUND$ (HG) on vascular endothelial growth factor (VEGF) expression in bone marrow stem cells and @PROTEIN$/STAT-3 signalling.	0
746	This study was to investigate the effect of high glucose (@COMPOUND$) on vascular endothelial growth factor (@PROTEIN$) expression in bone marrow stem cells and JAK2/STAT-3 signalling.	0
747	This study was to investigate the effect of high glucose (@COMPOUND$) on vascular endothelial growth factor (VEGF) expression in bone marrow stem cells and @PROTEIN$/STAT-3 signalling.	0
748	This study was to investigate the effect of high glucose (@COMPOUND$) on vascular endothelial growth factor (VEGF) expression in bone marrow stem cells and JAK2/@PROTEIN$-3 signalling.	0
749	This study was to investigate the effect of high @COMPOUND$ (HG) on vascular endothelial growth factor (@PROTEIN$) expression in bone marrow stem cells and JAK2/STAT-3 signalling.	0
750	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for serotonin (5-HT), @COMPOUND$ (D cells), glucagon, motilin, polypeptide YY (@PROTEIN$) and insulin.	0
751	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for @COMPOUND$ (5-HT), somatostatin (D cells), @PROTEIN$, motilin, polypeptide YY (PYY) and insulin.	0
752	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for serotonin (@COMPOUND$), somatostatin (D cells), glucagon, motilin, polypeptide YY (PYY) and @PROTEIN$.	0
753	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for @COMPOUND$ (5-HT), somatostatin (D cells), glucagon, @PROTEIN$, polypeptide YY (PYY) and insulin.	0
754	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for serotonin (@COMPOUND$), somatostatin (D cells), glucagon, @PROTEIN$, polypeptide YY (PYY) and insulin.	0
755	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for serotonin (5-HT), @COMPOUND$ (D cells), @PROTEIN$, motilin, polypeptide YY (PYY) and insulin.	0
756	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for @COMPOUND$ (5-HT), somatostatin (D cells), glucagon, motilin, polypeptide YY (PYY) and @PROTEIN$.	0
757	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for @COMPOUND$ (5-HT), somatostatin (D cells), glucagon, motilin, polypeptide YY (@PROTEIN$) and insulin.	0
758	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for serotonin (@COMPOUND$), somatostatin (D cells), @PROTEIN$, motilin, polypeptide YY (PYY) and insulin.	0
759	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for serotonin (5-HT), @COMPOUND$ (D cells), glucagon, motilin, polypeptide YY (PYY) and @PROTEIN$.	0
760	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for serotonin (@COMPOUND$), somatostatin (D cells), glucagon, motilin, polypeptide YY (@PROTEIN$) and insulin.	0
761	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for serotonin (5-HT), @COMPOUND$ (D cells), glucagon, @PROTEIN$, polypeptide YY (PYY) and insulin.	0
762	In the gizzard, endocrine cells secreting @COMPOUND$, 5-HT and @PROTEIN$ were detected, while those secreting glucagon and insulin were not.	0
763	In the gizzard, endocrine cells secreting somatostatin, @COMPOUND$ and PYY were detected, while those secreting glucagon and @PROTEIN$ were not.	0
764	In the gizzard, endocrine cells secreting @COMPOUND$, 5-HT and PYY were detected, while those secreting @PROTEIN$ and insulin were not.	0
765	In the gizzard, endocrine cells secreting somatostatin, @COMPOUND$ and PYY were detected, while those secreting @PROTEIN$ and insulin were not.	0
766	In the gizzard, endocrine cells secreting somatostatin, @COMPOUND$ and @PROTEIN$ were detected, while those secreting glucagon and insulin were not.	0
767	In the gizzard, endocrine cells secreting @COMPOUND$, 5-HT and PYY were detected, while those secreting glucagon and @PROTEIN$ were not.	0
768	In the final part of the gizzard, endocrine cells secreting @COMPOUND$ were more frequent, and cells secreting somatostatin and @PROTEIN$ were not detected.	0
769	In the final part of the gizzard, endocrine cells secreting 5-HT were more frequent, and cells secreting @COMPOUND$ and @PROTEIN$ were not detected.	0
770	The present study was designed to evaluate the impact of zinc status before burn on the recovery of injury with focus on plasma @PROTEIN$ and @COMPOUND$ levels.	0
771	Blood and tissue samples were collected 3, 6, and 24 h after injury in order to study biochemical parameters and the @COMPOUND$/@PROTEIN$ response in relation with the zinc status.	0
772	In addition, the burn-induced insulin resistance, leading to protein catabolism, was emphasized, with higher plasma insulin, @COMPOUND$, and @PROTEIN$ levels in zinc-deficient animals versus normal-fed rats.	0
773	In addition, the burn-induced @PROTEIN$ resistance, leading to protein catabolism, was emphasized, with higher plasma insulin, @COMPOUND$, and leptin levels in zinc-deficient animals versus normal-fed rats.	0
774	Previously we have shown that @COMPOUND$ has antiinflammatory actions not explicable by activation of @PROTEIN$,but possibly by the glucocorticoid receptor (GR).	0
775	Previously we have shown that @COMPOUND$ has antiinflammatory actions not explicable by activation of PPARgamma,but possibly by the @PROTEIN$ (GR).	1
776	@COMPOUND$ drives @PROTEIN$ expression from a simple glucocorticoid-response element containing reporter gene in a GR-dependent manner (EC50 4 microm), with a similar amplitude response to the partial GR agonist RU486.	1
777	Circulating oxidized LDL (oxLDL) levels are strongly correlated to LDL-@COMPOUND$ (LDL-c) and apolipoprotein-B100 (@PROTEIN$), making it difficult to disentangle their independent contributions to cardiovascular risk.	0
778	FMD of the brachial artery and plasma concentrations of oxLDL, LDL-@COMPOUND$, and @PROTEIN$ were measured in 624 men and women (age range 50 to 87 years), participating in a population-based cohort study.	0
779	After adjustment for age, sex, @COMPOUND$ tolerance status, and Framingham risk score, the oxLDL/@PROTEIN$ ratio was negatively related to FMD (P = 0.017).	0
780	Immunotoxicity of perfluorooctanoic acid and perfluorooctane @COMPOUND$ and the role of @PROTEIN$.	0
781	The secretion of endorphins, @COMPOUND$ (P(4)), human chorionic gonadotropin, 17beta-estradiol, and @PROTEIN$ by trophoblasts that lie adjacent to the embryoblast in the blastocyst suggests that these pregnancy-associated factors may directly signal the growth and development of the embryoblast.	0
782	The secretion of endorphins, progesterone (P(4)), human chorionic gonadotropin, @COMPOUND$, and @PROTEIN$ by trophoblasts that lie adjacent to the embryoblast in the blastocyst suggests that these pregnancy-associated factors may directly signal the growth and development of the embryoblast.	0
783	Influence of @PROTEIN$ on buffalo (Bubalus bubalis) spermatozoa motility, membrane integrity, lipid peroxidation and @COMPOUND$ uptake in vitro.	0
784	The objective of the present experiment was to examine the influence of mean physiological concentration of insulin-like growth factor-I (@PROTEIN$) on frozen-thawed Surti buffalo (Bubalus bubalis) spermatozoa functional parameters, i.e., motility, plasmalemma integrity, acrosomal integrity, functional membrane integrity, lipid peroxidation and @COMPOUND$ uptake in vitro.	1
785	Frozen-thawed semen samples (n=6) were washed in @COMPOUND$ and divided into two equal parts (control and @PROTEIN$ groups).	0
786	@COMPOUND$ utilization was significantly higher in @PROTEIN$ 0.01) of incubation.	0
787	Signaling involving @COMPOUND$ is organized in subcellular compartments and a distinct cAMP compartment might be required for proper @PROTEIN$ mobility and function.	1
788	Control @COMPOUND$-loaded @PROTEIN$ nanoparticles with IgG2a antibodies yielded only marginal effects.	1
789	The potassium channels blockade by either @COMPOUND$ or @PROTEIN$ also resulted in a potent inhibition of HEDS-induced aortic relaxation, whereas apamine only slightly reduced it.	0
790	The potassium channels blockade by either tetraethylammonium or @PROTEIN$ also resulted in a potent inhibition of HEDS-induced aortic relaxation, whereas @COMPOUND$ only slightly reduced it.	0
791	Recently, we reported stimulatory effect of ghrelin alone and in combination with growth hormone (GH) on @COMPOUND$ secretion, @PROTEIN$ activity in parallel with inhibitory effect on cell apoptosis.	0
792	Recently, we reported stimulatory effect of ghrelin alone and in combination with @PROTEIN$ (GH) on @COMPOUND$ secretion, aromatase activity in parallel with inhibitory effect on cell apoptosis.	1
793	Recently, we reported stimulatory effect of @PROTEIN$ alone and in combination with growth hormone (GH) on @COMPOUND$ secretion, aromatase activity in parallel with inhibitory effect on cell apoptosis.	1
794	In cultures treated together ghrelin and (D-Lys-3)-GHRP-6, @COMPOUND$ secretion, @PROTEIN$ activity and cell proliferation returned to control levels.	0
795	In cultures treated together @PROTEIN$ and (D-Lys-3)-GHRP-6, @COMPOUND$ secretion, aromatase activity and cell proliferation returned to control levels.	1
796	Nevertheless, certain clinical cases manifest themselves with the onset of acute renal failure bought upon by the administration of blockers of the rennin-@PROTEIN$-@COMPOUND$ system, or by some other causes responsible for a sudden drop in renal plasma flow (e.g., thrombosis of the renal artery).	1
797	After 2 and 6 weeks of treatment, parotid gland was removed and total protein and @COMPOUND$ (free and total) concentration and amylase and @PROTEIN$ activities were determined.	0
798	At week 2 of the study, parotid gland of diabetic rats presented a reduction of total protein concentration (55%) and an increase of amylase (120%) and @PROTEIN$ (160%) activities, free (150%) and total (170%) @COMPOUND$ concentration.	0
799	To investigate the metabolism of @COMPOUND$ through the @PROTEIN$ (CYP450) metabolic pathway, we studied the in vitro rat liver microsomal production of hydroxylated metabolites and their activity at recombinant human TRPV(1) receptors.	1
800	Functional expression of @PROTEIN$ responsible for protection against oxidative stress through promotion of @COMPOUND$ synthesis after Nrf2 upregulation in undifferentiated mesenchymal C3H10T1/2 stem cells.	1
801	Functional expression of beta2 adrenergic receptors responsible for protection against oxidative stress through promotion of @COMPOUND$ synthesis after @PROTEIN$ upregulation in undifferentiated mesenchymal C3H10T1/2 stem cells.	0
802	Exposure to adrenaline not only increased cAMP formation, phosphorylation of cAMP responsive element (CRE) binding protein (@PROTEIN$) on serine133 and CRE reporter activity in a manner sensitive to @COMPOUND$, but also rendered C3H10T1/2 cells resistant to the cytotoxicity of hydrogen peroxide, but not of either 2,4-dinitirophenol or tunicamycin.	1
803	Exposure to adrenaline not only increased cAMP formation, phosphorylation of cAMP responsive element (CRE) binding protein (@PROTEIN$) on serine133 and CRE reporter activity in a manner sensitive to propranolol, but also rendered C3H10T1/2 cells resistant to the cytotoxicity of @COMPOUND$, but not of either 2,4-dinitirophenol or tunicamycin.	1
804	These results suggest that adrenaline may selectively protect mesenchymal C3H10T1/2 cells from oxidative stress through a mechanism related to the promoted biosynthesis of @COMPOUND$ in association with transient @PROTEIN$ expression after activation of beta(2)AdR.	1
805	To verify the possible involvement of lipids and several other compounds including @COMPOUND$ (H(2)O(2)) and glyceraldehyde-3-phosphate dehydrogenase (@PROTEIN$) in the response of Hordeum vulgare to early potassium deprivation, plants were grown in hydroponic conditions for 30d with a modified Hewitt nutrient solution containing 3mM K(+).	0
806	To verify the possible involvement of lipids and several other compounds including @COMPOUND$ (H(2)O(2)) and @PROTEIN$ (G3PDH) in the response of Hordeum vulgare to early potassium deprivation, plants were grown in hydroponic conditions for 30d with a modified Hewitt nutrient solution containing 3mM K(+).	0
807	Effect of the inoculum size on carbapenem susceptibilities of @PROTEIN$-negative, @COMPOUND$-resistant Haemophilus influenzae.	0
808	However, the effect of inoculum size of @PROTEIN$-negative, @COMPOUND$-resistant H. influenzae (BLNAR) on MICs for carbapenems has not been investigated.	0
809	It has been proposed that there is improvement in @COMPOUND$ and @PROTEIN$ metabolism after weight loss in patients who underwent diet restriction and bariatric surgery.	0
810	After incubation with 4- androstene-3,17-dione (4-dione), there are no estrogens, estrone (E1) and @COMPOUND$ (E2), detected suggesting that the pathway of @PROTEIN$ is not important in these cell lines.	0
811	After incubation with 4- androstene-3,17-dione (4-dione), there are no estrogens, @COMPOUND$ (E1) and estradiol (E2), detected suggesting that the pathway of @PROTEIN$ is not important in these cell lines.	0
812	The parameters measured in E. albidus whole body were: lipid peroxidation (LPO), total @COMPOUND$ (TG), as well as the enzymatic activities of superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione reductase (GR), glutathione peroxidase (GPx) and glutathione S-transferase (GST).	0
813	The parameters measured in E. albidus whole body were: lipid peroxidation (LPO), total @COMPOUND$ (TG), as well as the enzymatic activities of superoxide dismutase (SOD), catalase (CAT), glutathione reductase (GR), glutathione peroxidase (GPx) and glutathione S-transferase (@PROTEIN$).	0
814	The parameters measured in E. albidus whole body were: lipid peroxidation (LPO), total @COMPOUND$ (TG), as well as the enzymatic activities of superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione reductase (GR), glutathione peroxidase (GPx) and glutathione S-transferase (GST).	0
815	The parameters measured in E. albidus whole body were: lipid peroxidation (LPO), total @COMPOUND$ (TG), as well as the enzymatic activities of superoxide dismutase (SOD), catalase (CAT), glutathione reductase (GR), glutathione peroxidase (GPx) and @PROTEIN$ (GST).	0
816	The parameters measured in E. albidus whole body were: lipid peroxidation (LPO), total @COMPOUND$ (TG), as well as the enzymatic activities of @PROTEIN$ (SOD), catalase (CAT), glutathione reductase (GR), glutathione peroxidase (GPx) and glutathione S-transferase (GST).	0
817	The parameters measured in E. albidus whole body were: lipid peroxidation (LPO), total @COMPOUND$ (TG), as well as the enzymatic activities of superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GR), glutathione peroxidase (GPx) and glutathione S-transferase (GST).	0
818	The parameters measured in E. albidus whole body were: lipid peroxidation (LPO), total @COMPOUND$ (TG), as well as the enzymatic activities of superoxide dismutase (SOD), catalase (CAT), glutathione reductase (GR), @PROTEIN$ (GPx) and glutathione S-transferase (GST).	0
819	The parameters measured in E. albidus whole body were: lipid peroxidation (LPO), total @COMPOUND$ (TG), as well as the enzymatic activities of superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione reductase (GR), glutathione peroxidase (GPx) and glutathione S-transferase (GST).	0
820	In accord with published results, we could show that treatment with @COMPOUND$ resulted in depletion of @PROTEIN$, a known Hsp90 client protein.	1
821	In accord with published results, we could show that treatment with @COMPOUND$ resulted in depletion of Chk1, a known @PROTEIN$ client protein.	0
822	In addition, we observed a time- and dose-dependent decrease in @PROTEIN$ kinase level, a negative regulator of mitosis, after @COMPOUND$ treatment in gastrointestinal cancer cells.	1
823	Multiple studies suggest increased conversion of @COMPOUND$ to bile acids by @PROTEIN$ (CYP7A1) protects against dyslipidemia and atherosclerosis.	1
824	Multiple studies suggest increased conversion of @COMPOUND$ to bile acids by cholesterol 7alpha-hydroxylase (@PROTEIN$) protects against dyslipidemia and atherosclerosis.	1
825	The objective of this study was to examine the impact of polymorphisms in the acyl-CoA:diacylglycerol acyltransferase (DGAT1), @PROTEIN$ and growth hormone receptor genes on body energy (body condition score, total body energy content and cumulative effective energy balance) and blood metabolic traits (levels of @COMPOUND$, glucose and non-esterified fatty acids), measured once before the first calving and then repeatedly throughout first lactation in 497 Holstein cows.	0
826	The objective of this study was to examine the impact of polymorphisms in the acyl-CoA:diacylglycerol acyltransferase (@PROTEIN$), leptin and growth hormone receptor genes on body energy (body condition score, total body energy content and cumulative effective energy balance) and blood metabolic traits (levels of @COMPOUND$, glucose and non-esterified fatty acids), measured once before the first calving and then repeatedly throughout first lactation in 497 Holstein cows.	0
827	The objective of this study was to examine the impact of polymorphisms in the acyl-CoA:diacylglycerol acyltransferase (DGAT1), leptin and @PROTEIN$ receptor genes on body energy (body condition score, total body energy content and cumulative effective energy balance) and blood metabolic traits (levels of beta-hydroxybutyrate, @COMPOUND$ and non-esterified fatty acids), measured once before the first calving and then repeatedly throughout first lactation in 497 Holstein cows.	0
828	The objective of this study was to examine the impact of polymorphisms in the acyl-CoA:diacylglycerol acyltransferase (DGAT1), @PROTEIN$ and growth hormone receptor genes on body energy (body condition score, total body energy content and cumulative effective energy balance) and blood metabolic traits (levels of beta-hydroxybutyrate, @COMPOUND$ and non-esterified fatty acids), measured once before the first calving and then repeatedly throughout first lactation in 497 Holstein cows.	0
829	The objective of this study was to examine the impact of polymorphisms in the acyl-CoA:diacylglycerol acyltransferase (@PROTEIN$), leptin and growth hormone receptor genes on body energy (body condition score, total body energy content and cumulative effective energy balance) and blood metabolic traits (levels of beta-hydroxybutyrate, @COMPOUND$ and non-esterified fatty acids), measured once before the first calving and then repeatedly throughout first lactation in 497 Holstein cows.	0
830	The objective of this study was to examine the impact of polymorphisms in the acyl-CoA:diacylglycerol acyltransferase (DGAT1), leptin and @PROTEIN$ receptor genes on body energy (body condition score, total body energy content and cumulative effective energy balance) and blood metabolic traits (levels of @COMPOUND$, glucose and non-esterified fatty acids), measured once before the first calving and then repeatedly throughout first lactation in 497 Holstein cows.	0
831	@PROTEIN$-@COMPOUND$ (HDL-C) is invertedly related to the incidence of cardiovascular events.	1
832	Emerging evidence that both @PROTEIN$ (BDNF) and @COMPOUND$ suppress FoxO activity suggests a potential role of FoxOs in regulating mood-relevant behavior.	0
833	Emerging evidence that both brain-derived neurotrophic factor (@PROTEIN$) and @COMPOUND$ suppress FoxO activity suggests a potential role of FoxOs in regulating mood-relevant behavior.	0
834	Three enzymes function in biosynthesis of GDP-mannose from the glycolytic intermediate @COMPOUND$ : phosphomannose isomerase (PMI), phosphomannomutase (PMM) and @PROTEIN$ (GMPP).	1
835	Three enzymes function in biosynthesis of GDP-mannose from the glycolytic intermediate @COMPOUND$ : phosphomannose isomerase (PMI), @PROTEIN$ (PMM) and GDP-mannose pyrophosphorylase (GMPP).	1
836	Three enzymes function in biosynthesis of GDP-mannose from the glycolytic intermediate @COMPOUND$ : @PROTEIN$ (PMI), phosphomannomutase (PMM) and GDP-mannose pyrophosphorylase (GMPP).	1
837	Three enzymes function in biosynthesis of GDP-@COMPOUND$ from the glycolytic intermediate fructose 6-phosphate : @PROTEIN$ (PMI), phosphomannomutase (PMM) and GDP-mannose pyrophosphorylase (GMPP).	1
838	Three enzymes function in biosynthesis of GDP-@COMPOUND$ from the glycolytic intermediate fructose 6-phosphate : phosphomannose isomerase (PMI), phosphomannomutase (@PROTEIN$) and GDP-mannose pyrophosphorylase (GMPP).	1
839	Three enzymes function in biosynthesis of GDP-@COMPOUND$ from the glycolytic intermediate fructose 6-phosphate : phosphomannose isomerase (PMI), phosphomannomutase (PMM) and @PROTEIN$ (GMPP).	1
840	Three enzymes function in biosynthesis of GDP-mannose from the glycolytic intermediate @COMPOUND$ : phosphomannose isomerase (@PROTEIN$), phosphomannomutase (PMM) and GDP-mannose pyrophosphorylase (GMPP).	1
841	Three enzymes function in biosynthesis of GDP-mannose from the glycolytic intermediate @COMPOUND$ : phosphomannose isomerase (PMI), phosphomannomutase (@PROTEIN$) and GDP-mannose pyrophosphorylase (GMPP).	1
842	Three enzymes function in biosynthesis of GDP-@COMPOUND$ from the glycolytic intermediate fructose 6-phosphate : phosphomannose isomerase (@PROTEIN$), phosphomannomutase (PMM) and GDP-mannose pyrophosphorylase (GMPP).	1
843	Three enzymes function in biosynthesis of GDP-@COMPOUND$ from the glycolytic intermediate fructose 6-phosphate : phosphomannose isomerase (PMI), @PROTEIN$ (PMM) and GDP-mannose pyrophosphorylase (GMPP).	1
844	Synthesis of GDP-@COMPOUND$ from exogenous mannose requires @PROTEIN$ or phosphotransferase enzymes together with PMM and GMPP.	1
845	Synthesis of GDP-@COMPOUND$ from exogenous mannose requires hexokinase or phosphotransferase enzymes together with @PROTEIN$ and GMPP.	1
846	Uptake of @COMPOUND$, losartan, and cefadroxil was quantified in HeLa cells after heterologous expression of human @PROTEIN$ (hPEPT1).	0
847	Uptake of valsartan, @COMPOUND$, and cefadroxil was quantified in HeLa cells after heterologous expression of human @PROTEIN$ (hPEPT1).	0
848	Uptake of valsartan, losartan, and @COMPOUND$ was quantified in HeLa cells after heterologous expression of human @PROTEIN$ (hPEPT1).	0
849	In contrast to cefadroxil, no @PROTEIN$-specific uptake of @COMPOUND$ and losartan was found.	0
850	In contrast to cefadroxil, no @PROTEIN$-specific uptake of valsartan and @COMPOUND$ was found.	0
851	In contrast to @COMPOUND$, no @PROTEIN$-specific uptake of valsartan and losartan was found.	1
852	We found associations between the @COMPOUND$ phenotype and age, diagnosis of hypertension and one htSNP (141689) located upstream of @PROTEIN$.	0
853	The presented study is aimed at reactivation of @COMPOUND$-inhibited butyrylcholinesterase since this enzyme play an important role in Alzheimer's disease as deputy for @PROTEIN$ and furthermore it could be applied as a scavenger in case of overdosing.	0
854	These results underscore the differential regulation of GPX expression in response to cadmium, aluminium and @COMPOUND$, and strongly support a role for @PROTEIN$ and possibly other GPX genes in stress and/or metabolic signalling.	1
855	These results underscore the differential regulation of @PROTEIN$ expression in response to cadmium, @COMPOUND$ and nitric oxide, and strongly support a role for GPX6 and possibly other GPX genes in stress and/or metabolic signalling.	1
856	These results underscore the differential regulation of GPX expression in response to cadmium, @COMPOUND$ and nitric oxide, and strongly support a role for @PROTEIN$ and possibly other GPX genes in stress and/or metabolic signalling.	1
857	These results underscore the differential regulation of @PROTEIN$ expression in response to cadmium, aluminium and @COMPOUND$, and strongly support a role for GPX6 and possibly other GPX genes in stress and/or metabolic signalling.	1
858	The previous amphotericin B, @PROTEIN$, hyperbaric @COMPOUND$ and nasal and left maxillary sinus surgical debridement therapy was ineffective in stopping the progression of the infection to the brain.	0
859	The previous @COMPOUND$, @PROTEIN$, hyperbaric oxygen and nasal and left maxillary sinus surgical debridement therapy was ineffective in stopping the progression of the infection to the brain.	0
860	Colonization of germ-free (GF) mice has been shown to induce the gastrointestinal form of the @COMPOUND$-dependent glutathione peroxidases, @PROTEIN$.	1
861	Colonization of germ-free (GF) mice has been shown to induce the gastrointestinal form of the @COMPOUND$-dependent @PROTEIN$, GPx2.	1
862	The role of @COMPOUND$+)-insensitive @PROTEIN$, if any, in sperm volume regulation was studied in transgenic mice.	0
863	Therefore, the @COMPOUND$+)-sensitive @PROTEIN$, which was localized in elongated spermatids and spermatozoa, is a likely candidate for a water channel responsible for physiological sperm volume regulation crucial to in vivo fertilization.	1
864	Increased intrahepatic vascular tone in cirrhosis has been attributed to a decrease of hepatic @COMPOUND$ (NO) secondary to disturbances in the post-translational regulation of the enzyme @PROTEIN$.	0
865	@PROTEIN$ deficiency is a rare autosomal disorder of de novo @COMPOUND$ synthesis, which results in the accumulation of succinylpurines in body fluids.	1
866	Both patients had an increased @COMPOUND$/SAICAr ratio of 1.6, and exhibited a novel homozygous missense mutation (c.674T&gt;C; p.Met225Thr) in the exon 6 of the @PROTEIN$ gene.	1
867	Complex modulation of L-type @COMPOUND$+) current inactivation by @PROTEIN$ in isolated rabbit cardiomyocytes.	1
868	In the present work, the activity of the enzymes xylose reductase (XR); @COMPOUND$ dehydrogenase (XD); and glucose-6-phosphate dehydrogenase (@PROTEIN$) during cultivation of Candida guilliermondii on rice straw hemicellulosic hydrolysate was measured and correlated with xylitol production under different pH values (around 4.5 and 7.5) and initial xylose concentration (around 30 and 70 g l(-1)).	1
869	In the present work, the activity of the enzymes @PROTEIN$ (XR); @COMPOUND$ dehydrogenase (XD); and glucose-6-phosphate dehydrogenase (G6PD) during cultivation of Candida guilliermondii on rice straw hemicellulosic hydrolysate was measured and correlated with xylitol production under different pH values (around 4.5 and 7.5) and initial xylose concentration (around 30 and 70 g l(-1)).	1
870	Tests were carried out on cell cultures of human keratinocytes and mouse 3T3 fibroblasts incubated with radiolabeled acetate, and on homogenates prepared from yeast cells expressing human @PROTEIN$, incubated with radiolabeled @COMPOUND$.	0
871	The @COMPOUND$-enhanced degradation of @PROTEIN$ involves both proteasomal and lysosomal activities.	1
872	As this effect might be related to deregulation of @PROTEIN$ (Cx43) synthesis, trafficking, or degradation, we investigated the impact of @COMPOUND$ on these events.	1
873	As this effect might be related to deregulation of connexin 43 (@PROTEIN$) synthesis, trafficking, or degradation, we investigated the impact of @COMPOUND$ on these events.	1
874	Inhibition of either proteasomes or lysosomes with their specific inhibitors largely restored total @PROTEIN$ protein levels, thus suggesting that both proteasomes and lysosomes may participate in the @COMPOUND$-enhanced Cx43 internalization and degradation.	1
875	Finally, @COMPOUND$ also interfered with restoration of gap junction plaques following the inhibition of @PROTEIN$ transport to plasma membrane.	1
876	Taken together, multiple modes of action seem to contribute to downregulation of @PROTEIN$ in @COMPOUND$-treated rat liver epithelial cells.	1
877	The renin-angiotensin-@COMPOUND$ system: approaches to guide @PROTEIN$ inhibition in patients with coronary artery disease.	0
878	It was identified as producer of extended-spectrum @PROTEIN$ (ESBL) by double-disk synergy test between @COMPOUND$-clavulanate and cefotaxime, ceftriaxone, ceftazidime and aztreonam.	1
879	It was identified as producer of extended-spectrum @PROTEIN$ (ESBL) by double-disk synergy test between amoxicillin-clavulanate and cefotaxime, ceftriaxone, @COMPOUND$ and aztreonam.	1
880	It was identified as producer of extended-spectrum @PROTEIN$ (ESBL) by double-disk synergy test between amoxicillin-clavulanate and @COMPOUND$, ceftriaxone, ceftazidime and aztreonam.	1
881	It was identified as producer of extended-spectrum @PROTEIN$ (ESBL) by double-disk synergy test between amoxicillin-clavulanate and cefotaxime, @COMPOUND$, ceftazidime and aztreonam.	1
882	It was identified as producer of extended-spectrum @PROTEIN$ (ESBL) by double-disk synergy test between amoxicillin-clavulanate and cefotaxime, ceftriaxone, ceftazidime and @COMPOUND$.	1
883	It was identified as producer of extended-spectrum @PROTEIN$ (ESBL) by double-disk synergy test between amoxicillin-@COMPOUND$ and cefotaxime, ceftriaxone, ceftazidime and aztreonam.	1
884	@COMPOUND$ was the most potent regulator of @PROTEIN$ affinity, with concentrations of 5 mmol L(-1) causing an increase in p(50) from 5 to 19 mm Hg at pH 7.5, while the order of potency of the other phosphates was IHP&gt;ATP&gt;BPG.	1
885	The objective of this study was to determine: (i) the prevalence of resistance in current clinical isolates of Streptococcus pneumoniae, Staphylococcus aureus, Haemophilus influenzae, Moraxella catarrhalis and Klebsiella pneumoniae; (ii) the prevalence of production of extended-spectrum @PROTEIN$ (ESBLs) and @COMPOUND$ resistance in S. aureus; and (iii) regional differences in the prevalence of ESBL production and clonality of K. pneumoniae isolates.	1
886	LDL from all subjects stimulated both the basal and @PROTEIN$-induced @COMPOUND$ and cortisol release from adrenocortical cells.	1
887	LDL from all subjects stimulated both the basal and @PROTEIN$-induced aldosterone and @COMPOUND$ release from adrenocortical cells.	1
888	Here we present evidence of distinct @COMPOUND$-induced modulation of @PROTEIN$ functions using high-resolution live-cell imaging approaches.	1
889	Quantitative analysis yielded 0.81 and 1.8 microM for EC(50) values of @COMPOUND$-induced cell edge translocation of abl-KD-@PROTEIN$ (GFP) and wild-type abl-GFP, respectively.	1
890	By conducting this initial screen on EMT6 cells and applying protein function and genomic structure criteria to genes identified as upregulated in response to @COMPOUND$/TSA, we were able to identify two characterized breast cancer TSGs (Timp3 and Rprm) and four putative TSGs (Atp1B2, @PROTEIN$, FoxJ1 and Smpd3) silenced in this line.	1
891	By conducting this initial screen on EMT6 cells and applying protein function and genomic structure criteria to genes identified as upregulated in response to @COMPOUND$/TSA, we were able to identify two characterized breast cancer TSGs (@PROTEIN$ and Rprm) and four putative TSGs (Atp1B2, Dusp2, FoxJ1 and Smpd3) silenced in this line.	1
892	By conducting this initial screen on EMT6 cells and applying protein function and genomic structure criteria to genes identified as upregulated in response to @COMPOUND$/TSA, we were able to identify two characterized breast cancer TSGs (Timp3 and Rprm) and four putative TSGs (Atp1B2, Dusp2, @PROTEIN$ and Smpd3) silenced in this line.	1
893	By conducting this initial screen on EMT6 cells and applying protein function and genomic structure criteria to genes identified as upregulated in response to @COMPOUND$/TSA, we were able to identify two characterized breast cancer TSGs (Timp3 and Rprm) and four putative TSGs (Atp1B2, Dusp2, FoxJ1 and @PROTEIN$) silenced in this line.	1
894	Concentrations of @COMPOUND$, @PROTEIN$, C-peptide, nonesterified fatty acids, triacylglycerol, total and exogenous glucose kinetics were assessed for 6 h postprandially.	0
895	After 120 min, @COMPOUND$ and @PROTEIN$ responses declined, but remained higher after the Pol 0.05) in parallel to the inhibition of lipolysis.	0
896	In this article, the intracellular signal transduction mechanisms mediating the actions of some of these regulators, including GTH-releasing hormones, @PROTEIN$, @COMPOUND$, ghrelin, sex steroids, activin, and follistatin from experiments with goldfish are reviewed and discussed in relation with recent findings.	0
897	In this article, the intracellular signal transduction mechanisms mediating the actions of some of these regulators, including GTH-releasing hormones, pituitary adenylate cyclase-activating polypeptide, @COMPOUND$, @PROTEIN$, sex steroids, activin, and follistatin from experiments with goldfish are reviewed and discussed in relation with recent findings.	0
898	In this article, the intracellular signal transduction mechanisms mediating the actions of some of these regulators, including @PROTEIN$-releasing hormones, pituitary adenylate cyclase-activating polypeptide, @COMPOUND$, ghrelin, sex steroids, activin, and follistatin from experiments with goldfish are reviewed and discussed in relation with recent findings.	0
899	Goldfish gonadotropes possess multiple pharmacologically distinct intracellular Ca2+ stores that together with voltage-sensitive Ca2+ channels, Na+/H+ exchangers, protein kinase C, @COMPOUND$, NO, protein kinase A, ERK/@PROTEIN$, and Smads allows for integrated control by different neuroendocrine factors.	0
900	Goldfish gonadotropes possess multiple pharmacologically distinct intracellular Ca2+ stores that together with voltage-sensitive Ca2+ channels, Na+/H+ exchangers, protein kinase C, @COMPOUND$, NO, protein kinase A, @PROTEIN$/MAPK, and Smads allows for integrated control by different neuroendocrine factors.	0
901	Goldfish gonadotropes possess multiple pharmacologically distinct intracellular Ca2+ stores that together with voltage-sensitive Ca2+ channels, Na+/H+ exchangers, @PROTEIN$, @COMPOUND$, NO, protein kinase A, ERK/MAPK, and Smads allows for integrated control by different neuroendocrine factors.	0
902	Goldfish gonadotropes possess multiple pharmacologically distinct intracellular Ca2+ stores that together with voltage-sensitive Ca2+ channels, Na+/H+ exchangers, protein kinase C, @COMPOUND$, NO, @PROTEIN$, ERK/MAPK, and Smads allows for integrated control by different neuroendocrine factors.	0
903	The foregoing three main anatomic loci of control are regulated by intermittent time-delayed signal exchange, principally via gonadotropin-releasing hormone (@PROTEIN$), luteinizing hormone (LH) and testosterone/@COMPOUND$ (Te/E(2)).	0
904	The foregoing three main anatomic loci of control are regulated by intermittent time-delayed signal exchange, principally via @PROTEIN$ (GnRH), luteinizing hormone (LH) and testosterone/@COMPOUND$ (Te/E(2)).	0
905	The foregoing three main anatomic loci of control are regulated by intermittent time-delayed signal exchange, principally via @PROTEIN$ (GnRH), luteinizing hormone (LH) and @COMPOUND$/estradiol (Te/E(2)).	0
906	The foregoing three main anatomic loci of control are regulated by intermittent time-delayed signal exchange, principally via gonadotropin-releasing hormone (@PROTEIN$), luteinizing hormone (LH) and @COMPOUND$/estradiol (Te/E(2)).	0
907	We present a robust and simple method for the direct detection of multiple point mutations in the Mycobacterium tuberculosis @PROTEIN$ gene during the development of @COMPOUND$ (RIF) resistance using an electrochemical genosensor.	1
908	The main source of extracellular @COMPOUND$ stems from a coordinated two-step enzymatic conversion of precursor nucleotides via the @PROTEIN$ (CD39) and the ecto-5'-nucleotidase (CD73).	1
909	The main source of extracellular @COMPOUND$ stems from a coordinated two-step enzymatic conversion of precursor nucleotides via the ecto-apyrase (@PROTEIN$) and the ecto-5'-nucleotidase (CD73).	1
910	The main source of extracellular @COMPOUND$ stems from a coordinated two-step enzymatic conversion of precursor nucleotides via the ecto-apyrase (CD39) and the @PROTEIN$ (CD73).	1
911	Among these indicators is @COMPOUND$ (PS) translocation from the inner to the outer leaflet of the plasma membrane, which can be detected by annexinV (@PROTEIN$) conjugation.	1
912	Among these indicators is @COMPOUND$ (PS) translocation from the inner to the outer leaflet of the plasma membrane, which can be detected by @PROTEIN$ (ANXA5) conjugation.	1
913	In addition to @COMPOUND$ and hyperforin, the anticancer drug paclitaxel has also been shown to be an inducer of CYP3A4 via activation of the pregnane X receptor (@PROTEIN$).	0
914	In addition to rifampicin and @COMPOUND$, the anticancer drug paclitaxel has also been shown to be an inducer of CYP3A4 via activation of the pregnane X receptor (@PROTEIN$).	0
915	In addition to rifampicin and hyperforin, the anticancer drug @COMPOUND$ has also been shown to be an inducer of CYP3A4 via activation of the @PROTEIN$ (PXR).	1
916	In addition to rifampicin and @COMPOUND$, the anticancer drug paclitaxel has also been shown to be an inducer of CYP3A4 via activation of the @PROTEIN$ (PXR).	0
917	In addition to @COMPOUND$ and hyperforin, the anticancer drug paclitaxel has also been shown to be an inducer of CYP3A4 via activation of the @PROTEIN$ (PXR).	0
918	In addition to rifampicin and hyperforin, the anticancer drug @COMPOUND$ has also been shown to be an inducer of CYP3A4 via activation of the pregnane X receptor (@PROTEIN$).	1
919	We examined the relationship between @PROTEIN$ and serum calcium, @COMPOUND$, 1,25(OH)(2)D(3), and PTH levels in haemodialysis patients.	0
920	Here we use an array of flow cytometric analyses to characterize silkworm hemocytes with various molecular probes, such as @COMPOUND$, green fluorescence protein, monoclonal antibodies, and fluorescent @PROTEIN$.	0
921	This effect is independent of any change in neutrophil adhesion or adhesion molecule expression but is related to the ability of statins to reduce @COMPOUND$-induced @PROTEIN$ activity in neutrophils.	1
922	This was confirmed by the ability of the @PROTEIN$ precursor @COMPOUND$ to rescue the statin-mediated reduction in neutrophil transendothelial migration.	1
923	We hypothesized that conditioned medium from macrophages pretreated with palmitate or LPS would directly affect @PROTEIN$ action and @COMPOUND$ uptake in muscle cells.	0
924	Surprisingly, and opposite to its effects on adipose cells, conditioned medium from LPS-treated macrophages stimulated myoblast insulin-stimulated @COMPOUND$ uptake, @PROTEIN$ translocation, and Akt phosphorylation without affecting stress kinases or inflammation indexes.	0
925	Surprisingly, and opposite to its effects on adipose cells, conditioned medium from LPS-treated macrophages stimulated myoblast @PROTEIN$-stimulated @COMPOUND$ uptake, GLUT4 translocation, and Akt phosphorylation without affecting stress kinases or inflammation indexes.	1
926	Surprisingly, and opposite to its effects on adipose cells, conditioned medium from LPS-treated macrophages stimulated myoblast insulin-stimulated @COMPOUND$ uptake, GLUT4 translocation, and @PROTEIN$ phosphorylation without affecting stress kinases or inflammation indexes.	0
927	This study investigated the acute effects of treatment with @COMPOUND$ on dipeptidyl peptidase-4 (DPP-4) activity, glucagon-like peptide 1 (@PROTEIN$) concentration, pancreatic hormone levels, and glucose metabolism.	0
928	This study investigated the acute effects of treatment with @COMPOUND$ on @PROTEIN$ (DPP-4) activity, glucagon-like peptide 1 (GLP-1) concentration, pancreatic hormone levels, and glucose metabolism.	0
929	This study investigated the acute effects of treatment with @COMPOUND$ on dipeptidyl peptidase-4 (DPP-4) activity, glucagon-like peptide 1 (GLP-1) concentration, @PROTEIN$ levels, and glucose metabolism.	0
930	This study investigated the acute effects of treatment with @COMPOUND$ on dipeptidyl peptidase-4 (DPP-4) activity, @PROTEIN$ (GLP-1) concentration, pancreatic hormone levels, and glucose metabolism.	0
931	This study investigated the acute effects of treatment with @COMPOUND$ on dipeptidyl peptidase-4 (@PROTEIN$-4) activity, glucagon-like peptide 1 (GLP-1) concentration, pancreatic hormone levels, and glucose metabolism.	0
932	The primary aims were to determine the effects of @PROTEIN$-4 inhibition on GLP-1 clearance and on hepatic @COMPOUND$ uptake.	0
933	The primary aims were to determine the effects of DPP-4 inhibition on @PROTEIN$ clearance and on hepatic @COMPOUND$ uptake.	0
934	These results suggest that @COMPOUND$ by activation of ERK1/2 and @PROTEIN$/Akt signal pathways protects SH-SY5Y cells from H(2)O(2)-induced apoptosis.	1
935	These results suggest that @COMPOUND$ by activation of @PROTEIN$/2 and PI3K/Akt signal pathways protects SH-SY5Y cells from H(2)O(2)-induced apoptosis.	1
936	These results suggest that @COMPOUND$ by activation of ERK1/2 and PI3K/@PROTEIN$ signal pathways protects SH-SY5Y cells from H(2)O(2)-induced apoptosis.	1
937	Profile of serum @PROTEIN$ and IL-10 shortly after ovariectomy and @COMPOUND$ replacement in rats.	0
938	Profile of serum IL-1beta and @PROTEIN$ shortly after ovariectomy and @COMPOUND$ replacement in rats.	0
939	Each residue was modified with one to three @COMPOUND$ units, and the most dominant @PROTEIN$ glycoform was modified with nine hexose units.	1
940	We further demonstrate that loss of @PROTEIN$ stress fibers is due to a @COMPOUND$, protein kinase A-mediated pathway that results in Rho inhibition.	1
941	We further demonstrate that loss of actin stress fibers is due to a @COMPOUND$, @PROTEIN$-mediated pathway that results in Rho inhibition.	1
942	We further demonstrate that loss of actin stress fibers is due to a @COMPOUND$, protein kinase A-mediated pathway that results in @PROTEIN$ inhibition.	1
943	The nuclear NF-kappaB @PROTEIN$ expression after treatment with the SFN-@COMPOUND$ combination was also evaluated by western blot analysis.	0
944	Treatment ACCs cells with SFN and @COMPOUND$ in combination, led to synergistic inhibition on cell growth and a decreased expression in nuclear NF-kappaB @PROTEIN$ protein.	1
945	Our results demonstrate synergism between SFN and @COMPOUND$ at higher doses against the ACC-M and ACC-2 cells, which was associated with the decreased expression of nuclear NF-kappaB @PROTEIN$ protein.	1
946	Antiobesity effect of @COMPOUND$ involves the @PROTEIN$ and PPAR-gamma signal pathways.	1
947	Antiobesity effect of @COMPOUND$ involves the AMPK and @PROTEIN$ signal pathways.	1
948	This inhibitory effect of @COMPOUND$ on adipocyte differentiation was accompanied by @PROTEIN$ inhibition in rosiglitazone-treated cells.	1
949	Taken together, these results suggest that the antiobesity effect of red ginseng rich constituent, @COMPOUND$, involves the @PROTEIN$ signaling pathway and PPAR-gamma inhibition.	1
950	Taken together, these results suggest that the antiobesity effect of red ginseng rich constituent, @COMPOUND$, involves the AMPK signaling pathway and @PROTEIN$ inhibition.	1
951	Circulating @COMPOUND$, adiponectin, leptin, @PROTEIN$, hsCRP and insulin levels were determined both at baseline and after TLC intervention and statin treatment.	0
952	Circulating @COMPOUND$, adiponectin, leptin, TNF-alpha, hsCRP and @PROTEIN$ levels were determined both at baseline and after TLC intervention and statin treatment.	0
953	Circulating @COMPOUND$, adiponectin, @PROTEIN$, TNF-alpha, hsCRP and insulin levels were determined both at baseline and after TLC intervention and statin treatment.	0
954	Currently, adreno-corticotrophic hormone (@PROTEIN$), steroids and @COMPOUND$ (VGB) form the mainstay of its treatment.	0
955	The aim of this study was to assess in rats the effect of protein feeding on the: 1) distribution of endogenous @COMPOUND$ production (EGP) among gluconeogenic organs, and 2) repercussion on the @PROTEIN$ sensitivity of glucose metabolism.	1
956	Transcription of @PROTEIN$ in the rodent ovary and placenta: alternative modes of @COMPOUND$ dependent and independent regulation.	1
957	The substrate for the synthesis of all steroid hormones is cholesterol, and its conversion to the first steroid, @COMPOUND$, by the cholesterol side-chain cleavage cytochrome P450 (@PROTEIN$) enzyme complex takes place in the inner mitochondrial membranes.	1
958	The substrate for the synthesis of all steroid hormones is cholesterol, and its conversion to the first steroid, @COMPOUND$, by the cholesterol side-chain cleavage @PROTEIN$ (CYP11A1) enzyme complex takes place in the inner mitochondrial membranes.	1
959	Collectively, these studies identify a novel role for @COMPOUND$ (3) and the @PROTEIN$ in the control of adipocyte metabolism and lipid storage in vivo.	0
960	Muscular oxidative stress and inflammation induced by @COMPOUND$ or MS were assessed by measurements of isoprostanes and @PROTEIN$ levels.	1
961	In control rats, @COMPOUND$, @PROTEIN$ and MS significantly enhanced the HFV response.	0
962	Pre-treatment with @PROTEIN$ abolished the post-MS-enhanced HFV response whereas diclofenac lowered the peak HFV response to MS and @COMPOUND$.	0
963	Pre-treatment with @PROTEIN$ abolished the post-MS-enhanced HFV response whereas @COMPOUND$ lowered the peak HFV response to MS and H2O2.	0
964	@COMPOUND$ injection and MS elicited significant and similar increases in isoprostanes and @PROTEIN$.	1
965	Cocaine stimulated @PROTEIN$, @COMPOUND$, and LH, whereas cocaine+nalbuphine in combination produced a smaller increase in ACTH, and decreased cortisol and LH.	0
966	Thus it appears that nalbuphine attenuated cocaine's effects on @PROTEIN$, @COMPOUND$, and LH.	0
967	BDNF, NGF, adrenocorticotropic hormone (ACTH), @COMPOUND$ and growth hormone (GH) were determined at baseline on postnatal days (@PROTEIN$) 14, 30 and 60 by means of specific ELISA and RIA procedures.	0
968	@PROTEIN$, NGF, adrenocorticotropic hormone (ACTH), @COMPOUND$ and growth hormone (GH) were determined at baseline on postnatal days (PND) 14, 30 and 60 by means of specific ELISA and RIA procedures.	0
969	BDNF, NGF, @PROTEIN$ (ACTH), @COMPOUND$ and growth hormone (GH) were determined at baseline on postnatal days (PND) 14, 30 and 60 by means of specific ELISA and RIA procedures.	0
970	BDNF, NGF, adrenocorticotropic hormone (ACTH), @COMPOUND$ and growth hormone (GH) were determined at baseline on postnatal days (PND) 14, 30 and 60 by means of specific ELISA and @PROTEIN$ procedures.	0
971	BDNF, @PROTEIN$, adrenocorticotropic hormone (ACTH), @COMPOUND$ and growth hormone (GH) were determined at baseline on postnatal days (PND) 14, 30 and 60 by means of specific ELISA and RIA procedures.	0
972	BDNF, NGF, adrenocorticotropic hormone (@PROTEIN$), @COMPOUND$ and growth hormone (GH) were determined at baseline on postnatal days (PND) 14, 30 and 60 by means of specific ELISA and RIA procedures.	0
973	BDNF, NGF, adrenocorticotropic hormone (ACTH), @COMPOUND$ and @PROTEIN$ (GH) were determined at baseline on postnatal days (PND) 14, 30 and 60 by means of specific ELISA and RIA procedures.	0
974	A substrate regeneration cycle coupling @PROTEIN$ with l-@COMPOUND$ (AsA: 0, 1.0, 3.0, 10.0 and 50.0 mmol/l; as reducing reagent system) was applied to the chemo-mechanical reaction unit in order to amplify the output signal of the tonometric biosensor.	0
975	Despite widespread expression of @PROTEIN$ (EGF) receptors (EGFRs) and EGF family ligands in non-small-cell lung cancer (NSCLC), EGFR-specific tyrosine kinase inhibitors (TKIs) such as @COMPOUND$ exhibit limited activity in this cancer.	0
976	Despite widespread expression of epidermal growth factor (EGF) receptors (@PROTEIN$) and EGF family ligands in non-small-cell lung cancer (NSCLC), EGFR-specific tyrosine kinase inhibitors (TKIs) such as @COMPOUND$ exhibit limited activity in this cancer.	0
977	It is noteworthy that FGF2 and FGF9 as well as @PROTEIN$ IIIc and/or FGFR2 IIIc mRNA and protein are frequently coexpressed in NSCLC cell lines, especially those that are insensitive to @COMPOUND$.	0
978	It is noteworthy that @PROTEIN$ and FGF9 as well as FGFR1 IIIc and/or FGFR2 IIIc mRNA and protein are frequently coexpressed in NSCLC cell lines, especially those that are insensitive to @COMPOUND$.	0
979	It is noteworthy that FGF2 and @PROTEIN$ as well as FGFR1 IIIc and/or FGFR2 IIIc mRNA and protein are frequently coexpressed in NSCLC cell lines, especially those that are insensitive to @COMPOUND$.	0
980	It is noteworthy that FGF2 and FGF9 as well as FGFR1 IIIc and/or @PROTEIN$ IIIc mRNA and protein are frequently coexpressed in NSCLC cell lines, especially those that are insensitive to @COMPOUND$.	0
981	Using neighborhood approaches, we were able to assign seven novel functional partners in @PROTEIN$ synthesis, @COMPOUND$ metabolism, and quorum sensing to BLUF domain-containing proteins (involved in light sensing).	0
982	Chondroitin lyases (or @PROTEIN$) are a family of enzymes that depolymerize @COMPOUND$ (CS) and dermatan sulfate (DS) galactosaminoglycans, which have gained prominence as important players in central nervous system biology.	1
983	This downregulation was abolished following treatment with the histone deacetylase (HDAC) inhibitor trichostatin A (TSA) and cytosine methylation inhibitor @COMPOUND$ (5-Aza), suggesting that an epigenetic regulatory mechanism may be involved in @PROTEIN$ silencing by hypoxia.	1
984	This downregulation was abolished following treatment with the histone deacetylase (HDAC) inhibitor @COMPOUND$ (TSA) and cytosine methylation inhibitor 5-aza-2-deoxycytidine (5-Aza), suggesting that an epigenetic regulatory mechanism may be involved in @PROTEIN$ silencing by hypoxia.	1
985	@COMPOUND$-@PROTEIN$ conjugate selectively overcomes multidrug resistance in leukaemia cells.	1
986	The purpose of this study was to examine the distribution and action of @COMPOUND$-@PROTEIN$ conjugate (DOXTRF) in a leukaemia cell line (HL60), a multidrug-resistant leukaemia cell line (HL60ADR) and a normal tissue cell line (human fibroblasts).	1
987	In the present work we studied the effect of @PROTEIN$ and-3 on neuronal @COMPOUND$ release and the short-term regulation of tyrosine hydroxylase in the olfactory bulb.	0
988	Results showed that both endothelins increased tyrosine hydroxylase activity through the activation of a non-conventional endothelin G-protein coupled receptor, coupled to the stimulation of @PROTEIN$ and C, as well as @COMPOUND$+)/calmodulin-dependent protein kinase II.	0
989	Results showed that both endothelins increased tyrosine hydroxylase activity through the activation of a non-conventional endothelin G-protein coupled receptor, coupled to the stimulation of @PROTEIN$ A and C, as well as @COMPOUND$+)/calmodulin-dependent protein kinase II.	0
990	Results showed that both endothelins increased tyrosine hydroxylase activity through the activation of a non-conventional endothelin G-protein coupled receptor, coupled to the stimulation of protein kinase A and C, as well as @COMPOUND$+)/@PROTEIN$-dependent protein kinase II.	1
991	End-point measures were HOMA (homoeostasis model assessment)-IR, androgens, lipids, inflammatory markers (hsCRP (high-sensitivity C-reactive protein)) and endothelial function (FMD (flow-mediated dilation), ADMA (@COMPOUND$), PAI-1 (plasminogen activator inhibitor-1) and vWF (@PROTEIN$)).	0
992	End-point measures were HOMA (homoeostasis model assessment)-IR, androgens, lipids, inflammatory markers (hsCRP (high-sensitivity C-reactive protein)) and endothelial function (FMD (flow-mediated dilation), @COMPOUND$ (asymmetric dimethylarginine), PAI-1 (plasminogen activator inhibitor-1) and vWF (@PROTEIN$)).	0
993	This study investigated the effects of atorvastatin on @PROTEIN$ and ABCC1 mRNA expression on peripheral blood mononuclear cells (PBMC) and their relationship with gene polymorphisms and lowering-@COMPOUND$ response.	0
994	This study investigated the effects of atorvastatin on ABCB1 and @PROTEIN$ mRNA expression on peripheral blood mononuclear cells (PBMC) and their relationship with gene polymorphisms and lowering-@COMPOUND$ response.	0
995	Pretreatment with DEX abrogated @PROTEIN$ inhibition by sst (2)-preferring analogue @COMPOUND$ in TT.	1
996	Serum NO, @PROTEIN$ and @COMPOUND$ were measured.	0
997	Serum @COMPOUND$ and @PROTEIN$ levels were significantly lower in FM patients than controls.	0
998	The effects of industrial storage on the changes of the cell viability and the activities of intracellular alcohol dehydrogenase (@PROTEIN$) and glucose-6-phosphate dehydrogenase (G6PDH) in brewer's yeast, and the corresponding capacity for the bioconversion of ethyl-3-oxobutanoate (@COMPOUND$) to ethyl (S)-3-hydroxybutanoate ((S)-EHB), were investigated.	1
999	The effects of industrial storage on the changes of the cell viability and the activities of intracellular alcohol dehydrogenase (@PROTEIN$) and glucose-6-phosphate dehydrogenase (G6PDH) in brewer's yeast, and the corresponding capacity for the bioconversion of ethyl-3-oxobutanoate (EOB) to ethyl (@COMPOUND$ ((S)-EHB), were investigated.	1
1000	The effects of industrial storage on the changes of the cell viability and the activities of intracellular alcohol dehydrogenase (ADH) and glucose-6-phosphate dehydrogenase (@PROTEIN$) in brewer's yeast, and the corresponding capacity for the bioconversion of @COMPOUND$ (EOB) to ethyl (S)-3-hydroxybutanoate ((S)-EHB), were investigated.	1
1001	The effects of industrial storage on the changes of the cell viability and the activities of intracellular @PROTEIN$ (ADH) and glucose-6-phosphate dehydrogenase (G6PDH) in brewer's yeast, and the corresponding capacity for the bioconversion of @COMPOUND$ (EOB) to ethyl (S)-3-hydroxybutanoate ((S)-EHB), were investigated.	1
1002	The effects of industrial storage on the changes of the cell viability and the activities of intracellular alcohol dehydrogenase (@PROTEIN$) and glucose-6-phosphate dehydrogenase (G6PDH) in brewer's yeast, and the corresponding capacity for the bioconversion of ethyl-3-oxobutanoate (EOB) to ethyl (S)-3-hydroxybutanoate ((S)-@COMPOUND$), were investigated.	1
1003	The effects of industrial storage on the changes of the cell viability and the activities of intracellular @PROTEIN$ (ADH) and glucose-6-phosphate dehydrogenase (G6PDH) in brewer's yeast, and the corresponding capacity for the bioconversion of ethyl-3-oxobutanoate (EOB) to ethyl (S)-3-hydroxybutanoate ((S)-@COMPOUND$), were investigated.	1
1004	The effects of industrial storage on the changes of the cell viability and the activities of intracellular @PROTEIN$ (ADH) and glucose-6-phosphate dehydrogenase (G6PDH) in brewer's yeast, and the corresponding capacity for the bioconversion of ethyl-3-oxobutanoate (@COMPOUND$) to ethyl (S)-3-hydroxybutanoate ((S)-EHB), were investigated.	1
1005	The effects of industrial storage on the changes of the cell viability and the activities of intracellular alcohol dehydrogenase (ADH) and glucose-6-phosphate dehydrogenase (@PROTEIN$) in brewer's yeast, and the corresponding capacity for the bioconversion of ethyl-3-oxobutanoate (EOB) to ethyl (S)-3-hydroxybutanoate ((S)-@COMPOUND$), were investigated.	1
1006	The effects of industrial storage on the changes of the cell viability and the activities of intracellular alcohol dehydrogenase (ADH) and glucose-6-phosphate dehydrogenase (@PROTEIN$) in brewer's yeast, and the corresponding capacity for the bioconversion of ethyl-3-oxobutanoate (EOB) to ethyl (@COMPOUND$ ((S)-EHB), were investigated.	1
1007	The effects of industrial storage on the changes of the cell viability and the activities of intracellular @PROTEIN$ (ADH) and glucose-6-phosphate dehydrogenase (G6PDH) in brewer's yeast, and the corresponding capacity for the bioconversion of ethyl-3-oxobutanoate (EOB) to ethyl (@COMPOUND$ ((S)-EHB), were investigated.	1
1008	The effects of industrial storage on the changes of the cell viability and the activities of intracellular alcohol dehydrogenase (ADH) and glucose-6-phosphate dehydrogenase (@PROTEIN$) in brewer's yeast, and the corresponding capacity for the bioconversion of ethyl-3-oxobutanoate (@COMPOUND$) to ethyl (S)-3-hydroxybutanoate ((S)-EHB), were investigated.	1
1009	The effects of industrial storage on the changes of the cell viability and the activities of intracellular alcohol dehydrogenase (@PROTEIN$) and glucose-6-phosphate dehydrogenase (G6PDH) in brewer's yeast, and the corresponding capacity for the bioconversion of @COMPOUND$ (EOB) to ethyl (S)-3-hydroxybutanoate ((S)-EHB), were investigated.	1
1010	The intracellular levels of @PROTEIN$ and G6PDH after permeabilization of these stored cells with cetyltrimetylammonium bromide (@COMPOUND$) were much higher, which showed only slight decrease within 2 weeks during the industrial storage.	1
1011	The intracellular levels of ADH and @PROTEIN$ after permeabilization of these stored cells with cetyltrimetylammonium bromide (@COMPOUND$) were much higher, which showed only slight decrease within 2 weeks during the industrial storage.	1
1012	Prediction of the effect of erythromycin, @COMPOUND$, and their metabolites, alone and in combination, on @PROTEIN$ inhibition.	0
1013	Prediction of the effect of @COMPOUND$, diltiazem, and their metabolites, alone and in combination, on @PROTEIN$ inhibition.	0
1014	Validation of a food frequency questionnaire measurement of dietary acrylamide intake using @PROTEIN$ adducts of acrylamide and @COMPOUND$.	1
1015	Effects of weight loss on visceral and abdominal subcutaneous adipose tissue blood-flow and @PROTEIN$-mediated @COMPOUND$ uptake in healthy obese subjects.	1
1016	This injury induces central sensitization leading to tactile allodynia and is mediated by activation of @COMPOUND$+) permeable AMPA/kainate receptors through @PROTEIN$ and PKA.	1
1017	Treatment with acidified saline reduced fetal basal pH from 7.35+/-0.01 to 7.29+/-0.01 but did not alter basal cardiovascular variables, blood @COMPOUND$, or plasma concentrations of catecholamines, @PROTEIN$, and cortisol.	0
1018	Treatment with acidified saline reduced fetal basal pH from 7.35+/-0.01 to 7.29+/-0.01 but did not alter basal cardiovascular variables, blood glucose, or plasma concentrations of catecholamines, @PROTEIN$, and @COMPOUND$.	0
1019	During hypoxemia, treatment with acidified saline increased the magnitude of the fetal bradycardia and femoral vasoconstriction and concomitantly increased chemoreflex function and enhanced the increments in plasma concentrations of catecholamines, @PROTEIN$, and @COMPOUND$.	0
1020	Previous work has shown that repeated @COMPOUND$ treatment causes downregulation of the norepinephrine transporter (@PROTEIN$) and persistent antidepressant-like effects on behavior, ie effects observed 2 days after discontinuation of drug treatment when acute effects are minimized.	1
1021	Previous work has shown that repeated @COMPOUND$ treatment causes downregulation of the @PROTEIN$ (NET) and persistent antidepressant-like effects on behavior, ie effects observed 2 days after discontinuation of drug treatment when acute effects are minimized.	1
1022	Treatment for 14 days with 70 mg/kg per day venlafaxine, which inhibits both the @PROTEIN$ and SERT, or 10 mg/kg per day @COMPOUND$, a monoamine oxidase inhibitor, produced antidepressant-like effects on behavior without altering NET or SERT expression.	0
1023	Treatment for 14 days with 70 mg/kg per day venlafaxine, which inhibits both the NET and @PROTEIN$, or 10 mg/kg per day @COMPOUND$, a monoamine oxidase inhibitor, produced antidepressant-like effects on behavior without altering NET or SERT expression.	0
1024	To evaluate the potential of using heme-containing lipocalin nitrophorin 1 (@PROTEIN$) as a template for protein engineering, we have replaced the native axial heme-coordinating @COMPOUND$ residue with glycine, alanine, and cysteine.	0
1025	To evaluate the potential of using heme-containing lipocalin nitrophorin 1 (@PROTEIN$) as a template for protein engineering, we have replaced the native axial heme-coordinating histidine residue with glycine, @COMPOUND$, and cysteine.	0
1026	To evaluate the potential of using heme-containing lipocalin nitrophorin 1 (@PROTEIN$) as a template for protein engineering, we have replaced the native axial heme-coordinating histidine residue with @COMPOUND$, alanine, and cysteine.	0
1027	To evaluate the potential of using heme-containing lipocalin nitrophorin 1 (@PROTEIN$) as a template for protein engineering, we have replaced the native axial heme-coordinating histidine residue with glycine, alanine, and @COMPOUND$.	0
1028	Two crystal structures of the H60C_ @PROTEIN$ in complex with @COMPOUND$ and histamine were solved to 1.7- and 1.96-A resolution, respectively.	1
1029	Two crystal structures of the H60C_ @PROTEIN$ in complex with imidazole and @COMPOUND$ were solved to 1.7- and 1.96-A resolution, respectively.	1
1030	Both structures show that the H60C mutation is well tolerated by the protein scaffold and suggest that heme-@COMPOUND$ coordination in H60C_ @PROTEIN$ requires some movement of the heme within its binding cavity.	0
1031	Both structures show that the H60C mutation is well tolerated by the protein scaffold and suggest that @COMPOUND$-thiolate coordination in H60C_ @PROTEIN$ requires some movement of the heme within its binding cavity.	0
1032	Different lag-time of pulse-released nerve growth factor (@PROTEIN$) from genipin-crosslinked gelatin within @COMPOUND$ (PCL) conduits was evaluated in large-gap peripheral nerve repair.	0
1033	Different lag-time of pulse-released nerve growth factor (@PROTEIN$) from @COMPOUND$-crosslinked gelatin within polycaprolactone (PCL) conduits was evaluated in large-gap peripheral nerve repair.	0
1034	In this study, 10% (w/v) gelatin was mixed with @PROTEIN$, crosslinked with 0%, 0.1%, 0.5%, and 1% (w/v) @COMPOUND$, and then sucked into the wall of PCL conduits.	0
1035	Effects of @PROTEIN$/ANKK1 gene variations and clinical factors on @COMPOUND$ efficacy in schizophrenic patients.	1
1036	Effects of DRD2/@PROTEIN$ gene variations and clinical factors on @COMPOUND$ efficacy in schizophrenic patients.	1
1037	It is suggested that in this animal model, characterized by TSH elevation and low-grade inflammation, an increased expression and function of @PROTEIN$, resulting in @COMPOUND$ generation, accounts for an impaired NO availability.	1
1038	Selective elevation of adiponectin production by the natural compounds derived from a medicinal herb alleviates @PROTEIN$ resistance and @COMPOUND$ intolerance in obese mice.	0
1039	These changes were associated with an alleviation of hyperglycemia, @COMPOUND$ intolerance, and @PROTEIN$ resistance.	0
1040	We assessed in vivo carotid sinus nerve activity (CSNA) at baseline, in response to acute hypoxia, in response to infused @COMPOUND$, and in response to infused endothelin-1 (@PROTEIN$) with and without MK-801, an NMDA receptor blocker.	0
1041	We assessed in vivo carotid sinus nerve activity (CSNA) at baseline, in response to acute hypoxia, in response to infused @COMPOUND$, and in response to infused @PROTEIN$ (ET-1) with and without MK-801, an NMDA receptor blocker.	0
1042	Immunofluorescence microscopy of live human umbilical vein endothelial cells showed that @PROTEIN$ multimers rapidly formed strings several hundred micrometers long on the cell surface after stimulation with @COMPOUND$.	1
1043	Soluble P-selectin reduced the number of platelet-decorated @PROTEIN$ strings in the absence of @COMPOUND$+) and Mg(2+) but had no effect in the presence of these cations.	1
1044	A naturally occurring glycine to @COMPOUND$ mutation at position 169 (G169D) in the putative transmembrane domain 4 (@PROTEIN$) makes mice susceptible to Salmonella typhimurim, Leishmania donovani, and Mycobacterium bovis.	1
1045	A naturally occurring @COMPOUND$ to aspartic acid mutation at position 169 (G169D) in the putative transmembrane domain 4 (@PROTEIN$) makes mice susceptible to Salmonella typhimurim, Leishmania donovani, and Mycobacterium bovis.	1
1046	L-@COMPOUND$ was the most effective promoter of @PROTEIN$ absorption compared with others CPPs.	1
1047	A dose-dependent relationship of L-@COMPOUND$ and @PROTEIN$ bioavailability was statically significant.	1
1048	There was no significant difference in the release of @PROTEIN$ in nasal lavage fluid and the integrity of nasal respiratory epithelium when L-@COMPOUND$ was present.	0
1049	Levels of interleukin-8 (@PROTEIN$) and @COMPOUND$ were measured in epithelial lining fluid (ELF) from central and peripheral airways separately collected using a bronchoscopic microsampling technique.	0
1050	Levels of @PROTEIN$ (IL-8) and @COMPOUND$ were measured in epithelial lining fluid (ELF) from central and peripheral airways separately collected using a bronchoscopic microsampling technique.	0
1051	The SoxN protein is proposed to harbor the heme b of lower reduction potential and the @COMPOUND$ (s), and @PROTEIN$ the other heme b.	0
1052	It can use a dithiol-disulfide active-site to transfer reducing equivalents from @COMPOUND$ to thioredoxin (@PROTEIN$), via the cofactor FAD.	1
1053	It can use a dithiol-disulfide active-site to transfer reducing equivalents from @COMPOUND$ to @PROTEIN$ (Trx), via the cofactor FAD.	1
1054	DnaB (BA) demonstrated a strong DNA @PROTEIN$ activity that required ATP or @COMPOUND$.	1
1055	@PROTEIN$ (BA) demonstrated a strong DNA helicase activity that required ATP or @COMPOUND$.	1
1056	@PROTEIN$ (BA) demonstrated a strong DNA helicase activity that required @COMPOUND$ or dATP.	1
1057	DnaB (BA) demonstrated a strong DNA @PROTEIN$ activity that required @COMPOUND$ or dATP.	1
1058	The effect of tropomyosin on @PROTEIN$ filaments was independent of ionic strength, but became stronger as the @COMPOUND$ concentration increased.	1
1059	The effect of @PROTEIN$ on actin filaments was independent of ionic strength, but became stronger as the @COMPOUND$ concentration increased.	1
1060	The acyl @PROTEIN$ peptide features a unique post-translational modification of O-n-octanoylation at @COMPOUND$ 3, and is the only gastrointestinal signal that increases meal size.	1
1061	Tests of the blood samples obtained at the ED revealed leucocytosis (11 070.6+/-4302.5/microl), increased blood @COMPOUND$, @PROTEIN$, CK and CK-MB levels.	0
1062	@PROTEIN$ from goldfish white muscle: regulatory properties and redistribution under exposure to high environmental @COMPOUND$ level.	1
1063	Both sodium and potassium ions activated goldfish @PROTEIN$ at low concentrations, with maximal activation at about 80 mM of each @COMPOUND$ salt, whereas higher concentrations became inhibitory.	0
1064	Magnesium and calcium ions also inhibited goldfish muscle @PROTEIN$, as did phosphate and @COMPOUND$ ; at a concentration of 8 mM, each anion reduced activity by about 66%.	1
1065	Magnesium and calcium ions also inhibited goldfish muscle @PROTEIN$, as did @COMPOUND$ and fluoride ; at a concentration of 8 mM, each anion reduced activity by about 66%.	1
1066	Age-associated impairment of @PROTEIN$ phosphorylation in primary rat hepatocytes is remediated by @COMPOUND$ through PI3 kinase, PTEN, and PP2A.	1
1067	Age-associated impairment of Akt phosphorylation in primary rat hepatocytes is remediated by @COMPOUND$ through PI3 kinase, @PROTEIN$, and PP2A.	1
1068	Age-associated impairment of Akt phosphorylation in primary rat hepatocytes is remediated by @COMPOUND$ through @PROTEIN$, PTEN, and PP2A.	1
1069	Age-associated impairment of Akt phosphorylation in primary rat hepatocytes is remediated by @COMPOUND$ through PI3 kinase, PTEN, and @PROTEIN$.	1
1070	Unfolding and inactivation of abalone (Haliotis diversicolor) @PROTEIN$ during denaturation by @COMPOUND$.	1
1071	Unfolding and inactivation of @PROTEIN$ from abalone (Haliotis diversicolor) during denaturation by @COMPOUND$ (GuHCl) of different concentrations has first been studied.	1
1072	Moreover, the dopaminergic and glutamatergic regulation of @PROTEIN$ gene activation by @COMPOUND$ was investigated.	1
1073	The acute @COMPOUND$-mediated activation of @PROTEIN$ gene was regulated by D1 but not D2 dopamine receptors.	1
1074	Activation of @PROTEIN$ gene may contribute to the @COMPOUND$-mediated synaptic and behavioral plasticity.	1
1075	Eukaryotes plus their archaebacterial sisters form the clade neomura, which evolved from a radically modified derivative of an actinobacterial posibacterium that had replaced the ancestral eubacterial murein peptidoglycan by N-linked @PROTEIN$, radically modified its DNA-handling enzymes, and evolved cotranslational protein secretion, but not the isoprenoid-@COMPOUND$ lipids of archaebacteria.	0
1076	Eukaryotes plus their archaebacterial sisters form the clade neomura, which evolved from a radically modified derivative of an actinobacterial posibacterium that had replaced the ancestral eubacterial murein @COMPOUND$ by N-linked @PROTEIN$, radically modified its DNA-handling enzymes, and evolved cotranslational protein secretion, but not the isoprenoid-ether lipids of archaebacteria.	1
1077	Increased apoptosis of a human salivary gland (HSG) cell line occurred only in the presence of @COMPOUND$ (LPS-) and interferon (@PROTEIN$)-gamma-stimulated human monocytic THP-1 cells, which was reversed when caspase-1 in THP-1 cells was targeted by siRNA.	0
1078	Reversible two-step unfolding of @COMPOUND$-human @PROTEIN$ : a (1)H-NMR relaxometric and circular dichroism study.	1
1079	Human serum albumin (@PROTEIN$) participates in @COMPOUND$ scavenging, the bound heme turning out to be a reactivity center and a powerful spectroscopic probe.	1
1080	Human @PROTEIN$ (HSA) participates in @COMPOUND$ scavenging, the bound heme turning out to be a reactivity center and a powerful spectroscopic probe.	1
1081	Here, the reversible unfolding of @COMPOUND$-@PROTEIN$ has been investigated by (1)H-NMR relaxometry, circular dichroism, and absorption spectroscopy.	1
1082	@COMPOUND$-Epac2-mediated activation of @PROTEIN$ in developing male germ cells: RA-RhoGAP as a possible direct down-stream effector.	1
1083	@COMPOUND$-@PROTEIN$-mediated activation of Rap1 in developing male germ cells: RA-RhoGAP as a possible direct down-stream effector.	1
1084	Taken together, our results, obtained with endogenously expressed proteins, are consistent with a @COMPOUND$/Epac2/@PROTEIN$-mediated signaling that could exert its action, among others, through RA-RhoGAP to promote the progression of spermatogenesis.	1
1085	Taken together, our results, obtained with endogenously expressed proteins, are consistent with a @COMPOUND$/@PROTEIN$/Rap1-mediated signaling that could exert its action, among others, through RA-RhoGAP to promote the progression of spermatogenesis.	1
1086	Cholesterol promotes basal and @COMPOUND$-induced ATPase activity of P-@PROTEIN$ (P-gp).	1
1087	@PROTEIN$, an intracellular sensor of bacteria-derived @COMPOUND$ (MDP) has been implicated as a key player in intestinal immune health and disease.	1
1088	@PROTEIN$ expression coupled with infusion of the IGF binding protein inhibitor @COMPOUND$ significantly prevented corticospinal motor neuron death 0.05), but did not promote corticospinal axon regeneration.	1
1089	Genotoxic effect of 2,4,6-@COMPOUND$ on @PROTEIN$ gene in zebrafish liver.	1
1090	However, these events were blocked by treatment with the antioxidant, @COMPOUND$ (NAC), as well as @PROTEIN$ overexpression.	0
1091	This analysis reveals @PROTEIN$ as major and unsuspected gates of @COMPOUND$+) entry that contribute, depending on context, to activation of transcription factors, apoptosis, vascular contractility, platelet activation, and cardiac hypertrophy, as well as to normal and abnormal cell proliferation.	1
1092	After MRI, one group of animals had BBB permeability measured in the WM with (14)C-@COMPOUND$, and another had Evans blue (EB) injected for fluorescent microscopy for MMP-2, @PROTEIN$, tight junction proteins (TJPs), and in situ zymography.	0
1093	After MRI, one group of animals had BBB permeability measured in the WM with (14)C-sucrose, and another had @COMPOUND$ (EB) injected for fluorescent microscopy for @PROTEIN$, MMP-9, tight junction proteins (TJPs), and in situ zymography.	0
1094	After MRI, one group of animals had BBB permeability measured in the WM with (14)C-sucrose, and another had @COMPOUND$ (EB) injected for fluorescent microscopy for MMP-2, @PROTEIN$, tight junction proteins (TJPs), and in situ zymography.	0
1095	After MRI, one group of animals had BBB permeability measured in the WM with (14)C-@COMPOUND$, and another had Evans blue (EB) injected for fluorescent microscopy for @PROTEIN$, MMP-9, tight junction proteins (TJPs), and in situ zymography.	0
1096	Effects of dissolved @COMPOUND$ tension and agitation rate on the production of heat-shock protein @PROTEIN$ 96 by MethA tumor cell suspension culture in stirred-tank bioreactors.	0
1097	Reactivity of @COMPOUND$ with the (4Fe-4S) cluster of @PROTEIN$ from Escherichia coli.	1
1098	The rate constant for the initial reaction between NO and the @PROTEIN$ (@COMPOUND$ is estimated to be (7.0+/-2.0)x10(6) M(-2) x s(-1) at 25 degrees C, which is approx.	1
1099	This review will focus on recent evidence that @COMPOUND$, @PROTEIN$ and neuropeptide Y act by converging on neuronal cyclic nucleotide-dependent pathways to alter the autonomic phenotype in both health and disease.	1
1100	This review will focus on recent evidence that @COMPOUND$, natriuretic peptides and @PROTEIN$ act by converging on neuronal cyclic nucleotide-dependent pathways to alter the autonomic phenotype in both health and disease.	1
1101	Glucocorticoid-activated GR repressed @PROTEIN$ gene induction by @COMPOUND$ (LPS).	1
1102	The purpose of this research was to enhance intranasal drug targeting to the CNS by incorporating a vasoconstrictor (phenylephrine (PHE)) into nasal formulations containing therapeutic @PROTEIN$ (hypocretin-1 (HC) or the dipeptide L-Tyr-D-Arg (D-@COMPOUND$)).	0
